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I Abstract 
Tight health budgets are increasingly strained in Low and Middle Income Countries 
(LMICs) through shifting burdens of disease, placing new constraints on how HIV is 
controlled. As HIV transitions from an acute to a chronic disease, control policies which 
potentially improve effectiveness, minimise cost or, both warrant investigation. 
Integration of HIV programs or services with other health system components is one 
such policy.  
Integration is a general term for processes of aligning two or more system components 
towards common goals. Alignment is in response to system inefficiency driven through 
differentiation of those components. Contention exists, however, as to how effective 
different integration modalities are within health systems. This is in part due to inherent 
methodological issues facing empirical evaluation of integration.  
Four issues limit the scope of evaluating the comparative impact of HIV integration 
modalities. Firstly, integration is unlikely to be randomised given it is often 
implemented fixed to health establishments with limited variation in how individuals 
access it. Secondly, integration is most frequently applied to places as opposed to 
individuals, which results in clustering. Thirdly, evaluation of integration is frequently 
performed ex-post meaning policy analysts have little control over the evaluation 
process. Finally, evaluation is complicated by contention around conceptualisations of 
integration itself and appropriate indicators reflecting differences in modalities being 
compared.  
This thesis aims to understand and address issues in evaluating integration. It 
primarily explores how methodological issues may be overcome through the combined 
use of quasi-experiments and MultiLevel regression Models (MLMs). Quasi-
experiments exploit aspects of study design to recreate some benefits of 
randomisation. A class of quasi-experiment, the Propensity Score (PS); created 
through regression is used to reduce measured systematic biases. MLMs are 
regression models which allow inclusion of cluster level information. PSs have 
traditionally been constructed using naïve, non-MLM regression. By instead 
constructing PSs using MLMs, known as a MLM-PS, non-randomisation and clustering 
may be simultaneously addressed. MLM-PS is sufficiently flexible to be applied ex-
post with relatively little information on policy assignment compared to other quasi-
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experiments. The MLM-PS approach is potentially able to overcome methodological 
issues inhibiting HIV integration evaluation. 
To address issues of selecting plausible indicators for evaluation a theoretical 
framework is constructed for the thesis. It builds upon existing work deconstructing 
comparative integration modalities mapping them across a standard framework for 
evaluating quality in health programs. Indicators are described as reflecting the relative 
impact of comparable integration modalities through plausible mechanisms of action.   
Feasibility of MLM-PS and the theoretical framework are explored through application 
to two case studies of HIV integration. Both case studies originate from an 
implementation of integrated HIV services in Peru. Integration in both case studies has 
been applied non-randomly and clustered at district level with evaluation conducted 
ex-post reflecting the common issues described above. 
The first case study examines the impact of increasing HIV and Antenatal Care (ANC) 
integration, on the use of essential testing services. MLM-PS is shown to demonstrably 
reduce bias while controlling for clustering and including important cluster level 
information in the PS. Using the method, increased integration is shown to be highly 
effective. The second case study examines the impact of HIV/TB integration on 
essential testing services. MLM-PS method is also shown to reduce biases 
incorporating control for clustering, while using conceptually different data. Using the 
method, higher levels of integration are shown to have mixed results. As a 
demonstration of robustness, different iterations of MLM-PS for both case studies are 
explored. Here the importance of using MLMs in the PS when clustering is present is 
also established. 
MLM-PS is concluded to be a useful pragmatic alternative when more robust methods 
are not available. It is flexible enough to be applied when data are limited, and little 
control is available over evaluation. It is suggested as a potential tool for policy 
analysts and policy makers to improve estimates of integration impact, or indeed other 
similar polices. This is with a view to strengthening evidence-based decision making 
on policies critical to the control of HIV. 
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1 Introduction; integration, impact evaluation and, thesis outline 
HIV1 is a leading cause of death and disability worldwide [5]. In 2010 it was the most common 
cause of death in people aged 15-49 and the tenth most common in children under the age 
of 5 [6, 7]. In the same year it was responsible for 3.44% of all mortality in Low and Middle 
Income Countries (LMICs) [7] accounting for 1.3 million deaths [6], 103,000 of which were 
children [8]. In many LMICs controlling the disease is a health systems priority [5]. 
Despite HIV’s relative burden the number of new infections and deaths from the disease are 
reducing [9]. Global incidence peaked in 1997 at 2.8 million new infections steadily declining 
in following years [9]. Decreasing incidence can largely be attributed to interventions such 
as the introduction and scale-up of Antiretroviral Therapy (ART) [10]. While incidence is 
dropping, prevalence is increasing as more People Living with HIV/AIDS (PLHA) increase 
their life-span [11]. For most PLHA today, HIV is a chronic disease [9]. Although encouraging, 
this shift necessitates that alternative control measures be devised which take into account 
the changing nature of the epidemic [11, 12]. 
HIV control increasingly requires the incorporation of policies focused on long term 
accessible services and sustainable management [12]. One such policy is the integration of 
HIV programs/services with other components of the health system [12-16]. Drawn from 
organisational theory, integration implies combining health system components towards 
common goals [17-19]. Integration is designed to derive system efficiency2 by overcoming 
barriers to optimal health system function. For the components involved this can improve 
effectiveness, reduce costs, or both [12, 13, 21-23].  
The term ‘integration’ describes a variety of processes for combining system components 
[13-17, 22]. Processes differ depending on the components integrated, why/how they are 
integrated and the context in which integration takes place [13, 14, 17, 24]. Integration is most 
useful as targeted towards specific inefficiencies [13]. Therefore modalities of targeted 
processes warrant evaluation to inform evidence-based policy.  
Evidence-based policy hinges on the best available methods for estimating impact [25-28]. 
Integration as a health policy however, has common problems which complicate its 
                                                          
1 HIV is used as a general term to refer to HIV/AIDS 
2 Where efficiency refers to technical efficiency defined as how far a system is minimizing the use of inputs in 
producing its chosen outputs [20] 
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evaluation. Firstly, integration is unlikely to be randomised [27-30]. Consequently, groups of 
individuals subject to comparative models of integration may systematically differ in other 
factors aside from the policy. This may bias estimates of policy impact. Secondly, integration 
is often only able to be applied to places as opposed to people [31]. This results in 
evaluations where data are organised hierarchically, known as clustering. This has 
implications for statistical methods used to estimate impact and increases the potential for 
bias at multiple levels [32-34]. Both issues are infrequently addressed in the empirical HIV 
integration literature as will be demonstrated in chapter 4 of this thesis. 
Non-randomisation and clustering are exacerbated by a common occurrence in policy 
evaluation in health systems. Policy evaluation often occurs ex-post [35]. This refers to 
evaluation which is conducted after the policy has been implemented. Conducting an 
evaluation ex-post limits the control which policy analysts have over many aspects of 
analysis [36].. Evaluating integration is also complicated a lack of clarity in how it is 
described.  This complicates the selection of appropriate indicators for evaluation [22, 37-40]. 
Given issues with potential bias, clustering and ex-post evaluation there is an opportunity 
for a middle ground in evaluating the impact of HIV integration3. It is a space for methods 
which do not hinge on randomisation, however, are still able to control for different classes 
of bias, incorporate clustering and be flexible enough to be applied ex-post. Overcoming 
these issues allows policy makers more confidence in the evidence presented on the impact 
of HIV integration.  
This thesis explores methods which may address issues limiting evaluation of integration, 
albeit with distinct assumptions and limitations. It reviews methods used for impact 
evaluation with non-randomised data and techniques used in the presence of clustering. 
The feasibility of a relatively novel combination of the two is explored. This is through 
application to two case studies of ex-post impact evaluations of HIV integration.  
This Chapter begins by introducing important concepts discussed throughout this thesis, 
followed by the context surrounding the case studies. Aims and objectives of the thesis are 
presented along with the scope of the research. Finally, the structure of the thesis is 
described.   
                                                          
3 Unless otherwise specified HIV integration is used as a general term to describe the integration of HIV services, HIV 
programs or HIV program components. This differentiation is further elaborated in Chapter 2. 
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1.1 Integration and health systems 
The term integration refers to a variety of processes of combining health system components 
[13-17, 22]. This variety leads to contention around definitions of integration, a [13-16, 41, 42]. 
Despite frequent use across a diversity of settings there is no current agreed definition of 
‘integration’ in the health systems context [15, 22, 41].  
The process of integration differs depending on the context which it is applied [43]. 
Resourced and highly responsive health systems may focus integration on teams or 
networks of individuals responding to individual patient needs [16]. In less resourced settings 
such as many LMICs, integration is more focused towards addressing program specific 
barriers which limit health system efficiency [13]. This thesis focuses on integration in the 
LMIC context. 
Integration in a health systems context can be broadly grouped into two categories [16]. The 
first relates to integration of  health services into other social sectors. An example being 
combining mental health and welfare services [44, 45]. The second relates to integration of 
two or more individual components or programs within the health system itself [16]. This  can 
range from entire programs combined at the national level to providing joint services to a 
single patient [16]. This thesis focuses on the latter category of integration.  
In response to contention in what health system integration entails various conceptual 
frameworks have been developed to describe different integration processes [13-17, 22]. 
These may differ depending on the structural component of the health system under which 
they fall or health system functions which they affect where structural components refer to 
the structures under which different health system functions are able to be performed [13, 
17, 46]. They may also differ across dissections of the health system, such as primary or 
secondary levels of care or different geographical sub-national units [15, 16, 47]. 
1.2 HIV integration 
HIV programs or services are priority health system components for integration in many 
LMICs [12, 48, 49], for three key reasons. Firstly, HIV is linked to other health conditions such 
as Tuberculosis (TB) [12, 46, 50]. This is through synergies in virus/bacteria lifecycle and 
through similar service delivery models [51, 52]. Integration of HIV program components and 
services with other diseases that present as other frequent co-infections with HIV (such as 
TB) can benefit the delivery of health services targeting both diseases [53].  
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Secondly, as with most infectious diseases, HIV has distinct routes of transmission. HIV 
transmission may occur at various stages of infection, including when an infected person is 
unaware they have the disease [9]. Integration may provide an opportunity for early detection 
of HIV amongst those engaging with the related services [54]. This has the benefit 
maximising interactions with the health system to prevent further morbidity or infection, such 
as early detection of HIV in pregnant women [55]. This is important for population level 
control of the disease [56]. 
Thirdly, HIV is now largely a chronic condition [11]. Many PLHA can now be hopeful of a 
potentially long life, albeit with a manageable chronic disease [11]. Equally promising is that 
the availability of ART has not been confined to higher income countries [6, 10, 57]. Despite 
the success of ART, HIV epidemics remain and many infections go untreated or 
undiagnosed, particularly in LMICs [58]. Consequently pressure is mounting on health 
systems and policy makers to find efficient methods of preventing, diagnosing and treating 
HIV infections within the context of tightening health budgets and competing disease 
priorities [59]. HIV integration is being investigated as an effective strategy to cost-effectively 
optimise health system performance [12, 60-62]. 
HIV integration generally relates to combining HIV and other system services/program 
components. Alternate components to be integrated will usually have an intrinsic link to HIV. 
Such programmatic areas, in LMICs, refer to disease focused programs such as HIV or TB 
or population focused programs, such as Maternal and Child Health (MNCH) [13, 14, 17, 24, 
63].Two consequent program groupings of integration of HIV in primary health services 
recommended by the World Health Organization (WHO) are: (1) HIV services integrated 
with Antenatal Care (ANC) [61, 64]; and (2) the integration of HIV and TB services [65].  
Across the empirical literature, integration in primary care is described as the combination 
of two or more program/service areas. For example, HIV integrated with TB, or nutrition 
programs integrated with MNCH. This may also include describing integration of a single 
service area into primary care in general, common when decentralising services from higher 
levels of care to primary [66, 67, 428]. This thesis refers to this dimension of integration as ‘the 
integration complex’. For example, integration of HIV and TB services is termed the HIV/TB 
integration complex. 
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1.3 Impact Evaluation 
To assess if policy such as HIV integration has achieved its objectives, its’ impact should be 
evaluated.  Randomised control trials (RCTs) are the current standard for assessing the 
impacts of medical treatments [68-70]. Traditionally they have been the realm of medicine 
and physical sciences but are increasingly used in economic, health systems, and health 
services research [68, 71]. Randomisation is used to yield an unbiased estimate of treatment 
effects by  minimising the effect of systematic differences  or biases between policy and 
control groups [425]. These biases are any factor which might influence a measured outcome 
between policy and control which is not the implementation of the policy itself [68, 71]. RCTs, 
however, are difficult and costly to perform when used to investigate policy, particularly at 
the national or regional level. RCTs applied to policy are also often subject to ethical 
constraints over and above standard experiments [72].  
When RCTs are not feasible, quasi-experiments can be exploited as pragmatic methods of 
evaluating the impact of programs or policies [71]. Quasi-experiments can be used to attempt 
to re-create benefits of randomisation by addressing different forms of endogeneity [73, 74]. 
Various quasi-experimental approaches exist that differ on study design, statistical 
techniques used and requisite data. A common technique used to exploit quasi-experimental 
study design used throughout this thesis is conditioning on the Propensity Score (PS). This 
involves using measured covariates to create similar distributions of potential confounding 
factors between treatment groups attempting to recreate some of the benefits of 
randomisation. PS is expanded upon further in Chapter 2. 
All techniques which are used to exploit quasi-experimental study designs are subject to 
strong assumptions and will have distinct limitations. The primary pre-requisites for valid 
quasi-experimental design are separate treatment and control groups, both with a 
measurable indicator of impact [70]. Aside from these, different techniques will also only be 
useful given certain data characteristics or study designs. Quasi-experiments are often 
exploited as a next best alternative if randomisation is not possible, as such they remain 
controversial particularly for claims of causality. This is due to their ability to claim that both 
observed and unobserved confounding factors are theoretically balanced in the absence of 
randomisation without strong assumptions. For example, conditioning on the PS is only able 
to balance based on measured covariates and claims of causality must rely on an 
assumption of no un-measured confounders. Despite their shortcoming quasi-experimental 
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methods allow stronger claims of causality over study designs which do not consider 
selection and other biases.  
Both randomisation and quasi-experimental methods revolve around establishing a valid 
counterfactual [72, 75]. This refers to a valid comparison of what may have occurred if the 
same individual both was and was not subject to policy. This is clearly impossible however; 
a counterfactual scenario may be created as best as may be likely through randomisation 
or situations which mimic it. In doing so, baseline characteristics may be evenly distributed 
between policy groups limiting their effect on outcomes. [76-80]. Establishing a valid 
counterfactual implies nullifying the effect of  confounders between policy groups, allowing 
causal comparison of policy [72, 75]. 
1.4 Multilevel Models and Impact Evaluation  
When conducting an RCT, the traditional approach has been to provide treatment directly 
to individuals. Most health policy, particularly relating to provision of services, cannot be 
effectively provided this way. Instead it is provided indirectly to the individual through 
application at a higher organisational level such as the district or health facility [81].  
Data on individuals drawn on a health policy applied to multiple higher units will have an 
inherent hierarchical structure. Such data are often termed clustered or multilevel, with the 
cluster referring to the higher unit. Clustering complicates the use of impact evaluation 
techniques that rely on regression [82]. This is due to the assumptions inherent in performing 
naïve, or standard non-multi-level regression, which are violated under clustered data. 
Further complicating clustered impact evaluation is the possibility of individuals sharing 
similarities within, but not across, clusters [83]. If multiple clusters are present in the data, 
some clusters may share similarities, as with individuals [32-34, 82], examples being 
population size or district HIV incidence. These may create measurable and unmeasurable 
biases at the level of the cluster [33]. Contextual information, such as cluster level similarities, 
has been shown to affect the ability to implement integration and its success [43]. 
To address these issues, one may make use of multilevel regression models (MLMs), 
specifically those incorporating fixed and random effects, at different stages of impact 
evaluation when warranted. These models, among other possible approaches, allow the 
assumptions of naïve regression to be relaxed to account for clustering [32-34, 82]. MLMs 
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also allow cluster level biases to be controlled for in certain situations [32-34, 82]. How this is 
applied depends on how treatments are assigned to clusters. 
1.4.1.1 Treatment assignment mechanisms 
Distinctions can be drawn between two types of treatment assignment in the presence of 
multiple clusters. Firstly, individuals may be assigned treatment and control within each 
cluster. This results in clusters with both treatment and control individuals and can be termed 
‘within cluster treatment assignment’ [32-34].  
Secondly, entire clusters are assigned to treatment or control. This results in clusters which 
have entirely treatment or entirely control observations [32-34]. This treatment assignment is 
here termed ‘cluster level treatment assignment’. The distinction between different clustered 
treatment assignment mechanisms is important when considering the specification of MLMs 
used for evaluation.  
1.4.2 Multilevel impact evaluation models 
Recent research has explored the use of MLMs and conditioning on the PS To 
simultaneously address clustering and selection bias [32-34, 82]. Through the combined use 
of MLM and PS selection bias may be controlled at both individual and cluster level, while 
also allowing the proper use of regression in the presence of clustering. Multilevel Propensity 
Score Model (MLM-PS) literature has focused primarily on impact evaluation of within cluster 
treatment assignment. This thesis extends upon this research to use MLM-PS to address 
cluster level treatment assignment.  
1.5 HIV Integration Case Studies 
Two case studies are performed as part of this thesis to explore the feasibility of MLM-PS in 
evaluating HIV integration. They both revolve around implementation of comparable 
modalities of integrated HIV services in Peru.  
HIV in Peru is a significant public health issue warranting exploration of optimal service 
delivery models. The country is in the midst of a concentrated HIV epidemic [84], defined by 
relatively low HIV prevalence in the general population but high prevalence in key risk 
groups [84, 85]. Concentrated epidemics require constant monitoring and control strategies 
geared towards prevention to prohibit increased spread of the disease to the general 
population [86, 87].  
8 
 
Integration of HIV with other health services has the potential to strengthen 
services/program delivery allowing improved control of the disease. Evaluation of service 
integration as a health systems policy is important and relevant to policy makers in the 
country [88].  
Until 1996 HIV services in Peru were limited [89, 90]. After scale up of the HIV program in 
1996 voluntary HIV testing was introduced for key populations, including pregnant women 
and TB patients, however, restricted to secondary facilities [91]. From 2005 onwards 
universal access to ART for all PLHA has been pursued with help from Global Fund to Fight 
AIDS, Tuberculosis and Malaria (GFATM) [92]. Following 2005 different combinations of HIV 
services have been integrated into primary facilities throughout the country. In line with 
GFATM strategy [93], select primary facilities have integrated HIV services, including ART 
[84, 92, 94]. In the remainder of primary facilities throughout the country basic prevention and 
testing, but not ART, have been integrated [84, 92]. This has resulted in two HIV integration 
modalities which are able to be compared. Importantly for evaluation, the selection of sites 
to integrate all services has been relatively arbitrary, although non-random. 
Drawing from common terms used primarily within the HIV service integration literature [62], 
this thesis specifies the two different modalities as ‘partially integrated’ and ‘fully integrated’. 
The partially integrated model has only some HIV services co-delivered with all services of 
another program at a single facility. The fully integrated model has all services of both 
programs co-delivered at the same facility by the same health staff. As of 2005 there have 
been twelve fully integrated primary facilities. This contrasts with the rest of primary facilities 
throughout the country which have had only partially integrated services [84, 92]. 
Two HIV integration complexes important in the Peruvian setting are HIV/ANC and HIV/TB 
[88, 92, 94]. HIV/ANC is important as it is the primary platform for preventing Mother To Child 
Transmission (MTCT) of HIV [88]. It also plays a large role in monitoring and control of the 
disease [88]. In line with global recommendations [95]. HIV/TB is important due to a relatively 
large TB epidemic within the country, characterised by high incidence in the general 
population and high mortality rates in high TB mortality risk groups [96, 97]. These two 
integration complexes within Peru form the two case studies presented within the thesis 
used to explore MLM-PS. 
1.5.1 Case study 1: Comparing integrated HIV/ANC service modalities in Peru 
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As noted above, since 2005 two different delivery models of integrated HIV/ANC services in 
primary facilities have existed in Peru; partially and fully integrated. The partially integrated 
modael is standard for most primary health facilities. In this model primary facilities provide 
all ANC services but only initial HIV testing. All other services must be sought through 
referral to higher facilities [91, 98] [99]. The fully integrated model is only available at select 
primary health facilities throughout the country. The HIV/ANC case study estimates the 
marginal impact of fully over partially HIV/ANC integrated services in primary facilities. 
1.5.2 Case study 2: Comparing integrated HIV/TB service modalities in Peru 
As with HIV/ANC two different integration service delivery models for HIV/TB exist in Peru 
in primary care facilities, fully and partially and integrated. The partially integrated model has 
been the standard model throughout the country since 2005. Since this time all health 
facilities in Peru have technically provided free HIV testing and counselling for all confirmed 
TB patients. Following referral, higher facilities have offered HIV confirmatory tests for TB 
patients [84, 100] [101]. The fully integrated model has been implemented in select facilities 
throughout the country.  In these, all HIV services have been made available co-located with 
all TB services in primary health facilities [84, 100]. The HIV/TB case study estimates the 
marginal impact of fully over partially HIV/TB integrated services in primary facilities. A 
summary of the integrated service delivery models by case study can be seen in Table 1.1 
below. 
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Table 1.1. HIV/ANC and HIV/TB service delivery modlities in Peru 
  Services in 
Primary care 
Available 
   
Services in 
Primary care 
Available 
Partially integrated setting   Fully integrated setting 
HIV/ANC 
ANC check Yes 
HIV/ANC 
ANC check Yes 
HIV rapid initial test Yes HIV rapid initial test Yes 
HIV confirmatory 
test No 
HIV confirmatory 
test Yes 
ART No ART Yes 
HIV/TB 
Tuberculosis tests 
and treatment Yes 
HIV/TB 
Tuberculosis test 
and treatment Yes 
HIV rapid initial test Yes HIV rapid initial test Yes 
HIV confirmatory 
test No 
HIV confirmatory 
test Yes 
ART No ART Yes 
Notes: The data in the table are derived from the structures of interventions currently 
available in Peru informed by the National TB program [84, 92]  
1.5.3 Evaluation of HIV integration in Peru 
The implementation of integrated facilities within Peru presents an opportune situation for 
exploring how MLM-PS can deal with common issues in HIV integration evaluation. As 
mentioned above only twelve primary facilities have been fully integrated. As will be 
discussed further in Chapter 2, the selection of these facilities to be fully integrated has been 
relatively arbitrary, however not random.  Comparisons of integration models within the 
country, without appropriate control, are likely to be biased. 
Within Peru, individuals can access primary public facilities only within the area where they 
reside. Areas are determined by physical location from the facility and the district where the 
facility is located. Multiple facilities are frequent in a single district. Various districts exist 
throughout the country which contain only fully or only partially integrated facilities. The 
decision to fully integrate facilities has been made at the level of the district. Integration can 
therefore be considered applied at the level of the cluster. Evaluation of HIV integration has 
not been conducted or planned prior to implementation. In this thesis it is conducted ex-post. 
Data informing the evaluation has been drawn from alternate sources and not collected as 
an aspect of implementation. 
1.6 Aims and Objectives of the thesis 
The general aim of this thesis is to explore methods for evaluating the impact of HIV 
integration, given common issues of an inability to randomise, frequent clustering, and ex-
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post evaluation. Methods are explored using two case studies, each comparing two different 
models of HIV integration and using different data sources which represent common themes 
in the empirical literature.  
Under this general aim, three specific aims relating to six objectives are pursued. These are: 
1) Analyse and assess concepts and methods for evaluation surrounding HIV 
integration in the literature. 
Objective 1. Develop a theoretical framework for understanding and 
comparing key concepts around HIV integration in primary facilities in relation 
to selection of indicators for evaluation. 
Objective 2. Examine the extent to which studies measuring effectiveness of 
HIV integration appropriately account for selection bias and clustering. 
 
2) Identify methods for evaluating the effectiveness of HIV integration as a health policy 
able to be applied ex-post. 
Objective 3. Define methods for measuring impact of policy such as HIV 
integration which account for selection bias, clustering and are sufficiently 
flexible to be applied ex-post with little information on treatment assignment. 
 
3) Test identified methods estimating impact of HIV service integration given key issues 
around policy evaluation and data limitations, exploring potential reductions in bias 
and control for clustering. 
Objective 4. Explore the feasibility of identified methods through impact 
evaluation of HIV/ANC service integration. 
Objective 5. Explore the feasibility of identified methods through impact 
evaluation of HIV/TB service integration. 
Objective 6. Explore the robustness of the methods and data used to evaluate 
HIV service integration. 
These objectives are designed to explore and fill a gap in the literature around empirical 
evidence for HIV integration. This is to in turn optimize the evaluation of HIV integration in 
line with key pragmatic issues.  
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1.7 Thesis scope 
The thesis covers a broad range of topics across public health, health systems and applied 
econometrics. Writing is focused on applicability to a suitably broad audience as such some 
concepts are explained intuitively in the first instance. Despite the multidisciplinary approach 
the research and contributions of the thesis fall within a limited scope described below. 
Impact evaluation methods in this thesis are explored through the lens of HIV integration. 
Impact can be evaluated in relation to improved outcomes such as mortality/morbidity, 
service use, or reduced costs. Given limitations of the data use to form case studies, the 
thesis focuses primarily on outcomes relating to service use and mortality/morbidity. 
As will become apparent, modalities of integration differ substantially between LMICs and 
upper income countries with the latter placing a greater focus on patient satisfaction and 
outcomes for complicated cases [14, 22]. Integration in LMIC settings is often focused on 
increased coverage and greater efficiency, particularly in the case of HIV [102]. Results 
drawn from this thesis are most relevant to LMIC settings.  
Notwithstanding this, the research adds several valuable insights into the evaluation of HIV 
integration as a health system strengthening policy. 
Firstly, this thesis provides a framework for selecting indicators for evaluation of HIV 
integration in LMIC settings. Various frameworks for conceptualising integration are 
reviewed as part of the thesis, most of which are focused on defining integration models and 
discussing stakeholder perspectives. The framework constructed for the thesis presents a 
focus on mapping quantitative indicators for HIV integration impact and consequent 
evaluation methods, novel in the literature.  
Secondly, the thesis elucidates the current state of evidence for HIV integration in primary 
facilities in LMIC settings. This is achieved through a systematic review of the empirical 
literature. The review focuses on the reliability of analysis methods used when evaluating 
impact. To the author’s knowledge this is the only review focusing on methods for 
quantitatively evaluating HIV service integration. 
Thirdly, this thesis explores a relatively novel method, although not developed by the author, 
for evaluating health policy in the presence of clustered treatment assignment. This method 
has yet to be applied when evaluating integration and health policy in general. The 
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successful application of these methods may suggest their utility in building the evidence-
base for HIV integration.  
Fourth this research evaluates the impact of both HIV/ANC and HIV/TB service integration 
in Peru. To the author’s knowledge this is the first HIV service integration evaluation for 
these complexes in Peru.  
1.8 Thesis outline 
The thesis is comprised of nine Chapters and is structured as follows: Following the 
introduction and background provided in Chapter 1, Chapter 2 is a review of key literature 
around important concepts explored throughout the thesis. These include integration, impact 
evaluation and the context for the case studies. Key limitations surrounding methods for 
rigorous evaluation of HIV integration are introduced. An important gap in the theoretical 
integration literature is also described.  
Chapter 3 addresses a gap in the literature for mapping theoretical constructs and 
definitions of integration processes to indicators which can be used for evaluation. Here a 
novel framework is presented. It is designed to link established categorisations of different 
integration modalities to indicators which can be used for impact evaluation. The framework 
is applied to the two case studies used in the thesis to derive appropriate indicators for 
evaluation which are later used in case study Chapters 6 and 7. 
Chapter 4 is a systematic review of methods used to evaluate the impact of HIV integration. 
The systematic review is performed with the aim of determining the breadth of key 
methodological limitations in empirical literature of HIV integration. These limitations relate 
to selection bias, clustering and ex-post evaluation.  
Chapter 5 provides a discussion around methods for evaluating HIV integration considering 
common limitations. MLM-PS is explored in relation to selection bias when RCTs are not 
feasible, clustering is present, and evaluation is being conducted ex-post. The Chapter 
discusses the theoretical basis of how MLM-PS may address these limitations in evaluating 
HIV integration. It also qualitatively compares MLM-PS to other quasi-experimental methods 
and presents limitations and assumptions of the method. 
Chapter 6 is an application of MLM-PS to the case study of comparative models of HIV/ANC 
service integration. Here the method is applied to a cross sectional survey data set which 
represents the key limitations inhibiting rigorous evaluation of HIV integration. The feasibility 
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of using MLM-PS is explored when attempting unbiased impact estimates. Discussion 
around implications for the methods and of integration is provided. 
Chapter 7 is a further application of MLM-PS to a second case study using conceptually 
different data. It involves exploration of the method when attempting unbiased estimates of 
HIV/TB service integration impact using routine surveillance data. The case study also 
represents the key limitations of HIV integration however, with fundamentally distinct data. 
Application of MLM-PS is followed by a discussion around the findings.  
Chapter 8 explores the robustness and sensitivity of the results found in the two case 
studies. It explores potential misspecification during steps used in MLM-PS. It also tests the 
sensitivity of subsequent findings to potential unmeasured bias. The Chapter provides a 
deeper discussion around theoretical and practical aspects of applying MLM-PS for 
evaluating HIV integration, tying practice to theory. 
Finally, Chapter 9 presents a discussion around HIV integration in light of results from the 
case studies. The Chapter brings together the feasibility of MLM-PS to address limitations 
in evaluating HIV integration. This is tied to a discussion of key findings arising from the 
thesis. The Chapter then describes how aims and objectives have been met and provides 
consequent recommendations. Limitations of the research and areas of further research are 
presented followed by final conclusions. References and supporting appendices are 
provided at the end of the thesis. 
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2 Review of key literature; HIV integration, impact evaluation case studies 
The following Chapter is a literature review of important concepts relevant to the exploration 
of methods for HIV integration evaluation presented in this thesis. As highlighted in the 
introductory Chapter, four key issues inhibit evaluation of HIV integration. These are: the 
term integration itself, covering a broad array of concepts complicating indicator selection; 
likely inability to randomise integration; integration frequently being clustered; and 
evaluation of integration frequently being conducted ex-post. This Chapter gives 
background to each problem and consequent responses explored throughout this thesis.  
The review begins by discussing the theoretical underpinnings of integration and how 
individual integration modalities may be defined. It then differentiates and discusses HIV 
integration as a sub-type of health system integration. A background on impact evaluation 
methods is then provided. Here different methods are introduced and briefly discussed in 
relation to their relative applicability in addressing problems of non-randomisation, clustering 
and ex-post evaluation. Here a brief background to Multilevel Propensity Score Models 
(MLM-PS) is also provided. Following this, important context for the case studies is 
presented. 
2.1 Background to integration from organisational theory 
Integration in health systems has its roots in organizational theory [17]. The theory describes 
approaches to analysis of complex organisational systems which are in turn comprised of 
separate but interconnected components. Integration refers to a variety of processes of 
increasing collaboration of different organisational components within or across systems 
that seek to interact with one another [16, 18, 19]. Common goals are pursued by elements 
within the system, each element playing a complementary role in their tasks or functions [17, 
103].  
Organisational systems quickly form sub-systems through segmentation as they become 
increasingly complex and surrounding contexts or environments more unpredictable. In 
response organisations may seek to adapt, creating flexibility in structures and in norms, 
behaviours, attitudes or interests of organisational members [18, 19]. Such flexibility however 
tends to result in inefficiencies and a lack of effectiveness when conducting common tasks. 
This process is termed differentiation of organisational structures. It will often necessitate 
integration of components for optimal system function. Integration can therefore be 
considered a process of increasing existing collaboration among system components to 
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achieve unity of effort in response to differentiation driven by environmental demands [18, 
19]. 
Integration is not always ideal as differentiation allows, in certain circumstances, 
organisations to achieve goals [17, 24, 104]. Successful organisations will therefore be those 
able to find an effective equilibrium between integration and differentiation. The challenge in 
unifying people and structures involved in organisations towards common goals between 
integration and differentiation is a fundamental tension in organisational theory [17, 104]. 
2.2 Integration in health systems 
Organisations within the private sector generally target goals towards profit maximisation for 
primary stakeholders such as shareholders [17]. A singular goal such as this makes targeting 
integration relatively straightforward. Health systems, as organisations, however, tend to be 
more complex with a more diverse set of stakeholders and consequent goals [17, 105, 106]. 
Health systems seek to balance population health, social and financial risk protection and 
consumer or patient satisfaction [17, 90, 106-109]. Implementing integration in a health 
systems setting is therefore a multifaceted process.  
Given the multiplicity of goals, there is little consensus on a singular definition of integration 
within a health systems context [15, 22, 41]. This is despite integration becoming an 
increasingly significant topic in light of resource constraints and shifting burdens of disease 
[12]. A sample of some more common definitions can be seen in Box 2.1 below.  
Health system integration is applied in different ways across a variety of health system 
structures and functions [13]. In practice it is not a singular innovation, but a variety of 
processes which are linked by a common purpose of reducing system differentiation [14]. 
Integration modalities may have differing effects on the health system and therefore warrant 
comparison and evaluation [17].  
Applying integration in health systems has a wide range of connotations. Such ambiguity 
poses problems for evaluation. Modalities of integration under evaluation need be 
sufficiently specific to be able to provide reasonable comparisons. Without explicitly 
describing what is being evaluated, it is possible that two fundamentally dissimilar processes 
may be compared. This is analogous in medical research to comparing the relative effect of 
two antibiotics, without explicitly stating their intended purposes, intended patient groups or 
17 
 
modes of action. To adequately evaluate integration for decision making, the specific 
process under evaluation need to be articulated [24].  
 
2.2.1 Health system barriers and integration 
Integration is generally applied in response to a perceived need for improved efficiency 
and/or effectiveness within the health system [16]. This is driven by environmental factors 
which alter population health needs, shift in disease burdens, or increase differentiation and 
compartmentalisation of organisational components as the system grows [15, 110].  
In LMICs integration is also tied to historical precedents which have resulted in vertical or 
non-integrated system components [24, 90]. Verticality, which is analogous to differentiation, 
entails acting, to some degree, in isolation from other components of the health system [111], 
such as disease specific programs funded by external bodies. Vertical components or 
programs may arise through necessity in the face of acute disease specific circumstances, 
such as a rapid response to an epidemic. They may also arise due to weakly developed 
general health services [24, 90].  
Integration in LMICs is commonly designed to bring vertical components towards greater 
interaction and streamlining with the rest of the health system [24]. As with differentiation in 
organisational theory, there may be certain situations when a vertical component may be 
beneficial, such as reducing community stigma for a specific disease [112]. However, most 
often vertical programs may use resources less efficiently resulting in lessened quality and 
cost-savings due to lost opportunity within the system [24, 90]. Vertical system components 
Integrated health services as a “process of bringing together common functions within and between 
organisations to solve common problems, developing a commitment to shared vision and goals and 
using common technologies and resources to achieve these goals” [1] 
Integrated health services: “The management and delivery of health services so that clients receive a 
continuum of preventive and curative services, according to their needs over time and across different 
levels of the health system.”  [2] 
Integration “a process where disease control activities are functionally merged or tightly coordinated 
with multifunctional health care delivery.”[3].  
Integration “a process that involved creating and maintaining over time, a common structure between 
independent stakeholders (and organizations) for the purpose of coordinating their interdependence in 
order to enable them to work together on a collective project” [4]. 
Box 2-1 Selected definitions of integration in health systems 
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may lead to health services becoming expensive, isolated and unresponsive to patient 
needs [14].  
Losses of efficiency driven by verticality are described in this thesis as barriers to supply or 
demand within the health system [113]. Supply barriers limit the capacity of a health system 
in delivering quality and cost-effective care [114]. Demand barriers reduce the demand for 
necessary interventions causing avoidable mortality, morbidity and further cost to the system 
[115]. Most applications of integration are intended to overcome such barriers by brining 
functions between components of the health system together. In turn streamlining higher 
quality care at a lower cost and maintaining or improving recipients’ health and satisfaction 
[116]. The goal of an integration modality can be thought of as the benefit achieved from 
overcoming a system barrier. Integration for the purposes of evaluation can be defined by 
the functional process used to overcome a structural barrier to achieving a shared goal 
between system components.  
2.2.1.1.1 Defining barriers based on system structures 
Barriers caused by verticality differ as experienced by different constituent parts which make 
up the health system. Health systems are composed of building blocks described by the 
WHO as relating to: governance, financing, service delivery-including human resources, and 
information systems [14, 117]. Under each building block lie structures which underpin the 
various functions of a health system. Governance structures include the organisational and 
regulatory framework surrounding the health system. Financing structures are the sources 
of funding for health system goals. Service delivery structures relate to infrastructure, 
resource and human resource allocation within the system. Information system structures 
involve technology, communication, and reporting within the system [13, 17].  
Structures of two system components may be vertically aligned to one another causing 
barriers towards achieving common goals. An example may be TB and HIV programs, which 
share a common interest in efficient delivery of services to patients with comorbidity, 
however, are inhibited by separate infrastructure. Here the barrier is defined by the building 
block: service delivery, the structure: infrastructure, and the system components: the TB and 
HIV programs. Further example barriers for each system structure can be seen in Box 2.2 
below.  
19 
 
 
 
 
2.2.1.1.2 Defining integration modalities based on system functions 
In response to barriers imposed by verticality, integration may be employed as a process of 
aligning health system functions [13, 17]. Functions refer to the unique set of actions 
performed by the health system under each building block [13, 17]. Governance functions 
include: strategic and operational planning, accountability, regulation, and performance 
management.  Financing functions: include pooling of funds and provider payment 
mechanisms. Service delivery functions include: training and development of human 
resources, procurement and distribution of drugs and medical supplies, and care 
pathways/provision of interventions. Information systems functions include: data 
management involving collection; analysis and dissemination; and monitoring and 
evaluation of program activities and impact. 
By bringing together functions of two system components, the system can be streamlined 
towards a shared goal [13]. An integration modality can therefore be defined by the process 
taken to coordinate health system functions between system components in response to a 
structural barrier. Continuing from the previous example vertical TB and HIV services may 
be integrated through aligning of care provision pathways such as through formal referral, 
Governance structures: Two vertical programs which share common goals, but 
which act in isolation due to inadequate formal planning networks.  
Financing structures: Two related programs requesting funds individually losing the 
opportunity for: shared funding, fungibility, and the opportunity to pool financial 
resources.  
Service delivery structures: Various barriers may exist affecting both the supply and 
demand for essential services such as drug stock outs, lack of staff, lack of staff 
training, lack of sufficient avenues for service delivery, and inefficiencies in logistic 
networks.  
Information system structures: An example barrier is a lack of shared indicators for 
programs which may function more efficiently when acting jointly  
 
Box 2-2 - Example barriers caused by vertical system components 
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or through co-location of services. In this example modality is defined by the system building 
block: service delivery, the function: care provision pathways, the process: referral or co-
location, and the system components: TB and HIV programs.  It can also be defined by the 
barrier which the specific integration modality is designed to respond to, in this case 
infrastructure. Overall these describe the specific integration modality. Further examples of 
integration modalities across health system functions can be seen in Box 2.3 below.  
Integrated system functions will involve a range of interactions of increasing intensity 
between health system components [46]. The lowest, null, level of integration involves no 
formal interaction. The weakest interaction involves a series of unstructured interactions 
such as referrals or cooperation/guidelines on interactions, however not necessarily in a 
shared goal-oriented manner with separate program objectives, structures and/or functions. 
An intermediate state of integration may involve goal-oriented interactions between 
programs to address related health issues, sharing information or implementing activities, 
however with separate program objectives or structures/functions. Finally, the highest level 
of integration may be merging two programs together along all structures or functions [17]. 
Influencing how integration is both defined and evaluated is the context in which it is applied. 
2.2.1.2 Importance of context and stakeholders in defining integration 
modalities 
Context may involve the interplay between demographic, economic, political, legal, 
ecological, socio-cultural and technological factors surrounding the health system [13]. 
These contextual factors are important in facilitating the adoption of a targeted integration 
of an intervention [13]. For example, the process of integration between HIV and TB 
programs or services will differ depending on the relative size of both epidemics. Equally 
integration will be limited in the absence of political will favouring it [2]. The economic context 
directs the purpose of integration towards cost savings, improved effectiveness or both.   
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Context may also include stakeholders and their influence on the integration process. 
Stakeholders generally consist of actors, institutions and individuals involved in the broad 
context of the adoption of integration [13]. Examples are policy makers, health workers, 
managers and other personnel involved in the functioning of the health system. They may 
also include patients, patient groups, affected communities and other entities who are 
recipients of the health system changes. Finally, stakeholders may be those who are 
adjacent to the former two groups such as civil-society organisations, religious authorities 
and NGOs, among others [14]. Each stakeholder may have different perceptions of benefits 
and risks for integration. They may envision different purposes in turn shaping the process 
itself [13]. 
 
 
2.2.2 Integration across different dissections of the health system 
Health systems are large complex organisations which can be dissected into various sub-
sections. These include national/sub-national levels, functional levels, and/or levels of care 
within the system. Integration modalities differ across these dissections as described below. 
Governance functions: Integration along these functions may involve joint planning and 
goal setting between programs and a consequently integrated accountability framework. 
It may also involve joint regulation relating to specific co-morbidities, for example the 
combined use of HIV/TB treatment.  
Financing functions: Integrated funding may be performed at national or sub-national 
levels through budget requests. Integrated and pooled funds allow flexibility in how they 
are administered in line with common goals.  
Service delivery functions: An example of integrating human resource functions may 
involve training on co-morbidities, such as HIV/TB. This is to be able to effectively 
recognise and treat both diseases. Procurement and distribution involves aligning logistic 
chains for multiple programs. Care pathways are the physical location of services and 
integration involves aligning how patients access services from multiple programs.  
Information systems functions:  Integrating data management may involve using joint 
indicators for shared goals, such as the frequency of HIV tests being offered to TB 
patients. It may also involve information sharing between programs. 
 
Box 2-3 - Example integration modalities, by health system function 
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2.2.2.1 National and sub-national integration 
Health system integration is implemented at different physical locations dependent on 
system structure and level of decentralisation. It can be targeted nationally or at various sub-
national units at which the system operates, such as community, local (or facility), district or, 
region. The process of integration will differ dependent on where it is applied [65, 118]. For 
example, an integrated planning strategy for two interrelated programmes may involve joint 
budget making between two or more program areas nationally. Alternatively, it may involve 
decision making decentralised to the local level on a needs basis [24, 428]. The fundamental 
process, joint budget making, is essentially the same across both levels; however as a 
process differences will exist in how it is implemented [14]. 
2.2.2.2 Hierarchies of health system function 
Health systems are not comprised of health services or health professionals acting in 
isolation. They are held together by infrastructure, governance and financing structures [16]. 
In this way health systems can be described in terms of hierarchies of functions. Integration 
modalities differ depending on the level at which they are applied. 
As described by Valentejn et al [47] integration can be performed at three levels relating to 
the health system: micro, meso and macro. The macro level describes the overarching 
financing and governance infrastructure around health care. Integration at this level of the 
health system may involve joint strategic program decision making or joint budget allocation 
[15, 16]. 
At the meso-level, integration refers to the networks which individuals in different service 
areas or disciplines use to interact. Integration at this level may occur through formal or 
informal networks and training provided for professionals working within the joint services. 
It may also occur through informal expansion of these networks following integration at other 
levels [46]. The micro level refers to the services or service sites at which the patient interacts 
with the health system. A common example of micro level integration involves joint services 
being provided in-concert to a single patient [47]. 
2.2.2.3 Levels of care 
A final dissection of the health system involves the organisation of levels of care within the 
system. System levels relate to the availability of services directly to the public or with 
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restricted availability through referral [62]. The terms commonly used to describe the 
hierarchy are primary, secondary and tertiary care.  
Most integration models within the literature focus on health services as organisations within 
or towards primary care [62, 119]. This is in part due to primary care forming the cornerstone 
of most health systems. Primary care is the primary contact and entry point into the health 
system and most often provides comprehensive, continuous and coordinated care [120].  
Integration does not only occur in primary care. Integrated secondary or tertiary care focuses 
on highly responsive teams of medical professionals, often within hospitals, who interact to 
provide comprehensive care for a single patient [16]. Integration may also occur between 
levels. For example the connection of primary services to secondary through referral is often 
considered integration [16]. 
2.2.3 Limits of Integration and the need for evaluation 
Stemming from organisational theory a balance needs to be struck between integration and 
differentiation when applying it to complex systems. At one extreme a highly segregated 
health system with multiple vertical programs and services acting in isolation will be unable 
to provide responsive care. It runs inefficiently due to an inability to share resources across 
system components [24, 90]. At the other extreme an overly interconnected health system is 
unable to function efficiently with each care decision requiring input and consideration from 
multiple actors. Many unnecessary costs are incurred and health provider time is used 
unproductively [16]. Integration should be a targeted goal-oriented process that considers 
the context in which it is being applied [13]. To determine if targeted integration modalities 
are achieving their goal they warrant evaluation. 
Modalities of integration differ when targeted towards a specific goal. For example, 
integration may be applied to vertically aligned HIV and TB facilities which have no formal 
interaction, which are potentially causing low initiation and retention of treatment for TB/HIV 
patients. One modality may entail a process of providing all HIV and TB services at a single 
facility. Alternately it may be a process of providing all TB services but only HIV testing at a 
single facility with treatment provided at an alternate location. Finally, it may be a process of 
providing only referral between separated facilities. All three modalities are examples of 
integration and theoretically address the desired goal of improved treatment retention of 
comorbid TB/HIV patients. They fundamentally differ in their application, relative resources 
needed and potential impact.  
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In the above example more integrated services seem intuitively to be the most beneficial to 
improved treatment retention. Empirical evidence has shown however, this is not always the 
case. Higher integration may be no more beneficial for treatment retention in some settings 
[121]. In this case fully integrating services may still benefit the health system through cost-
savings [122], but it may also exacerbate already stretched system resources. If a health 
facility is unable to meet demand, adding extra burden through increased patient load will 
exhaust human and tangible resources resulting in poor care [24]. In countries with non-
responsive health systems integration may inhibit what care is available [24]. Integration, 
particularly in situations with no difference may also be subject to externalities, such as the 
risk of cross-contamination when integrating HIV and TB services [123].  
Given its importance to health system strengthening achieving an optimum level of 
integration requires focusing integration on priority areas and in-line with goals based on the 
current burden of disease and empirical evidence. As resources in a health system are 
limited evaluation is an important aspect of the application of integration. This is in terms of 
whether it should be applied towards a specific health system goal. It is also in terms of the 
relative impact of comparative modalities of integration towards the same goal, in terms of 
benefits costs, or both. 
2.2.4 Limitations integration poses for evaluation 
Integration has inherent issues which make its’ rigorous evaluation problematic. It faces a 
unique barrier which may not apply to other health policies. Health system integration often 
revolves around structural adjustments to the system designed at improving service 
provision. This implies that consumers of integrated health services access them from fixed 
locations. For evaluation this results in consumers being clustered in higher units such as 
the health centre where services are accessed. Randomisation used for rigorous evaluation 
is often predicated on a good given as a single discrete event, such as an antibiotic, or on 
an ongoing basis such as health insurance [124, 125]. Both however are not tied to a fixed 
location.  
The only mechanism for randomising integrated services is to randomise how patients 
access services. This may be possible when triage or referral is involved, such as described 
by Hewett et al [126], who evaluate integration by randomly assigning patients to receive 
different service models following an initial consultation. This however limits the services 
which may be evaluated. Alternatively, patients can be mandated to access specific 
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services; however, this is likely unethical or impractical and may unduly influence the health 
consumer decision making process [32, 34, 73].  
Given the necessity to measure services accessed from a fixed location evaluating service 
integration is limited to accepting non-randomisation or evaluating at the cluster level. 
Contextual information, such as at the cluster level, influences the relative success of 
integration [43]. Comparing integration modalities without considering this context may bias 
estimates of impact. 
Ideally evaluation of policies such as integration are included into the development and 
implementation process of the policy itself [73]. This is often not possible due to logistic 
constraints or may not be a primary concern of those implementing them. In these situations 
evaluating if policy has been successful is often restricted to collecting and analysing 
available data ex-post [35]. Evaluating this way poses further restrictions on methods and 
variables used to establish impact, particularly in the case of quantitative evaluation [36].  
As an additional barrier to evaluation the complexity which surrounds integration makes 
selecting appropriate indicators for evaluation difficult. As discussed in Section 2.1 
integration modalities may be defined in different ways. As with any evaluation defining 
plausible mechanisms by which integration can result in desired outcomes is an important 
step towards causality [127]. This complicates selecting indicators to best represent different 
modalities. Selection of indicators is a recognised issue in the integration literature [110, 128].  
This is largely due to limited guidance on linking deconstructions of integration modalities to 
appropriate indicators for evaluation. 
Originating from a systematic review performed in Chapter 4 of this thesis, the relative 
frequencies of issues inhibiting rigorous evaluation in the empirical HIV integration literature 
have been quantified.  The review confirms; a frequent lack of randomised design, frequent 
clustering, frequent use of ex-post evaluation and, difficulties in selecting indicators to 
measure integration impact. These are obstacles to improved estimates of the impact of 
integration. Methods need be explored which may overcome them and provide the best 
possible estimates of integration impact. 
2.3 Impact evaluation in policy 
The following section describes methods used to evaluate the impact of policy to inform 
decision making. Policy makers have a mandate to maximise social welfare through the 
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appropriate allocation of limited resources [124]. For this to occur, high quality information 
evaluating the costs and benefits of specific programs or policies must be available to inform 
the decision making process [129]. This information can be used to evaluate the impact of 
competing policy models. 
Impact evaluation can be defined as the estimation of the net change in outcomes amongst 
a group or groups of people that can be attributed to a specific treatment or policy [36]. 
Impact evaluation can be broadly grouped based on different methodological approaches. 
All methods imply some level of assumptions with consequent strengths of causal inference. 
Methodologies differ by study design, statistical techniques and requisite data [70].  
Strength of causal inferences is determined by an ability to account for endogeneity [74]. 
When testing the causal effect of a treatment on a given outcome, endogeneity refers to 
violations of assumptions that: changes in the outcome are caused by the treatment and 
random error; no other factors which affect the change in outcome; there are no other factors 
which alter effects on the outcome other than treatment; and that the relationship between 
outcome and treatment is not reversed i.e. changing outcomes does not affect the treatment 
[130]. In policy evaluation, treatment refers to the competing policy models under evaluation. 
When modelling the relationship between policy and outcome a common situation resulting 
in endogeneity is when variables affecting the relationship are omitted from the model. This 
frequently occurs when policy is selectively applied to certain groups, or when certain groups 
select themselves into policy or control groups, also known as selection bias. A main 
concern of impact evaluation is addressing selection bias, in doing so establishing a valid 
counterfactual scenario for policy evaluation [74]. 
As highlighted in Chapter 1, the concept of a valid counterfactual is drawn from a theoretical 
ideal in evaluation, one where outcomes can be observed for a single individual who 
simultaneously receives and does not receive policy [70-72, 75].  Under these circumstances 
any change in a given outcome can be attributed directly to the policy, having not been 
affected by bias [73]. Providing the same individual with simultaneous policies at the same 
time, however, is impossible. This implies that in practice evaluation is limited to comparing 
two different individuals who have been recipients of alternate policy models. When 
comparing individuals, biases may affect the measured outcome of the policy [72, 75].  
The scenario described above is described as the attribution problem [131]. It can be defined 
as the extent to which an effect may be truly attributed to the treatment in question. [132]. 
Techniques are available to recreate the provision of a single individual with both treatment 
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and control as accurately as may be possible. This provides the closest possible comparison 
of what would have happened in the presence and absence of treatment [132]. Impact 
evaluation approaches are presented below in relation to addressing the attribution problem. 
2.3.1 Methodologies not directly addressing selection bias  
Methodologies discussed here are described as those which do not directly address 
selection bias. They are included in this discussion due to their frequent use in evaluating 
HIV integration, as will be elaborated further in Chapter 4.  
2.3.1.1 Non-adjusted comparison of policy models 
This group of methodologies refers to approaches to impact evaluation which involve 
observing how outcomes differ between policy models without adjusting for potential bias. 
This may include policy applied in two different settings, known as treatment and control. It 
may also be observing changes from baseline to post-implementation of a single setting, 
known as before and after. It may also be a combination of the two, i.e. difference in 
difference4 [36]. Dependant on study design, a range of statistical techniques may be applied 
when estimating impact. Importantly however no attempt is made to adjust for potential 
confounders as a result of selection or other biases. 
Any estimates obtained from these methods are potentially incorrect representations of the 
effect of the policy. This is due to systematic biases which may be present in comparative 
policy groups [74]. Given this uncertainty the degree of confidence which can be placed in 
subsequent results for evidence-based policy will be limited [133]. These methodologies are 
often used due to a lack of data and lack of pre-planning for evaluation [70].  
2.3.1.2 Multivariable regression 
This group of methods involves estimating outcomes between treatment groups while 
adjusting for other non-treatment related factors. Multivariable regression relies on 
measures in the data of treatment, outcome and potential confounding factors. If available 
ordinary least squares regression, or variation thereof, may be applied to identify correlates 
with treatment outcome, including treatment assignment [134]. Using these methods alone, 
however, make causal inference unlikely [135]. This is because adding variables to control 
for differences between groups receiving comparative policy models may not adequately 
                                                          
4 This refers to competing policy groups measured at an aggregate level, before and after policy implementation. It 
does not refer to panel data methods, which are discussed in the following sections. 
28 
 
account for selection bias. In non-randomised data, multivariable regression alone will not 
be able to address unmeasured variables which are affecting outcomes. Assuming all 
affecting variables have been measured, multivariable regression is still not able to 
demonstrably reduce biases between groups, however, but only assume they are removed 
through inclusion in the regression model [70]. There are special cases where multivariable 
regression may control for specific types of bias [130]. For this thesis multivariable regression 
implies standalone use on non-randomised data, with variables included ex-post when 
available.  
2.3.2 Methodologies incorporating randomisation to control selection bias 
This class of methodologies comprises the most robust methods for evaluating policy 
outcomes. They involve incorporating randomisation into treatment assignment at different 
stages of evaluation [124, 125]. 
2.3.2.1 Randomised Controlled Trial 
The current gold standard for impact evaluation is through RCTs5. This methodology is the 
current best practice for observing causal treatment effects and is standard in medical 
research [136]. RCTs are largely able to overcome the attribution problem.  This is achieved 
by establishing a valid counterfactual through randomisation of treatment assignment [77]. 
If randomisation has been successfully achieved treatment effects may be directly compared 
between treatment and control groups. This assumes that any biases, such as selection 
bias, have been removed Treatment effect can then be estimated by a variation on a means 
test or regression [71]. 
2.3.2.2 Cluster randomised trials  
A common variation on the RCT is the cluster randomised controlled trial (CRT) [137]. This 
involves randomly applying a treatment to multiple clusters, as opposed to individuals. 
However, outcomes are observed at an individual level. It is a pragmatic alternative to full 
randomisation. Some criticisms of CRTs have been made, however, primarily on the lack of 
appropriate cluster sample size [138-142]. Producing un-biased results in CRTs often 
requires both a relatively large sample size within clusters and of clusters themselves. 
Through simulation it has been shown that using randomisation at the cluster level as the 
only means for controlling bias will likely require at least 80 clusters [138]. This is with the 
                                                          
5 Also termed Randomised Evaluations 
29 
 
caveat that sample size is highly specific to each individual study. CRTs have been used 
relatively frequently to evaluate integration as will be shown in Chapter 4. This is likely due 
to their pragmatism in overcoming the problem of fixed location intervention as discussed in 
Section 2.1.6.  
2.3.3 Quasi-Experimental methods addressing selection bias 
In many policy situations randomisation of an intervention may not be possible due to 
logistical or ethical concerns [70]. RCTs and CRTs often require a large sample size, for data 
to be collected before randomisation, and many other logistical requirements that 
substantially increase their cost [70]. Ethical concerns also exist surrounding suppression of 
treatment to control groups [129, 143]. It may often be of use to try and rigorously observe 
the effect of a given treatment despite an absence of randomisation. In these cases, 
methods which replicate some of the benefits of RCTs must be used in establishing valid 
counterfactual scenarios. Such methods can be termed quasi-experimental methods [71]. 
Quasi-experimental methods do not use randomisation to allocate units to treatment and 
control.  In non-randomised studies, treated subjects may systematically differ from 
untreated subjects. Unbiased estimates treatment effects therefore cannot be obtained by 
directly comparing the two groups [72].  
A variety of design and statistical techniques are used to control for selection bias and other 
forms of endogeneity. The choice of the specific technique used in concert with quasi-
experiments depends on the policy or intervention being evaluated and the nature of the 
available data [36]. Here several common quasi-experimental techniques are described 
primarily in relation to their ability to address potential selection bias. 
2.3.3.1 Instrumental variables 
The instrumental variable (IV) approach is used to estimate causal impacts of a policy 
controlling selection bias through identification of an appropriate instrument [144-146]. This 
is a variable which is highly correlated with treatment assignment but is uncorrelated with 
unobserved characteristics affecting outcomes. Through a two-stage regression process, 
the IV may be used to limit potential correlations that treatment assignment has with omitted 
confounding variables. This can potentially include measured, unmeasured and 
unmeasurable variables. In this way the IV approach may be able to be used to isolate and 
control for selection bias [72, 147].  Estimating impact using the instrumental variable hinges 
on the ability to identify an appropriate instrument. A weak instrument has been suggested 
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to potentially increase bias [148]. Issues arise with instrumental variables in ex-post design 
due to difficulties in defining an appropriate instrument [132]. IVs with relation to integration 
evaluation are further discussed in Chapter 5. 
2.3.3.2 Regression discontinuity design 
Regression discontinuity design is used when a program targets specific individuals for 
receiving a treatment based on an eligibility cut off. A common example is the targeting of 
policies towards individuals who lie below a certain poverty level based on annual income 
or other measures of socioeconomic status [149]. Individuals just below and above this cut 
off point become the treatment and control groups respectively. It is assumed in this 
technique that individuals who lie very close to the cut off will only differ in the single variable 
which was used to assess eligibility.  By restricting the sample to only those individuals near 
the cut off, systematic differences may be minimised and a valid counterfactual created [149].  
This technique can only be used when the attribution of treatment has been based on an 
index with defined cut off points. 
2.3.3.3 Conditioning using the Propensity Score 
Conditioning6 using a Propensity Score (PS) is a class of techniques which create a 
counterfactual by using common covariates between the treatment and control group [30]. 
These covariates are used to predict the individual likelihood of each observation having 
received treatment [30]. Likelihood is presented as a score between 0 and 1, which is termed 
the PS [75]. In terms of causal claims, this class of techniques have limited, however 
important, differences to standard regression analysis.  
Once predicted the data are conditioned using one of a variety of techniques to hold constant 
the effect of covariates between treatment and control groups [150]. In doing so it is hoped 
that any selection bias present in the non-random assignment of treatment has been 
accounted for [151, 152].  
The PS is most useful when the given data has several key characteristics. These are a 
clear treatment and control group, and a large array of covariates available for estimating 
the PS [153]. PS methodologies are not as reliant on a definitive rule for treatment 
                                                          
6  The term conditioning is used as opposed to the more common ‘propensity score matching’ as the thesis involves 
discussion of a variety of classes of adjustment using the propensity score. These include matching, weighting, 
stratification and covariate adjustment 
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assignment as other techniques, further discussed in Chapter 5 [154]. They may therefore 
be more amenable to certain ex-post analysis.  
2.3.3.3.1 Limitations of PS compared with other quasi-experimental methods 
When comparing with other techniques such as IV, it should be noted that PSs are only able 
to control bias based on measured covariates, a key limitation. PS analysis also hinges on 
important assumptions. [154, 155]. These include no unmeasured confounders and 
overlapping distributions of treatment and control groups to be able to provide reasonable 
comparison. Both are potentially strong assumptions and the use of PSs consequently 
remains controversial particularly in relation to claims of causality [155-157]. The limitations 
of PS compared to other quasi-experimental methods is further elaborated with reference to 
case study data in Chapter 5. 
2.3.3.4 Difference in difference 
As a special class of bias, time variant factors are those that may affect outcomes in an 
impact evaluation due to natural changes over time not associated with treatment [74]. A 
common approach to controlling time variant factors around a treatment and control group 
is the difference in difference approach [74].  
Here outcomes are measured before and after treatment assignment. In this way the 
marginal difference in outcome relating to treatment can be measured over time [74]. Time 
trends which may affect the measured outcome irrespective of treatment can be nullified. 
This is due to such trends also affecting the control group. Various difference in difference 
approaches may be used depending on the data [36].  
In the case of panel data, which implies study individuals are followed over time, a MLM, 
discussed further below, may be used. This involves controlling for repeated measurements 
of the same person when estimating outcomes [130].  
When panel data are not available an alternate difference in difference approach can be 
pursued. This involves repeat random samples drawn before and after integration [130]. 
Using this approach an interaction term between time period and treatment when estimating 
outcomes may be used to control for time variant bias [130].  
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Difference in difference designs are unable to account for non-time related biases such as 
selection bias. These methods however are often used in concert with other methods, such 
as PSs, capable of such control [36]. 
2.4 Multilevel models 
Increasingly analysts employing regression-based methods are aware of clustering within 
data. This is in line with inherent assumptions around use of many common regression 
techniques which make strong assumptions about a lack of clustering. If data are clustered 
and assumptions are ignored estimates using such models, make inferences drawn 
potentially incorrect. A class of regression techniques which relax the assumptions around 
clustering are MLMs7. They allow the proper incorporation of clusters through different 
approaches. Two of which are controlling variance at the cluster level or modelling standard 
errors within and across clusters [83]. 
MLMs have been used in impact evaluation to control for and measure differences between 
clusters when estimating treatment effects. Difference in difference models mentioned 
above also use MLMs by assuming that individuals with repeated measurements essentially 
form their own cluster of observations [159, 160]. This thesis, however, focuses on the use of 
MLMs in concert with other impact evaluation techniques which rely on the use of 
regression, such as IV or PS. Further elaboration on MLMs and specific details are provided 
in Chapters 4 and 5. 
2.5 HIV Integration 
Integration of HIV programs and services is key tool used for health system strengthening 
in many LMICs [12]. HIV’s increasing prevalence, continued incidence and transition to 
chronic disease status has meant increasing costs to already tight health budgets. 
Multilaterals, bilateral, foundations, and non-governmental organisations have provided 
US$51·6 billion for HIV8 in development assistance for health from 2000 to 2011 [161]. 
Consequently strategies for HIV management that are both effective and efficient are being 
investigated [162]. Integration of HIV services and/or programs with other health system 
                                                          
7 Other terms include clustered models, hierarchical models, mixed models, fixed and random effect models. 
Clustering may also be known by other terms such as multilevel, structured data, hierarchical data and panel data 
[158].  
8 price in 2011 US dollars 
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components is such a strategy. This is due to potential gains in efficiency from combining 
system components which are linked or share common goals. 
HIV has intrinsic links to other health conditions or services. Control strategies which 
incorporate these links can act on opportune interactions with the health system. As an 
example, HIV may be transmitted at various stages of infection [9, 57, 163]. At some stages, 
a PLHA may not be aware they are carrying the disease due to a lack of clinical symptoms. 
Consequently regular interactions with the health system may increase the probability of an 
early diagnosis for a HIV positive patient [164]. These interactions become particularly 
opportune if they have the potential for preventing further mortality, morbidity, or 
transmission. One such interaction is ANC where PMTCT is first applied [165]. Strategies for 
HIV management have been prioritised if they take into account these unique aspects of 
HIV’s lifecycle [162]. 
Opportunities for preventing morbidity and mortality may also consider HIV’s replication 
mechanisms [12]. During stages of the virus’s lifecycle it utilises components of the body’s 
immune system to reproduce. During replication a PLHAs immune system may become 
compromised. This results in PLHA becoming highly susceptible to other infections, even 
those which may not normally be pathogenic [166], termed opportunistic infection. Some 
examples of common opportunistic infections include meningitis, toxoplasmosis, candidiasis 
and tuberculosis (TB) [167]. Given the compromised nature of the PLHAs immune system 
opportunistic and other infections have a high potential to become lethal. Consequently the 
leading cause of AIDS related death worldwide is due to co-infection with TB [53, 168]. Given 
these issues HIV management is most effective if able to incorporate control of opportunistic 
infections. 
Despite its natural links to other health system components, HIV programs in LMICs often 
act in a highly vertical manner [24]. Integration of HIV components with other system 
components has been suggested as a pragmatic method of increasing the effectiveness of 
the HIV program, other program areas and reducing costs between both [12]. The natural 
links which HIV may have with other health system components create opportunities for 
targeted integration [12]. Integration of HIV program components into ANC has been 
highlighted as an appropriate service delivery model for HIV, for example, given the 
opportune nature of MNCH services [61, 63, 165]. Due to the similar delivery platforms and 
interconnected nature of TB and HIV, integration of components from both programs has 
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been suggested [65, 168]. These two HIV integration complexes are key to HIV control in 
many LMICs [2]. 
The combination of two or more system components is directional in that resources or 
infrastructure of one program are usually subsumed into the second program. The direction 
which integration takes place may be influenced by the level of epidemic, HIV or otherwise 
[65]. HIV epidemics have been classified by the WHO into four categories: general, 
concentrated, mixed and low-level epidemics. These are based on the prevalence of the 
disease throughout the population [169]. They are also based on prominent infection patterns 
defined by prevalence within sub-population risk groups. Risk groups include Men who have 
Sex with Men (MSM), sex workers, transgender people, and injecting drug users [62, 164]. A 
general epidemic is occurring if a country’s HIV prevalence is above 1%. If it is below 1% in 
the general population but above 5% in an at-risk group a concentrated epidemic is 
occurring [118, 164, 170, 171]. Mixed epidemics are defined by either more than one sub-group 
being at risk or at least one high-risk groups within a generalised epidemic. If prevalence is 
below 1% in pregnant women and below 5% in risk groups the country is in a low-level 
epidemic [118, 164, 170, 171]. These classifications potentially impact the relative size of the 
HIV program within the country [172]. 
In settings with a generalised epidemic where AIDS deaths make up a significant proportion 
of overall mortality, an HIV program may be relatively large, often acting in a vertical manner 
[62]. In these situations, the HIV program may be used as the vehicle for integration, for 
example having other services built into HIV service points. In concentrated HIV epidemic 
settings HIV services may be best integrated into the existing health infrastructure as the 
HIV program will likely be smaller relative to the secondary system component [48]. The 
importance of and justification for integration of HIV in these settings in light of competing 
disease burdens relates to the potential for containing the HIV epidemic as concentrated 
while also providing HIV services to PLHA in the most cost effective manner [65]. The 
epidemic creates important context which may alter the process of HIV integration.  
2.5.1 HIV service integration 
As a sub-class of HIV integration, HIV service integration is a process of combining HIV and 
other system components through joint service delivery [13, 17]. As will be shown in Chapter 
4, HIV service integration is the most common integration modality for which there is 
empirical evidence. Case studies used in this thesis focus around HIV service integration. 
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Service provision for HIV revolves around three modalities: prevention, detection and 
treatment. These modalities take into account the fact that HIV infection occurs with few 
exceptions through three pathways: through sexual contact, through parenteral pathways 
which are those involved with injection of an object such as a needle, and transmission from 
mother-to-child during birth or breastfeeding [173].   
Effective interventions exist across all three modalities. Prevention may involve behavioural 
or direct clinical interventions. For example, HIV counselling tied to HIV testing, often 
combined with distribution of free condoms which has shown to be highly effective in 
reducing unprotected sex in at risk individuals [55].  Detection can involve a combined use 
of biological markers, clinical symptoms and screening of at risk populations [164]. Treatment 
is based primarily around ART with further interventions involved in behavioural 
management and early diagnosis and treatment of opportunistic infections [174].  From a 
public health perspective targeting the care cascade to provide maximal benefit must involve 
recognition of the disease stages, unique transmission pathways and the socio-cultural and 
etiological attributes of at risk-groups [48]. HIV service integration involves combining 
services across some or all these modalities with services from a secondary program. This 
is to increase supply or demand for essential services or to provide cost-savings.   
Within HIV service integration literature, the term ‘integration’ can imply different meanings. 
For example a study of integration of a HIV/TB complex in South Africa [67] utilising the term 
‘integration’ describes it only as having services from both programs available at a single 
location, often also termed co-location. In contrast a pilot of HIV service integration with ANC 
services in India [175] describes a complex intervention ranging from joint service availability 
at a single location to demand generating community awareness campaigns around 
integration and specialist training for health workers. These activities fall under the term 
integration.  
Common terms for describing HIV service integration models are used throughout this thesis 
[62, 176]. These are: referral, in which distally located service sites offer referral-only for all 
services from one program to another; partially integrated, in which some services available 
at a single point while other services for counter program are accessed through referral; and 
one-stop shop/fully integrated, whereby a full spectrum of services from both programs are 
available at a single service point [176].  
HIV service integration can occur at all care levels (primary, secondary or tertiary) of the 
health system [12]. In many LMICs, however, HIV programs have arisen as vertical 
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components of the health system in the face of the HIV epidemic [177]. Given the specialist 
training and resources required during the rise of the epidemic services were traditionally 
provided at secondary as opposed to primary facilities. Consequently, achieving improved 
cost-effective performance of HIV program integration has focused on decentralisation of 
services from secondary to primary facilities with consequent connection to other common 
services provided there. 
HIV service integration may also involve different interplays between geographical locations. 
For example, a full array of HIV services may be decentralised and integrated into primary 
facilities at the district level. The same integration may occur only at select primary care 
facilities at the regional level. Partially integrated models may involve availability of 
prevention and testing services at district level with referral to higher facilities at a regional 
level. Finally HIV services can be considered integrated at the national level through 
legislative mandates, affecting indicators of performance [16]. 
Various examples of HIV service integration complexes exist in the literature. A list can be 
found as sub-headings in Chapter 4. This thesis focuses primarily on two of the most 
common complexes in terms of the empirical literature: HIV/ANC and HIV/TB. Both ANC 
and TB programs are naturally linked to the HIV program as discussed above. The WHO 
recommends integrating both services to different degrees depending on the relative sizes 
of the HIV and TB epidemics [64, 118]. These two complexes form the case studies used to 
explore the application of evaluation methods performed as part of this thesis. 
2.5.2 HIV/ANC service integration 
Integration of HIV/ANC services is generally designed to overcome barriers to improved use 
of HIV services. This is achieved utilizing a pregnant woman’s frequent interactions with the 
health system [55, 178, 179]. In addition, by leveraging combined logistic networks, availability 
of HIV testing and treatment may improve. Integration may provide more and improved HIV 
services in a greater variety of locations [114]. General monitoring activities may also be 
strengthened, as HIV tests during ANC form the primary metric which informs population 
level incidence of HIV in many countries [13]. 
ANC often falls under a full cascade of Reproductive, Maternal, Neonatal and Child Health 
(RMNCH) interventions [64]. The interventions involved often fluctuate and are highly context 
specific. They generally, however, involve tests for common infectious diseases, such as 
HIV, further blood and urine tests and weight and blood pressure checks [64]. ANC which 
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forms the first interaction with the RMNCH program during pregnancy is a specific yet 
interchangeable subset of interventions under RMNCH. These interventions span from 
family planning until birth [64].  
2.5.3 HIV/TB service integration 
As discussed above HIV service integration is best applied to services which have intrinsic 
links to HIV. TB is the leading cause of HIV related death worldwide [180]. Both diseases are 
synergistically linked through replication mechanisms and lifecycles [181]. Both diseases 
also share similarities in service delivery models [182]. Given these similarities the WHO has 
recommended integration of HIV/TB services in countries with relevant levels of both 
epidemics [118]. 
TB programs, as with HIV programs, are often disease specific system components that 
operate relatively vertically to the rest of the health system [46]. Services for treating TB can 
be grouped in a similar fashion to HIV: prevention, testing and treatment. The primary 
difference is that that TB treatment has a distinct end-point -- treatment completion – while 
HIV treatment is lifelong. TB treatment, however, is a relatively long process, often involving 
treatment upwards of five times a week for 6 months or two years in the case of MDR-TB 
[183].  
Treatment of both TB and HIV require a relatively large volume of medication taken over an 
extended period with frequent unavoidable side effects [184].  Issues around patient non-
compliance for both diseases is common. Incomplete medication for TB leads to drug 
resistance, a serious complication for both patients and health systems [185]. Non-
compliance for HIV leads to rapid progression of the disease and death, but can also aid the 
spread of the disease [86].  
Models of Directly Observed Therapy (DOT) for TB are now generally accepted as an 
effective measure for addressing non-compliance [186] In the clinic-led model DOT requires 
the patient to receive and take their medication in the presence of health staff at the health 
facility. Given the commonalities between TB and HIV, DOT is progressively being used to 
address HIV non-compliance [184]. Due to the synergies between TB and HIV, co-location 
of services is a natural step in contexts where both diseases persist. 
Integrated HIV/TB services are also targeted at treating complications caused by co-
infection. Treatment of HIV/TB co-infection involves recognising the high likelihood that a 
patient infected with either disease in a high TB or HIV burden setting will be infected with 
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the second disease. Consequently, it suggests a package of interventions involved in timely 
diagnostics, treatment and behavioural based prevention programs and treatment of both 
diseases. A list of the specific services involved in HIV/TB co-management has been 
reported by the WHO [65].  
2.6 Health system, HIV, TB, ANC and, integration in Peru 
The following section presents details on case studies used in the thesis to explore the 
application of MLM-PS. As described in Chapter 1, a policy change has resulted in 
comparable models of HIV integration, which form the basis for evaluation using the method 
in both case studies. This section describes important background around the health system 
relating primarily to HIV, TB, and ANC to inform the case studies. 
2.6.1 HIV in Peru 
The HIV epidemic in Peru is classified as concentrated. This is based on current national 
estimates of 0.4% adult prevalence. This figure represents 65,000 people currently living 
with the disease, 2,000 of whom are below the age of 15, and 20,000 of whom are women 
[84, 85].  
The epidemic however contains significant prevalence in key at risk groups. The HIV 
epidemic is primarily concentrated in the Men who have Sex with Men population (MSM) 
[84, 91], large proportions of which are made up of transgender persons [85]. Estimates have 
been as high as 28.9% prevalence in transgender women in 2012 [85] and 10% prevalence 
in MSM in 2013 [84, 85].  
The primary cause of death of PLHA’s in Peru, as is the case for the rest of the world, is TB 
[163, 187]. To date 2,800 deaths due to HIV in Peru have been recorded [84]. The epidemic 
is concentrated in urban centres of large cities, primarily the capital city Lima and the capital 
of the Amazonas region Iquitos [84]. While the HIV epidemic largely crosses the socio-
economic divide, deaths are still more abundant in low SES status individuals [84]. Risk 
factors for contracting the disease include lower education, beginning sexual contact at a 
younger age, higher number of sexual partners and frequent drug use [188-193]. 
2.6.2 Peru’s response to HIV 
Peru’s health system has greatly improved following terrorism and economic instability 
during the 1990’s. In 2004 only 34% of Peruvians were covered with universal health 
coverage, rising to be more than 83% in 2017 [426]. This increase has largely been through 
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the public insurance scheme Seguro integral de salud, and the employee provider scheme 
EsSalud. Government financing for health accounted for over 54% of GDP in 2015 placing 
Peru high within the Latin-American region [427]. Regardless Peru faces challenges of 
fragmentation of the health system resulting in losses in efficiency which will need to be 
rectified to reach targets of universal health coverage by 2021. [426]. 
HIV services in Peru are majority publicly run and funded. In 2015 The private sector 
comprised less than 3% of spending on HIV/AIDS in Peru [427]. The primary governing body 
of the HIV response being the ministry of health national HIV/AIDS program. Service delivery 
however, is largely decentralised to regional directorates for health, who request financing 
directly to the Ministry of Economics and Finance [426]. 
The Peruvian government response to the HIV epidemic was initially weak. Between 1985 
and 1995 little action was organised as the epidemic increased. From 1996 to 2000 more 
modern biomedical programs were developed linking HIV prevention to Sexually 
Transmitted Disease (STI) control based on a national strategy of improved surveillance. 
After 2001, government controlled resources became less available and the HIV program 
was reduced. During this time many HIV programs were funded through applications to the 
GFATM.  
In 2005 with support from the GFATM and UNAIDS a multi-sectoral plan for HIV/AIDS was 
created for Peru. This plan has involved near universal coverage for ART, complimentary 
testing for at-risk groups, such as those confirmed positive with TB, and community and 
preventative activities [91, 194, 195]. The testing and prevention aspects of HIV services 
have been made available at all primary health facilities throughout the country from 2005. 
ART has been made available only at higher facilities [92]. Primary health facilities such as 
health centres and health posts, which comprise a majority of the Peruvian public’s first 
interaction with the public health system, have not been provided with ART medications. 
Most other primary health care services are available at health posts of different classes, 
including GP consultations, vaccinations, basic maternal and child health services in Peru 
ANC in Peru falls under the National Sanitary Strategy for Maternal Neonatal and Child 
Health [196].  Key indicators for ANC in Peru have improved dramatically since the program’s 
reform in 1996. For example coverage of 1+ ANC check from a health professional has 
increased from 67% in 1996 to 96.9% in 2014 [197]. Just over 94% of pregnant women 
received four or more ANC checks in 2014 [197]. Under the national strategy a program of 
ANC checks in Peru must include: urine sample for infection, arterial pressure check, iron 
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supplementation, folic acid supplementation, tetanus vaccination, blood sample for STIs and 
HIV, height and weight check, fundral height check, syphilis, breastfeeding education, and 
further child care training [198]. These basic components of ANC are available in Peru free 
of charge. They can be sought from all MINSA health establishments from the health post 
level upwards [199]. Significant correlates for lower quality and less frequent ANC checks in 
Peru include lower SES, living in a rural setting, lower education levels, and mother being 
20 years or younger at time of birth [95, 98, 197, 200-203]. 
2.6.3 TB in Peru 
In 1990, Peru had the highest incidence of TB in the region of the Americas with over 300 
incident cases per 100,000 people per year [187]. This has reduced to just over 100 incident 
cases per 100,000 people in 2010 [187]. It remains, however, the country in the Americas 
with the second highest incidence of TB after Bolivia. Peru also accounts for over 35% of 
MDR-TB cases globally. Deaths from TB have reduced in Peru from 53 deaths per 100,000 
people in 1990 to 12 deaths per 100,000 people in 2010 [97, 187].  
Given the importance of TB to the country, services for the disease have been a major 
component of the Peruvian health system since its restructuring in 1991. The National 
Tuberculosis Program (NTP) expanded the services it provided and increased the 
percentage of health establishments in which it was present from 24% in 1991 to 99% in 
1997 [101].  From 1991 onwards decentralisation of all services has been pursued with initial 
diagnosis, drug sensitivity sampling and treatment for TB available at all primary facilities 
[101].  
Current TB control activities in Peru include complimentary sputum testing, including drug 
sensitivity tests. If confirmed positive a TB patient will receive standard first or second line-
treatments which include drug combinations 6 days a week for 6 and 12 months respectively 
[204]. If more complicated forms of MDR-TB are detected then specialised treatment is 
provided [205], however, the availability of the medications involved in this treatment is 
limited and frequently incurs devastating out-of-pocket costs [96]. Significant correlates 
associated with higher TB incidence in Peru include lower SES, lower nutritional status, and 
frequent drug and alcohol use [96, 187, 206]. 
2.6.4 Peru’s implementation of HIV service integration 
Two HIV service delivery models have been implemented in Peru since 2005 [94]. Within 5 
regions of Peru, 18 primary health facilities have been provided with fully integrated HIV 
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services, eleven of which lie within inner city Lima [84]. The second service delivery model 
has been rolled out throughout the rest of the country. This is partially integrated services 
where HIV treatment is available only at higher level facilities [92, 94].  
Implementation of full integration has been applied non-randomly to all health centres within 
select districts [92, 94]. This dictates that selection bias may be present amongst individuals 
receiving fully integrated or partially integrated care. Patients accessing public primary 
health facilities are restricted to the district in which they reside [207]. These districts are 
further grouped into higher level units such as regions or in some instances health 
administrative areas [207]. Consequently, individual units of observation drawn from the data 
are clustered at multiple levels. Evaluation has also been performed on secondary data ex-
post. The case studies appropriately reflect the common limitations of non-randomisation, 
clustering and ex-post evaluation, to HIV integration evaluation.  
2.7 Conclusions 
Literature reviewed in this Chapter focused on providing the background to HIV integration 
evaluations highlighted in Chapter 1, and introduced concepts and methods used in the 
thesis to overcome these limitations. It began by describing the theoretical background to 
integration drawn from organisational theory. Here differentiation of components of large 
complex organisational systems was concluded to lead to inefficiency. In response, 
integration was suggested as a strategy to align components towards common goals, thus 
improving efficiency. This idea was discussed in the context of health systems, where a 
diverse range of goals makes deciding what, how and why to integrate difficult.  
The term integration in a health systems context had been used as a general term in the 
health service and health economic literature to describe a varying array of processes of 
bringing together system components. In response, frameworks for describing health 
system integration had been developed to help individual integration modalities to be 
identified. Within these frameworks, however, a gap in the literature was highlighted, linking 
theoretical concepts to potential indicators. This was despite modalities of integration having 
different effects on the health system, warranting evaluation. 
Given the importance of HIV to many health systems integration was concluded to be a key 
sub-type of health system integration in many LMICs. Integration was also concluded to be 
critical to improved efficiency of HIV programs as evidence suggested them to have arisen 
vertically to other system components. As a consequence, integration of HIV with other key 
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system components, such as TB and ANC, has been commonly recommended by various 
stakeholders. Empirical literature on HIV integration showed it to be, on balance, associated 
with positive outcomes. However, given the manner in which integration was often employed 
it was concluded to be subject to various limitations which make unbiased evaluation of 
different modalities difficult. Difficulty was shown to be drawn from integration being unlikely 
to be randomised, likely to be implemented fixed to locations meaning that data on 
individuals was often clustered, and that that these issues were exacerbated by frequent ex-
post analysis. Such bias and limitations were concluded to cast doubt on the reliability of 
some existing estimates of integration impact.  
In response to these issues various quasi-experimental techniques were concluded to 
potentially allow strengthened claims of causality in the absence of randomisation. It was 
concluded that PS based techniques were likely the most flexible in relation to conducting 
evaluation ex-post. To address clustering, MLMs in concert with PSs were concluded to be 
feasible, in the absence of randomisation, based on recent literature. To explore the 
feasibility of applying MLM-PS to evaluate HIV integration, two case studies were 
introduced. Both relied on the implementation of two different HIV integration modalities 
within Peru: fully and partially integrated HIV services in primary care. The first case study 
was introduced as testing the relative impact of these two modalities on a HIV/ANC 
integration complex, the second on HIV/TB. Importantly for the use of MLM-PS, both case 
studies were demonstrated to rely on data and study design in which full integration had 
been implemented to non-randomly to clusters. Evaluation for both case studies was 
planned ex-post. 
The following Chapter returns to the first issue inhibiting HIV integrating evaluation. It 
responds to the gap in the theoretical literature mapping indicators to existing frameworks 
for integration. It presents a novel theoretical framework, constructed for this thesis, for 
selecting indicators and methods for HIV integration evaluation. 
 
 
  
43 
 
 
3 Theoretical framework for mapping indicators and methods to modalities of HIV 
integration 
Competing HIV integration modalities warrant evaluation, as described in the previous 
Chapter. Evaluation is inhibited, however, through limitations posed by how integration is 
conceptualised. Integration rarely describes the same concept. Instead, the term is used for 
a diverse, complex policy which can be deconstructed into a range of linked processes or 
organizational changes performed across various sections of a health system [133, 208]. This 
translates to a wide range of possible indicators which can reflect relative impact of different 
integration modalities. Given this diversity, describing plausible mechanisms by which 
appropriate indicators represent marginal improvements through integration is critical to 
sound evaluation [110, 128].  
Given the importance of selecting appropriate indicators, a theoretical framework has been 
constructed to overcome ambiguity surrounding HIV integration and help describe plausible 
mechanisms by which specific integration modalities can result in measurable outcomes. It 
does so by first providing a framework for defining HIV integration modalities. This is based 
on existing frameworks drawn from the integration literature described in Chapter 2. It then 
fits concepts drawn from the frameworks into an overarching structure for evaluating the 
quality of programs or policies with appropriate indicators. 
This Chapter first describes the methods and literature informing the development of the 
framework. The general structure of the framework is then presented, followed by its 
individual components, and a description of how it may be used. Finally, the framework is 
considered in light of the two case studies of HIV integration presented as part of this thesis, 
HIV/TB and HIV/ANC in Peru. The indicators mapped are later used to inform case study 
evaluations performed as Chapters 6 and 7. 
3.1 Methods and existing frameworks 
Literature on general and health system specific integration was reviewed to inform the 
construction of the framework. Its structure is underpinned by principles of health 
service/program evaluation defined by Donabedian’s quality of care paradigm [209]. This is 
a flexible conceptual model which has become common for defining how information for 
evaluation of quality of care can be categorised. It consists of classifying information into 
three categories: structure, function and outcome. Under this model, improvements in the 
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structural components of care lead to improvements in clinical processes, in turn leading to 
improvements in patient outcomes [209]. It is generally used to describe a program within an 
isolated setting within the health system. It is extrapolated in this thesis to describe 
integration within the whole of the health system.  
Structure, function, and outcome categories within the present framework are populated with 
sub-categories, informed by theoretical literature around integration and how it may be 
dissected. Such frameworks have described theoretical concepts of how integration is 
organised in the health system [16], how to implement integration of targeted interventions 
into the health system [13], how to describe such targeted integration [17], dimensions of 
integration [15], and concepts around the strength of integration and its effect on analysis  
[21, 22, 210].  
The present framework has been tested by applying it to the two case studies as part of this 
thesis. This includes mapping an array of potential indicators to be used for evaluation. 
These indicators have been informed by a systematic review (Chapter 4) performed as part 
of this thesis, and the wider integration/HIV literature. They have been grouped in line with 
concepts informing general economic and epidemiological evaluation.  Perspectives for 
cost, explained further below, have been derived from standard concepts in economic 
evaluation [124]. The framework stratifies concepts and indicators of integration along 
different levels at which a health system may function, standard in health systems research 
[16]. 
3.1.1 How the framework is applied 
The framework outlines key factors defining HIV integration modalities and that influence 
the selection of indicators and methods for its evaluation. It guides indicator selection by 
describing key concepts in integration planning, implementation and evaluation. It is also 
designed to describe mechanisms by which integration modalities may result in specific 
outcomes. 
The framework (Figure 3.1) is divided into structural barriers to optimal care, the processes 
which define an integration modality, and potential outcomes following integration. These 
components are stratified by different dissections of the health system. Overarching these 
concepts are the choice of HIV integration complex under evaluation, the unique context 
surrounding the health system and integration, and different stakeholders and perspectives 
involved in evaluation.  
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Structures are defined through a gap analysis, determining structural issues relating to gaps 
between optimal and current system performance. Indicators and consequent methods for 
evaluating integration are isolated following identification of the process which may be used 
to address such barriers. Commonly in ex-post analysis, methods will be determined by the 
availability of indicators. As a final step, appropriate methods are isolated from the available 
indicators. This section describes how each component of the framework can be applied to 
identify comparable integration modalities which may be evaluated through common and 
representative indicators.  
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 Figure 3-1. Theoretical framework 
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3.1.2 HIV integration complex 
Integration of HIV services relies on a secondary health system component with which to be 
integrated. As defined in Chapter 1, the combination of HIV and secondary component is 
termed the integration complex. A natural starting point for defining the integration modality 
under evaluation is to define its integration complex. This is a pragmatic approach as it will 
frame how all other concepts in the framework are defined.  
3.1.3 Structure 
Integration as a process can be described by changes in structure and function of different 
health system components [17]. The framework constructed in this Chapter expands this 
concept to consider purposive integration in response to a specific health system structural 
barrier. 
Integration as a process is designed to overcome barriers by bringing together system 
components in line with different functions of the health system [17]. In this way the concept 
of structure in the framework refers to the infrastructural components of the health system 
under which an identified health system barrier falls. A list of the different structural 
components can be found within the framework (Figure 3.1).  
The framework is designed for providing indicators for evaluation when comparing two 
models of integration, for example, partial vs. full integration of integrated services. 
Comparison relies on observing the improvement of one model over another, implying one 
model is considered a base model for comparison [208]. Structural barriers relate to the base 
case either directly or through potential opportunity cost it imposes [124, 208]. 
Barriers are imposed by system components acting vertically [90]. For example, when a HIV 
program operates with a high degree of verticality, structurally distinct from the TB program, 
services from both programs may be distally located. This can be thought of as a barrier to 
optimal function in responding to patients with HIV/TB comorbidity who need daily treatment 
for both diseases. In this example the barrier falls under the facilities (infrastructure) 
structural component of the health system.  
3.1.4 Process 
Process in the framework refers to how integration is performed [209]. It is the mechanism 
by which integration overcomes structural barriers in line with the different functions of the 
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health system. Functions can be sub-categorised based on health system building blocks 
[13, 17]. A list of the health system functions can be seen within the framework in Figure 3.1. 
An example function is the care pathways or provision of interventions which can be used 
to provide delivery of services to the health consumer [13, 17]. Such pathways may be 
integrated between two system components, such as the HIV and TB programs. This may 
be to overcome barriers to optimal supply and use of essential services [211] such as a lack 
of available sources for care; and demand side barriers [211] such as addressing issues of 
access due to travel times between programs. An example is mandating availability of HIV 
services into TB programmatic areas in primary facilities, or vice versa. 
As discussed above empirical evaluation involves comparing outcomes between a base and 
comparative model. The process of integration will refer to the changes to the system 
provided by the comparative model. For example, when comparing partial vs. full integration 
of HIV services, process will be defined by the system changes which full integration entails. 
3.1.5 Process indicators 
Process indicators are measurements of the direct effect that comparative models of 
integration have had on system function [209]. Deriving from the previous example, a 
process indicator may be the percentage of HIV patients receiving TB preventative testing 
or treatment services or vice versa.  
Process indicators are differentiated from outcome indicators [209], further discussed below, 
which relate to integration outcomes in line with general health system goals. For example, 
mortality/morbidity. Depending on context, process indicators may be more reflective of the 
relative improvements associated with different models of integration. This is due to a variety 
of factors contributing to mortality or morbidity in a complex system.  
3.1.6 Context 
Context surrounds all other framework factors. As discussed in Chapter 2, it involves the 
demographic, economic, socio-economic and technical environment in which the health 
system exists [13, 17]. 
Context influences structural barriers. For example, the political context surrounding the 
health system may influence the relative size of the HIV and TB programs within a country. 
One program may outweigh others in size, influence and resources. It may act as a monolith 
alongside other system components, and so increasing system differentiation, allocating 
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resources to service delivery only to its unique disease problem without considering issues 
such as co-morbidities [24]. This will likely increase structural barriers to optimal system 
function. 
Context may also affect the integration processes addressing such barriers [13, 17]. As an 
example, the relative size of HIV programs may influence the process by which integration 
is implemented. Integration is often performed directionally, integrating one program into 
another. There may be less transactional cost in integrating TB into HIV or vice versa. The 
direction between the two programs may therefore be driven by the relative size of the HIV 
program. 
Context may also affect the indicators used to assess the performance of integration models. 
For example, in a country with a generalised HIV epidemic and a relatively large TB 
epidemic, the primary control strategy for HIV may be focused on treating HIV as a means 
of prevention. Where HIV is a concentrated epidemic, opportune HIV case identification for 
the purposes of treatment may be a more appropriate primary control strategy. Such 
contextual differentiation will affect the usefulness of different process indicators. In a 
country focused on testing and prevention, the percentage of TB patients tested for HIV may 
be more indicative than the percentage of HIV patients abandoning treatment, given the 
relatively small number of patients receiving treatment. In a country with high HIV, ART 
abandonment will be highly indicative of system performance.  
3.1.7 Outcomes 
Outcomes describe the intended output and the integration process [209]. They refer to 
changes in: morbidity or mortality; improvements in knowledge, attitudes, practices of 
patients, at-risk persons, and the general population; and to cost savings. Further 
elaborations of some outcomes may also be useful, such as applying disability or other utility 
weights.  
As with process indicators, the choice of appropriate outcome indicator will be affected by 
contextual factors around integration. For example, the relative size of the HIV epidemic will 
determine the usefulness of mortality related indicators. If very few HIV/TB deaths occur 
within a given setting, determining the relative impact of integration will be likely subject to 
variability due to low sample numbers.  
A further contextual dictate is the economic perspective from which costs are calculated. 
These include the health system, the consumer or wider society among others [124, 212]. 
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Different perspectives will dictate which costs to attribute to the competing integration 
processes.  
3.1.8 Health system levels 
Integration modalities, process/outcome indicators and evaluation methodology will differ 
depending on the targeted dissection of the health system where integration is implemented. 
Such dissections are defined as: macro, meso and micro levels of the health system [16], 
national/sub-national application of integration [17], and primary/secondary/tertiary care 
[213].  Examples are provided below. 
3.1.8.1 Macro, meso and micro 
Indicators will differ depending on whether integration is performed at the macro/meso/micro 
level of the health system [16]. For example, process indicators of health service integration 
at the macro level may be limited to aggregate national measurements, such as the number 
of available facilities within the country or raw numbers of trained personnel. At the 
meso/micro levels process indicators will be able to reflect changes in key performance 
indicators  within the health system, such as improvements in the performance of individual 
facilities.  
3.1.8.2 National or sub-national 
National/sub-national application of integration will influence how integration has been 
performed, for example at the regional/district/facility levels and how its effect should be 
measured [17]. Integrating HIV and TB services at the regional level implies that both 
services are available at a single facility within the region. Integrating HIV and TB services 
at the district level implies that likely all facilities within that district of a specific class, such 
as primary or secondary, are integrated. Integration at the facility level may imply that 
specific improvements outside of availability of services are performed to improve services.  
3.1.8.3 Levels of care 
Finally, integration differs when applied to primary, secondary or tertiary facilities [213] 
affecting available indicators. As an example HIV and TB programs may be integrated in 
response to low coverage, which is in part driven by distally located service delivery sites 
[67]. Small primary facilities often employ limited staff who respond to a wide variety of health 
issues. Integration of services in these settings may not require major investments in 
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infrastructure or reorganisation. It may, however, focus on making novel integrated services 
available within the facility. Higher facilities such as hospitals, on the other hand, are much 
larger with individual programs operating in isolation despite residing in the same facility. 
Service integration, in this instance, will require a more formal structure be imposed to 
achieve desired improvements. 
3.1.9 Mapping selection of indicators 
Selecting indicators for impact evaluation implies that two similar modalities  of integration 
are being compared. Appropriate indicators should reflect differences between the 
modalities [133, 208]. Caution should be employed when selecting indicators for integration 
as not all possible indicators will accurately represent the unique mechanisms of the 
targeted comparison. Selecting indicators for impact based on the framework must also 
consider the unique context and perspective of stakeholders involved in evaluation.  
Generally, the eventual goal of integration will be to reduce mortality or morbidity due to HIV 
or another related disease, or to minimise costs. Such outcome indicators, however, may 
not suitably demonstrate the impact of all integration modalities. The direct mechanism by 
which the policy results in changes in the outcome may not be plausible. As discussed 
above, this is due to a variety of factors contributing to mortality or morbidity in a complex 
system [133, 208]. In many cases process indicators may be more appropriate for determining 
impact, particularly at lower dissections of the health system where deaths or incident events 
are relatively infrequent. In this way context interacts with the choice of indicators for 
evaluation.  
Context is also important in selecting process indicators. In situations where one system 
component outweighs others in terms of infrastructure or resources, smaller system 
components will likely be integrated into larger components [90]. This will affect choice of 
processes to measure. For example, consider a country with a large epidemic of injected 
drug use and small concentrated HIV epidemic. The country will likely have a small HIV 
program integrated into a larger program for treating Injecting Drug Users (IDUs) within 
primary facilities, such as frequently occurs in several eastern European countries [214]. Two 
types of patients, both of whom are unaware of their HIV status, may present at such primary 
facilities. Firstly, relatively few non IDUs who are HIV positive. Once confirmed positive these 
patients will receive education on common infection pathways such as shared needle usage. 
A consequent indicator used may be the percentage of confirmed positive HIV patients who 
receive counselling on HIV prevention. Secondly, relatively more IDU’s who are either HIV 
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positive or negative but who require testing regardless given their high-risk status. A 
consequent indicator for this group will be percentage of IDU’s being tested for HIV. Two 
process indicators may be used in this example. However, given the likely relative 
infrequency of non IDU HIV positive patients presenting in such a scenario, the second 
indicator will be much more indicative of impact. 
Finally, on a practical note, ex-post analysis may limit information or data available for 
evaluation. This framework provides a method to map potential indicators, based on 
plausible mechanisms, after defining integration modalities. Deciding which indicators are 
used in the final evaluation, however, will be dictated by their availability within the data.  
3.2 Application of the framework 
The following section provides two worked examples of the framework, using two case 
studies of HIV service integration evaluation. The framework is used to isolate appropriate 
indicators for impact evaluations which are later performed in Chapters 6 and 7. Drawing 
from the natural starting point of defining the integration complex, described above, the first 
example identifies plausible indicators for evaluating HIV/ANC integration, the second 
evaluating HIV/TB integration.  
As discussed in Chapter 1, both case studies focus on integration of HIV services. Two 
different models of service integration are compared per case study. They differ in the 
availability of different services available at primary facilities, with one model [full integration], 
having a full spectrum of HIV services available while the second model [partial integration] 
only HIV testing. The corresponding secondary program (i.e. TB or ANC) has all services 
available in both models in primary facilities. 
Each example deconstructs the competing modalities of integration under evaluation. 
Deconstruction involves highlighting health system barriers related to partial integration, 
consequent integration processes related to full integration and potential outcomes. 
Indicators linked to process and outcome are mapped and appropriate evaluation methods 
are suggested.  
These two models have been implemented in 2005 in Peru. Prior to this, HIV services within 
the public system were available only at secondary or tertiary facilities. As mentioned above, 
the analysis conducted in this thesis is ex-post. For the purposes of the thesis, evaluation is 
focused at the meso (service delivery) and micro (patient receiving services) levels. As will 
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be discussed below the evaluation is limited to primary care. It is also limited to analysing 
integration at the local (health facility) level. 
The framework above describes identification of barriers through a gap analysis which is 
often performed by stakeholder interview or reviews of system processes. This was outside 
the budget and time availabilities for this thesis. The barriers and processes identified below 
are limited to retrospective reviews of the literature. 
3.2.1 Framework applied to partial vs fully integrated HIV/ANC services in Peru 
As discussed in Chapter 2 HIV/ANC service integration has been recommended by the 
WHO as ANC services provide a first contact point for many potential HIV positive mothers 
[215]. ANC is a key platform for identifying women who are HIV positive, directing them to 
treatment and preventing transmission of HIV to their newborn child [216]. ANC is also a key 
surveillance platform for HIV [217]. Strengthening HIV related services during ANC is a HIV 
control priority in Peru [88].  
3.2.1.1 Context and stakeholders 
Key contextual factors, identified through a review of the literature, dictate modalities and 
evaluation of HIV/ANC integration in Peru. These factors are introduced and briefly 
discussed in this section, with further discussion on how they directly affect structure, 
process and outcomes. 
As discussed in Chapter 2, HIV in Peru is in a concentrated epidemic state [84, 85]. This has 
dictated that, while treatment of HIV is important, primary prevention may yield greater 
returns on investment as a control strategy. The HIV program has largely acted vertically 
prior to integration with primary functions performed in secondary facilities [194]. This has 
dictated the relative size of the HIV program with respect to infrastructure and budget. 
The ANC program is present throughout all primary and secondary facilities within Peru [88]. 
The MNCH program under which ANC falls is better resourced in comparison to HIV. ANC 
is a free service to all expectant mothers with a series of standard tests and procedures. 
Prior to, during and after integration a full ANC check has been available at all primary 
facilities throughout the country. The goal of integration is directed towards leveraging 
resources from the ANC program to strengthen HIV service delivery [88]. 
Prior to 2005, the HIV and ANC programs in Peru have operated vertically to one another, 
services from both programs were distally located, for example, with ANC in primary 
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facilities, HIV in secondary. Following 2005 HIV services were further decentralised to 
primary care facilities [84, 92].  
Primary stakeholders who may benefit from this evaluation are policy makers at the regional 
and national level, as this integration is essentially a trial of health policy, which may have 
ramifications for health system structuring in similar contexts. Given this emphasis, in 
relation to costs, the evaluation may be considered from a health systems perspective. 
3.2.1.2 Structure and barriers to optimal care 
In Peru finding and treating all expectant mothers who have HIV is key to optimal system 
performance. Early detection in pregnant women during ANC prevents lifelong infection of 
their child, prevents further spread of the disease and can be used as a platform for initiating 
treatment [218]. HIV testing during ANC is also the primary surveillance platform for 
assessing the level of the epidemic within the population. An optimally functioning system 
will be able to maximise HIV testing during ANC while ensuring further treatment following 
HIV integration. 
As described above the integration models under evaluation differ on how they deliver 
different services, thus falling under the service delivery structural component of the health 
system. Structural barriers to optimal function may be imposed by the separation of services 
under the partially integrated model. Suboptimal system performance may be through 
barriers relating to infrastructure, supply of drugs, technologies and medical supplies, and 
human resources. Table 3.1 below presents different structural barriers relating to the 
partially integrated HIV/ANC model. They are discussed below. 
3.2.1.2.1 Inadequate coverage (demand) 
Inadequate coverage (demand) may be driven by pregnant women’s inadequate 
appreciation of the implications of knowing their HIV status. If pregnant women are not 
aware of the importance of HIV status they may be unwilling to take the HIV test when 
offered. Partially integrated services may less effectively convey the importance of HIV 
status. This may affect women’s choice to accept the test. Joint services may also reduce 
stigma for people attending clinics and the general community [115]. Inadequate knowledge 
may also lead to pregnant women being unaware that an effective treatment is available for 
them and their children. It may also limit the likelihood that they access PMTCT drugs around 
the time of birth. Finally, HIV positive pregnant women may be less inclined to travel to 
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receive treatment before and around the time of pregnancy if they are required to travel to 
a secondary facility to receive it. 
3.2.1.2.2 Inadequate coverage (supply) 
Inadequate coverage (supply) barriers identified in the partially integrated model relate to 
the provision of essential services. Pregnant women who have HIV require sufficient 
coverage of ART to be able to make use of the service. If inadequate locations provide the 
service, supply will not be sufficient to cover key populations of HIV positive women. 
Infrastructural barriers also relate to potential cost-savings generated by sharing 
infrastructure between HIV and ANC system components. In fully integrated facilities HIV 
and ANC services will be delivered jointly using the same infrastructure. Partially integrated 
services necessitate separate infrastructure associated with ART in secondary facilities. 
This presents an extra cost to the health system. 
3.2.1.2.3 Logistics 
Logistics barriers relate to unified, and non-unified logistic chains for the provision of medical 
supplies and drugs [24]. Non-unified chains are more likely to experience stock-outs of 
supplies when needed [24]. Stock-outs occur when the health facility does not have 
sufficient consumable resources to provide the given service [219], in this case insufficient 
HIV test kits or ARVs. Pregnant women who may be ready and willing to be tested for HIV 
will be unable to have them. They may also not be able to access ART prior to giving birth. 
Initiating ART may be foregone if the woman is required to return to the health facility solely 
for ART. Stock-outs at the time of birth may also result in the unavailability of Neviprine 
which is critical in preventing MTCT. Finally separated logistic chains impose an opportunity 
cost as transport of HIV related services is potentially doubled (to both secondary and 
primary facilities). 
3.2.1.2.4 Human Resources 
HR structural barriers relate to inadequate knowledge about the importance of HIV status 
amongst health workers. Health workers may be inadequately trained, or generally unaware 
of the importance of providing HIV testing and services to pregnant women. They may also 
be unaware of the importance of articulating that ART services are free and available. Full 
integration imposes training, often informal but also formal, on health workers around such 
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issues. Partial integration will likely be associated with less comprehensive training on HIV 
and be a barrier to optimal care. 
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Table 3-1 Structural HIV/ANC service delivery barriers and functional integration modalities 
Service delivery structure and barrier Function and integration process 
Infrastructure Care pathways/provision of interventions 
Inadequate coverage (demand) Joint service delivery reducing access 
barriers  
Joint service delivery reducing stigma 
Inadequate coverage (supply) Integration HIV service to primary facilities, 
more avenues for care 
Drugs, medical technologies and, medical 
supplies 
Procurement and distribution of drugs 
and medical supplies 
Stock-outs Joint service delivery combining logistic 
networks 
HR Training/development of HR 
Health personnel inadequately trained on the 
importance of HIV services 
Health workers trained in HIV 
 
3.2.1.3 Process 
In response to these health system barriers HIV and ANC services may be fully integrated. 
This implies a process that encompasses unifying health system functions between the two 
programs. These functions include; procurement and distribution of drugs and medical 
supplies (ie logistics), cascade of care pathways/provision of interventions and, training 
development of HR. Descriptions of integration amongst these functions can be found in 
Table 3.1 above. They are further elaborated below. 
3.2.1.3.1 Care cascade/provision of interventions 
Combining care pathways by having all services available at a single centre provides the 
opportunity for pregnant women to receive confirmatory tests or ART, without having to 
travel following ANC or HIV testing. This likely increases ART initiation and retention. Full 
integration of both services may influence pregnant women’s knowledge of the importance 
of HIV status and ART thus increasing demand for services such as HIV testing. It has also 
shown to be associated with a reduction in stigma both for HIV patients and the wider 
community [112, 115].  
Full integration of services increases coverage of ART to primary facilities throughout the 
country. This implies a larger percentage of the population able to receive such services. 
Fully integrated services may also decrease cost through shared infrastructure. 
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3.2.1.3.2 Logistics 
By combining logistic chains, procurement and delivery of drugs may prevent the likelihood 
of stock outs. This will affect the provision of essential services allowing the timely delivery 
of HIV tests, ART when needed and Nevaprine at the time of birth. Combined logistic chains 
also present a cost savings on transport. 
3.2.1.3.3 Human Resources 
Full integration imposes a requirement on health personnel to learn the administration of 
ART. This implies that personnel will be able to articulate that effective treatment for HIV is 
available, that it is free within the country and that it can be used to prevent MTCT. Having 
to provide ART may also provide informal training which may allow the personnel to describe 
the importance of knowing HIV status prior to giving birth. 
3.2.1.4 Process indicators 
Drawing from the potential improvements, in response to structural barriers provided above, 
key indicators of improved processes can be mapped. A full list of indicators can be found 
in Table 3.2 below. Here a brief discussion around selection of indicators is provided.  
Indicators may be function specific, such as improved HIV knowledge of health personnel 
which relates to integrated HR training. They may also relate to more than one function, for 
example improved percentage of pregnant women receiving HIV tests during ANC.  This 
can relate to integration of care pathways, logistic chains and/or HR and training. 
Indicators can be at multiple levels of observation. An indicator associated with improved 
logistic chains may be the percentage of eligible women initiating ART during ANC at the 
facility level. It may also be the individual likelihood of initiating ART during ANC. Improved 
logistic chains may also be observed at the level of the facility, such as through 
demonstrating the availability of key drugs during audit.  
Indicators of care pathways will be dictated by the availability of data at different levels. In 
the partially integrated model, ART is not available in primary facilities, meaning that 
measuring the uptake of ART in this model is impossible. Such measurement will only be 
available if data on ART uptake at the corresponding secondary facility is available. This 
necessitates that integration be measured as an average over population in the area which 
the secondary facility serves (ie district or region). 
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In the instance where secondary facility data are not available or desirable, alternate 
indicators which are common between the two models may be used. For example, the 
likelihood of a pregnant woman receiving a HIV test during ANC. 
3.2.1.5 Outcomes 
Full integration of HIV/ANC services will potentially affect key outcomes. These outcomes 
fall under general categories of improvements in morbidity/mortality, knowledge attitudes 
and practices of patients, and cost savings. A list of potential outcomes is provided in Table 
3.2 below.  
As with process indicators certain outcomes will only reflect potential changes along a single 
integration function or in relation to a specific barrier. For example, costs savings related to 
transport will be limited to integration of logistic chains. More general indicators, such as 
reduced stigma may reflect integration of HR training and service delivery platforms. 
Mortality and morbidity indicators are very general and in some instances it may be difficult 
to directly attribute improvements to integration. In the case of Peru, relatively few HIV 
deaths occur within the country. If comparing change due to integration at higher sub-
national levels, such as region, there may be sufficient occurrences of death for a 
measurable difference associated with integration. If comparing at lower levels, however, 
limited number of deaths may cause large variability limiting the reliability of such measures
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Table 3.2 Map of indicators by health system function, reflecting improvements in full over partial integration of HIV/ANC services in Peru 
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Process indicators      
% of pregnant women receiving HIV test during ANC * *  * * 
% of pregnant women receiving HIV test results * *  * * 
% of pregnant women receiving HIV counselling during ANC (pre or post) *   * * 
% of HIV positive women receiving ART before birth * *  * * 
% of HIV positive pregnant women using Nevaprine before/during birth * *  * * 
% of HIV patients beginning/continuing/dropout of treatment * *  * * 
% of population within X distance of facility offering service *  *   
% of at-risk populations living within X distance of facility offering service *  *   
% of primary services offering services *  *   
Stock-out frequency     * 
Drug availability through audit   *   
Health worker knowledge     * 
Outcome indicators      
Mortality/Morbidity      
HIV death (general)   *  *  
HIV incidence (newborn)  * * * * 
HIV incidence (general) * * * * * 
KAP     * 
61 
 
Patient knowledge/attitudes towards HIV  (community)      
Patient knowledge/attitudes towards HIV (themselves) * *   * 
Women (pregnant women) risk behaviour (safe sex practices)  *   * 
Costs      
Patient travel time  *    
Shared infrastructure between programs  *    
Reduced transport costs for drugs supplies etc. *  * *  
Shared patient load for health workers *  *  * 
Patient loss of productivity due to disease/travel *  *   
Readmission for inadequate TB treatment * * *   
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3.2.1.6 Selection of indicators 
Selecting appropriate indicators for evaluating integration should consider context. The HIV 
program is relatively limited in terms of resources and infrastructure when compared to the 
reach of the ANC program. This dictates that improvements from integration be targeted at 
improving the under resourced HIV program. Limited HIV infections and deaths in the 
general population, due to the size of the epidemic, limit the usefulness of indicators relating 
to HIV treatment and death. 
Indicators which are likely to show a measurable change between partial and full integration 
models are limited in this case to those measurable within primary settings, as data are only 
available at this level. Consequently, process indicators which measure available services 
in both models in primary services are necessary. This limits indicators to those which 
measure HIV prevention or testing which are present in health integration models. 
The limit to primary services also restricts available outcome indicators. For example costs 
are also limited to those only incurred at primary facilities. This may include patient out of 
pocket cost, including direct and indirect costs due to travel for receiving treatment. These 
costs, however, are generally not considered from a health system perspective. Relevant 
outcome indicators may be those which measure changes in patient (with or without HIV) 
knowledge attitudes and practices towards HIV.  
The data used to evaluate HIV/ANC integration in the case study Chapter has restrictions 
which limit the availability of indicators. A sole process indicator - a pregnant woman’s 
likelihood of receiving an HIV test during ANC - is available. Two further outcome indicators 
associated with knowledge and attitudes of pregnant women towards HIV are used. No 
costing data was available. Further limitations within the data and the application of selected 
indicators are discussed in Chapters 5 and 6. 
3.2.1.7 Methods 
Methods in ex-post evaluation are largely dictated by the availability and quality of data. The 
above indicators are limited in scope to those which can demonstrate improvements in full 
integration through improved testing processes or knowledge/attitudes/practices towards 
HIV. This limits the use of cost analysis and consequently cost-effectiveness. Methods for 
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this case study therefore revolve around establishing the effectiveness of full integration 
through impact evaluation. 
3.2.2 Framework applied to partially vs fully integrated HIV/TB services in Peru 
This section presents the application of the framework of the HIV/TB case study of service 
integration in Peru. As discussed in Chapter 2, TB services are recommended for integration 
by the WHO due to the synergistic nature of the diseases and similarities in treatment 
models between the two diseases [65]. HIV patients in a TB endemic country run a high risk 
of being infected with TB and vice-versa. TB is also the leading cause of HIV related death 
world-wide [180]. HIV and TB treatment share similar delivery platforms. Both require 
patients to present frequently at treatment delivery centres to receive treatments which have 
strong side effects [182].  HIV/TB programs will be most effective when they are integrated 
in the presence of both diseases with similar delivery platforms [62].  
3.2.2.1 Context stakeholders and perspectives 
Several contextual factors influence the modality and evaluation of integration in Peru. 
These are primarily the ecological and political situation surrounding the health system, 
introduced below and further discussed in relevant sections.  
As with the previous case study an important contextual factor is the relative size of the HIV 
epidemic in Peru. In this case however it also includes the TB epidemic in the country. TB 
in Peru is endemic, and services have been historically intertwined with development of the 
country’s health system [220]. HIV is a smaller concentrated epidemic [84, 85]. The TB 
program is a monolith while the HIV program much smaller in relative terms [194]. Full 
integration of HIV services will aim at strengthening the HIV program by leveraging the 
resources from the relatively larger TB program. As with the previous case study primary 
stakeholders are policy makers at the regional and national level. Costs are framed from a 
health systems perspective. 
3.2.2.2 Structure and barriers to optimal care 
Given the synergistic nature of TB and HIV optimal health system performance in Peru will 
involve ensuring that all TB patients receive a selection of HIV services and vice versa. 
These include prevention, testing and treatment (if needed). Controlling HIV will revolve 
around ensuring that all TB patients are aware of their HIV status as a method of prevention. 
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Table 3.3 below presents different structural issues which may occur with a partially 
integrated HIV/TB model. These are further discussed here. 
As with HIV/ANC the difference in HIV integration models falls under the Service Delivery 
health system building block in Figure 3.1, as it is primarily health services that are being re-
organised with the same structural barriers.   
3.2.2.2.1 Infrastructure 
In the partially integrated model, HIV treatment is provided only at higher facilities. This 
presents a barrier to providing adequate coverage of some HIV services. The HIV program 
has a lesser reach, so patients need to travel further to receive them. Patients with both HIV 
and TB face costs related to travelling to multiple facilities to receive treatment. [221]. This is 
likely to contribute to treatment failure or drop out. HIV and TB treatment share similar 
delivery platforms in Peru. Treatments are often administered under DOT to ensure 
compliance. Both treatments are intensive, which is a burden on the patient exacerbated if 
they are required to travel to two facilities to receive treatment. Stigma is a common barrier 
to continued access with both models. Distally located HIV treatment services has been 
suggested to exacerbate stigma by making HIV patients more obvious when seeking 
treatment, particularly if HIV services are in a stand-alone facility [115]. TB patients may be 
less inclined to take a HIV test or wait for results in a partially integrated setting. Separate 
infrastructure (including utilities) and separate staff are also sources of opportunity cost. 
3.2.2.2.2 Logistics 
As with the previous case study separate logistic chains may result in stock-outs. 
Consequently, HIV and TB patients may not receive appropriate testing or treatment for both 
diseases. There is also an opportunity cost, the cost of transport, which is incurred when TB 
and HIV supplies are delivered separately.  
3.2.2.2.3 HR 
Health workers in the partially integrated setting have likely not received training (formal or 
informal) on available treatment of HIV once diagnosed. In this case the importance of 
knowing HIV status to TB patients may not be conveyed. Integration of HIV and TB services 
is also often coupled with specialist training on the synergistic nature of the diseases. 
Treatment regimens must often consider the HIV or TB status of the patient. Separated 
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services also mean a lost opportunity for cost sharing of resources between programs, such 
as human resources. 
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Table 3.3. HIV/TB Structural service delivery barriers and functional integration modalities 
Service delivery structure and 
barrier 
Function and integration 
Infrastructure Care pathways/provision of interventions 
Inadequate coverage (demand) Joint service delivery reducing access barriers  
Joint service delivery reducing stigma 
Inadequate coverage (supply) Integration HIV service to primary facilities, more avenues 
for care 
Separate infrastructure opportunity 
cost 
 
Drugs, medical technologies 
and, medical supplies 
Procurement and distribution of drugs and medical 
supplies 
Stock-outs Joint service delivery combining logistic networks 
Separate logistic networks 
opportunity cost 
 
HR Training/development of HR 
Health personnel inadequately 
trained on comorbidities 
Health workers trained in comorbidity (TB to HIV or vice 
versa) (formally or informal training) 
Separate staff for each programme 
opportunity cost 
Single personnel providing dual services 
 
3.2.2.3 Process 
As with the previous case study health system functions may be integrated between different 
system components along system functions in response to structural barriers imposed by 
partial integration. These processes are provided in Table 3.3 and discussed below.  
3.2.2.3.1 Care cascade 
Unifying care pathways of HIV and TB services may address low coverage by removing 
infrastructural barriers. By decentralising HIV services, more avenues for treatment, with 
less consequent travel time, become available. Joint infrastructure provision may also 
influence stigma and patient knowledge of HIV and TB. 
3.2.2.3.2 Logistics 
By integrating the procurement of medical supplies, HIV/TB programs can take advantage 
of strengthened logistic networks to avoid stock-outs. Joint logistic chains may also impose 
a cost savings on transport. 
3.2.2.3.3 HR 
Integrating treatment services often involves formal or informal training of health workers on 
co-morbidities such as HIV/TB. Improved health worker knowledge about both diseases may 
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overcome demand-side knowledge barriers by providing counselling and testing for HIV, 
when a patient has presented for TB and vice versa. Cost related barriers may be overcome 
by resource sharing through integrated infrastructure. Finally, improved provider training and 
available resources for co-morbidities will increase the quality and effectiveness of HIV/TB 
care. 
3.2.2.4 Process indicators 
Key indicators for comparing the impact of integration models are isolated in line with 
barriers and consequent processes discussed above. A list of process indicators and their 
relation to integration processes can be found in Table 3.5 below. Attention is drawn to them 
here. 
Process indicators relating to improved coverage can measure rate improvements for 
specific services. For example, the percentage of TB or HIV patients initiating, continuing, 
dropping out or completing treatment for their comorbidity.   
Indicators for improvements relating to logistic barriers may also be represented by 
improved use of essential services, for example the increased percentage of TB patients 
receiving an HIV test. Improved logistic chains can also be directly measured through 
indicators such as availability of resources at given facilities. For example, percentage of 
facilities with HIV tests on hand, following facility surveys. 
Improvements in human resource barriers may also be measured through improvements in 
service use. For example, the percentage of TB patients having an HIV test and receiving 
their results. This indicator may nuance certain barriers, such as a lack of health worker 
training on co-morbidities, compared to measures of tests given out. Direct measures of 
health worker training, such as knowledge tests, or completed trainings are also strong 
indicators. 
3.2.2.5 Outcomes 
Integrating HIV and TB services in this case study will have a variety of potential outcomes.  
Mortality indicators may be approached as general HIV related deaths, general TB deaths 
or HIV/TB related deaths. This depends on the way which death is codified. HIV/TB death 
will clearly be the most useful for measuring full integration. However, these indicators are 
often limited in scope, as is the case of Peru, as relatively few HIV/TB deaths occur, 
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particularly at sub-national levels. If measuring integration at primary services, issues arise 
around low occurrence in indicators, as with the HIV/ANC case study.  
Knowledge or risk behaviour outcomes may also be considered, including knowledge and 
attitudes towards both diseases — for example an HIV positive patient’s awareness of 
methods to prevent spreading the disease to sexual partners. These behavioural indicators 
may comprise a composite knowledge score or may be more targeted — as per prevention 
indicators. TB behavioural outcomes are also derived in this way, such as knowledge of the 
need to cover coughs, or the importance of completing full antibiotic treatment. Such 
indicators can be targeted towards either disease, or towards co-infected patients. For 
HIV/TB it may involve understanding the importance of taking both drug regimens where 
applicable.  
Measures of attitudes can involve stigma towards persons with HIV or TB or attitudes of 
despair which may impair continued treatment. Risk behaviour can involve the use of 
preventative measures to prevent further transmission of either disease.  
Cost indicators may involve potential savings of direct costs, such as savings on personnel, 
transport costs or infrastructure. Indirect costs may also be of value based on reductions in 
TB and HIV burden. Table 3.5 below provides a list of possible indicators. 
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Table 3.4. Map of indicators by health system function, reflecting improvements in full over partial integration of HIV/TB services in Peru 
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Process indicators      
% of at-risk TB patients receiving preventative HIV * *  * * 
% of HIV patients receiving preventative TB  * *  * * 
% of TB or HIV or HIV/TB patients using direct HIV prevention methods *   * * 
% of HIV patients with TB test and results * *  * * 
% of TB patients with HIV test and results * *  * * 
% of TB patients beginning/completing treatment/dropout * *  * * 
% of HIV patients beginning/continuing/dropout of treatment * *  * * 
%of TB patients beginning/continuing/dropping out of HIV treatment * *  * * 
%of HIV patients beginning/completing/dropping out of TB treatment * *  * * 
% of population within X distance of facility offering service *  *   
% of at-risk populations living within X distance of facility offering service *  *   
% of primary services offering services *  *   
Stock-out frequency    *  
Drug availability through audit    *  
Health worker knowledge     * 
Outcome indicators      
Mortality/Morbidity      
TB death *  * * * 
HIV/TB death *  * * * 
HIV incidence rate * * * * * 
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TB incidence rate  * * * * * 
HIV/TB comorbidity incidence * * * * * 
KAP      
Patient knowledge/attitudes towards HIV or TB (community) * *    
Patient knowledge/attitudes towards HIV or TB (themselves) * *   * 
Patient risk behaviour (safe sex practices)  *   * 
Patient knowledge of co-morbidities  *   * 
Costs      
Patient travel time *  *   
Shared infrastructure between programs   *   
Reduced transport costs for drugs supplies etc. *  * *  
Shared patient load for health workers *  *  * 
Patient loss of productivity due to disease/travel *  *   
Readmission for inadequate TB treatment * * *   
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3.2.2.6 Selection of indicators  
As with the previous case study, context and the relative size of the TB and HIV epidemics 
will dictate the usefulness different indicators for evaluating integration. Indicators reflecting 
proportions of TB patients receiving HIV tests will be more useful than HIV patients receiving 
TB tests. This is because of the relative infrequency of patients presenting for care in the 
first instance for HIV. The use of TB patients receiving HIV treatment as an indicator may 
also be problematic due to a limited frequency of HIV/TB. The case study evaluates HIV/TB 
integration at the level of primary facility, restricting the use of indicators relating to HIV 
treatment and death.  
In the case of Peru, TB death may be used as an indicator between the two models, although 
this may not be optimal. It is difficult to disaggregate TB deaths from other factors that 
integration might not affect. While useful to observe if possible, impact based on this sole 
indicator may not be a reliable indication of integration effectiveness. Depending on the 
integration modality different knowledge, aptitude and practices (KAP) indicators may be 
useful for evaluating HIV/TB integration. Cost indicators are useful, assuming cost savings 
can be scaled.  
Following review of the data used for this case study, further discussed in Chapters 5 and 
7, a range of indicators has been selected. Not all indicators discussed above are present 
in the data. Given this constraint, the following two primary indicators of impact were 
selected: percentage of TB patients receiving an HIV test, and the percentage of TB patients 
receiving an HIV test who also received their result. Because it was available, a secondary 
indicator was included: the rate of TB deaths/TB incidence. Costing of different integration 
models were not available. Given the restriction of indicators, evaluation is limited to 
establishing the effectiveness of higher integration. 
3.2.2.7 Methods 
Given the limitations of the data, and in line with the context in which integration has taken 
place, methods which measure the impact of HIV service integration are used. Methods 
which incorporate cost are not possible given the limitations of the data. 
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3.3 Discussion 
Impact evaluation relies on availability of indicators which reflect relative differences 
between treatments/policies. Establishing the mechanism by which integration can result in 
changes in select indicators is also an important step for potential claims of causality [127, 
222]. Selecting indicators and describing plausible mechanisms for causality are 
complicated by the broad variety of modalities and consequent outcomes which integration 
can entail.  
The framework constructed for this chapter was designed to explore the broad array of 
potential mechanisms by which HIV integration may have causal effects. Integration differs 
to other health policies through its inherent complexity. This complexity has largely been 
addressed in existing literature, through frameworks which describe different models, 
outcomes and purposes for integration [13, 15-17, 21, 22, 210]. This chapter extends these 
frameworks to guide selection of indicators to reflect differences in defined integration 
modalities and provides a map for causal mechanisms. 
Providing a clear pathway which can link policy to outcome is an important step in 
establishing causality [127, 222]. Commonly in randomised evaluations mechanisms are 
established prior to the application of the policy. Ex-post evaluation however, requires them 
to be established potentially post policy application. This involves mapping potential 
consequences of policy which conform to the current knowledge or evidence, or provide 
reasons why they may differ [127, 222]. Given the variety intended and un-intended 
consequences in policy, this becomes a challenging exercise. 
The structure/process/outcome paradigm helps to simplify mapping causal mechanisms by 
deconstructing and categorising a policy or program. It has become commonplace for 
evaluating health programs and policy [223] and is sufficiently flexible to be applied to 
quantitative [224] and qualitative studies, guiding systematic reviews [225], selecting key 
indicators [226] and constructing frameworks for evaluation [227]. It’s demonstrated fit to 
application of HIV integration evaluation presented in this chapter adds a further dimension 
to its applicability.  
As shown from both case studies above, the impact of HIV integration can be measured 
across a broad array of indicators. However, some indicators are better able to describe the 
relative impact of comparative policies. Both case studies described the relative difference 
between mortality/morbidity and health system strengthening indicators such as percentage 
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of TB positive patients given HIV tests.  Give the context surrounding the case studies it is 
difficult to suggest a mechanism by which integration has direct causal impacts on 
mortality/morbidity. This is reflective of literature around HIV integration [62], particularly in 
concentrated epidemic settings. Through application of the framework, process focused 
indicators are likely to better reflect the relative effect of the comparative integration models 
evaluated in this thesis. 
3.4 Conclusions 
This chapter was designed to provide a framework for mapping plausible indictors for 
evaluating comparative modalities of HIV integration. Drawing from literature reviewed in 
Chapter 2, the framework was used to sub-categorise integration as a wide variety of 
processes which address an equally wide array of structural health system issues. A 
resulting array of indicators were described and concluded to be plausible for evaluation 
dependant on sound mechanisms of action linking them to specific modalities. Different sub-
categories of indicator were described as better reflecting modalities, as was demonstrated 
through application of the framework to two case studies. Here it was concluded that the 
modalities evaluated were best reflected through process indicators as opposed to 
mortality/morbidity-based outcomes.  
The chapter focused on indicators used to evaluate HIV integration. As discussed in 
Chapters 1 and 2 however, integration evaluation is also inhibited by an inability to 
randomise, potential clustering and evaluation being conducted ex-post. The following 
Chapter provides insights into how HIV integration has previously been evaluated in the 
empirical literature with a focus on these specific issues.  
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4 Systematic review of methods for measuring the impact of HIV integration into 
primary facilities in LMICs 
HIV integration is an increasingly common approach to health systems strengthening in 
LMICs where HIV burdens are large. As a result a growing body of research has developed 
[14, 53, 60, 122]. Systematic reviews of empirical HIV integration research have found it to be, 
on balance, associated with positive impacts [53, 60, 62, 119, 122, 215, 216, 228-231]. For 
evidence-based decision making, however, methods used to derive impacts are important 
to consider when critically assessing the results [133, 208]. As discussed in Chapter 2, ideal 
methods or study designs will be able to control for selection and other biases. They will 
also use appropriate statistical techniques for sound inference, for example, accounting for 
clustering when present. Methods used that are unable to meet these criteria erode the 
confidence which can be placed in estimates of impact and means that decision makers rely 
on evidence which may be limited by selection bias.  
Previous systematic reviews of both HIV integration and general health system integration 
have provided only a cursory evaluation of study methods and designs; few address the 
methodological issues discussed above [53, 60, 62, 119, 215, 228, 229, 231, 232]. HIV integration 
is particularly susceptible to issues of selection bias and clustering. A review is therefore 
needed to determine the prevalence of such issues in the empirical HIV integration literature. 
This will aid in establishing the internal validity of the empirical HIV integration literature. 
This chapter systematically reviews all current empirical literature on HIV integration into 
primary care in LIMCs. It begins by re-iterating the methodological issues surrounding 
estimation of causal impacts of policy. Scope and methods are then provided, followed by 
the results of the review. This includes a discussion on common study designs found 
throughout the review. The Chapter ends with a discussion around the extent of 
methodological issues in the empirical HIV integration literature.  
4.1 Methodological issues in impact evaluation of policy 
Effective decision making for policy requires a strong evidence-base [233-235]. If evaluation 
is potentially biased or performed with inappropriate techniques for estimating impact, 
incorrect inferences about the effectiveness of the policy may be made. Biased evaluation 
can result in a misspecification of the size, direction or existence of an effect of policy [36]. 
4.1.1 Selection Bias 
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A primary criterion for scrutinising a method used for impact evaluation is its ability to control 
selection bias or other forms of endogeneity [74]. The method/study design used in an impact 
evaluation can determine if, on average, differences between recipients of different policy 
models exist. These differences in turn can confound causal comparisons of policy [36].   
When possible, selection bias is addressed through randomisation [236]. However, 
randomisation of policy is often not practical [237]. Consequently, policy analysts must 
decide what, if any, methods are used to produce unbiased estimates of policy effect in the 
absence of randomisation. The choice of method and its relative ability to control bias 
contributes the strength which can be applied to estimates of policy impact. 
4.1.2 Clustering of health policy 
As discussed in Chapter 2 health policy such as integration is often only able to be 
administered at higher level units such as districts or health centres, as opposed to 
individuals [33]. This results in data which has multiple clusters of individuals receiving 
treatment or control policy models. Such clustering may accentuate systematic differences 
between comparative policy models [33]. This is in addition to issues of systematic 
differences between the clusters themselves [32], such as HIV incidence at a district level or 
relative resources available for different health centres.  
Impact evaluation also frequently relies on regression. As further discussed in Chapter 5, 
standard (naïve) regression applied to clustered data are in violation of several classic 
assumptions [83]. This in turn reduces the validity and reliability of estimates of policy impact. 
If regression is to be used in the presence of clustering, statistical models should be used 
which consider the structure of the data.  
4.1.3 Ex-post evaluation 
As discussed in Chapter 1, ex-post evaluation is performed following the implementation of 
the policy or program being evaluated. This is as opposed to evaluations planned before 
implementation which consequently are capable of being incorporated into the roll-out of the 
policy. This has several benefits which may aid in establishing internal validity of the study 
[35]. 
Assuming the analyst has control over the application of the policy, they may be able to 
assign who does and does not receive treatment. Secondly, assuming the analyst has 
control over the scope of data collected to inform the evaluation, it means that important 
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variables may be included. Thirdly, assuming the analyst has control over when such 
variables are collected, they will be able to conduct data analysis both before and after the 
implementation of the policy. 
These three issues are not mutually exclusive. For example, the analyst may not have been 
able to control how policy was applied, but they may be able to control the data collection 
process. This, in turn, may be both before and after application of the policy or restricted to 
only after. Studies in this review were grouped as ex-post or otherwise. Ex-post was deemed 
to be any study performed after the fact with or without control over data collection.  
4.2 Scope of review 
This review focuses on how researchers have addressed issues of bias and clustering in 
study design or statistical methods in empirical research. Other important aspects of studies, 
such as ex-post evaluation, results, integration modality, indicators, and integration models 
are also briefly reviewed. It is outside the scope of this review, however, to provide 
exhaustive descriptions of each. A more detailed discussion on results with a focus on 
HIV/ANC and HIV/TB integration can be found in Chapters 6, 7, and 9. 
In the impact evaluation literature, quantitative impacts of a treatment, in this case policy, 
can only be ascertained when comparing two or more different models. Without a sound 
comparator it is impossible to ascertain the effect of introducing a new model [36]. This 
review is limited to studies comparing two or more models of integration. This includes 
comparisons of integration against a null, non-integrated, model. 
The review is restricted to primary research on impact evaluation. A common area of 
research involving impact evaluation involves estimations of Cost Effectiveness Analysis 
(CEA) [125]. CEA studies, however, commonly use secondary data or expert opinion to form 
the ‘effectiveness’ portion of CEA in policy research. Given the focus of this review on 
primary research, cost-effectiveness studies were only included if they included novel 
estimates of impact.  
As discussed in the previous three Chapters, integration lacks a clear definition within health 
systems contexts [15, 22, 41]. The term is used to describe a variety of related modalities for 
improving quality/effectiveness and/or reducing costs through differing levels of 
collaboration across different dissections of the health system. Within this review all 
concepts of HIV integration into primary care in LMICs are covered. This includes different 
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HIV integration complexes, integration along different dissections of the health system and 
different functional processes for integration. 
Finally, causal links are generally favoured in evidence-based policy [237] but are not always 
sought. Not all studies included in this review necessarily set out to establish causality. This 
review is designed to reflect the quality of the studies in relation to their ability to claim causal 
effects of policy regardless of the original aims of the study. 
4.3 Method 
This section presents the methods used to review all available literature on the impact of 
HIV integration in primary care in LMICs. Following a general systematic review 
methodology [238] all available relevant peer reviewed evidence on the subject was 
extracted and analysed. This involved reviewing research based on pre-determined 
inclusion and exclusion criteria following a comprehensive search of relevant databases. 
This section first describes the search strategy used to extract articles, inclusion/exclusion 
criteria, data extraction tools and finally the process used to analyse and synthesise results. 
4.3.1 Search strategy 
The search was conducted in English. Search terms were developed in concert with a 
librarian. They included variations around integration, HIV, LMICs, and primary care. A full 
list of search terms can be seen in Appendix 2. Databases searched were Scopus and 
Medline, including Medical Subject Heading (MeSH) terms.  Given the objective of 
ascertaining the best available evidence and the methods used, peer review was used as a 
test for rigor within the methods and therefore, grey literature was excluded. The protocol 
was registered on Prospero (PROSPERO 2017 CRD42017076415)9. 
4.3.2 Inclusion/exclusion criteria 
Following searching, pooling from different databases and removal of duplicates, articles 
were included/excluded based on their explicit relevance the topic. A flow diagram of the 
inclusion/exclusion criteria and results is presented in Figure 4.1 below and briefly discussed 
here.  
Firstly, based on title and abstract, articles were included if they examined the integration of 
HIV as defined using key words. Secondly articles were only included if the discussion of 
                                                          
9 Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017076415 
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HIV integration was regarding one or more other primary health programs/services, or 
primary care in general. Thirdly articles were only included if comparative models of 
integration were presented as this is a pre-requisite for empirical evidence. The comparator 
did not necessarily need to be in a different location from the original but needed to include 
comparisons of effectiveness before and after integration in the same location. Fourthly, 
articles were excluded if they did not present a measure, or potential measure (in the case 
of study protocols) of impact. Fifthly articles clearly not within a primary service setting were 
excluded. Primary setting was determined based on the various services generally 
considered primary and/or if the article explicitly stated it was not a primary setting. Sixthly, 
articles were excluded if they were not providing primary research on the effectiveness of 
HIV integration. Finally articles not conducted in an LMIC setting as defined by the World 
Bank [239] were excluded.  
Following selection, full articles were extracted. At this point a second reviewer10 
independently assessed each article using the same criteria. After this process the reference 
lists of all included articles were checked for further relevant articles. All review articles had 
their source articles included in the overall pool, if relevant, based on the selection criteria. 
Once a full list of articles had been identified data extraction was performed. 
 
 
Figure 4-1. Inclusion/Exclusion criteria for articles included in the systematic review 
Selection criteria 
  
    
1.      Does the study reference integration (as defined by any description of integration, 
collaboration, linked, co-located, cooperation, (joint etc.) coordinated, combined) of HIV 
programs or services? 
 
- HIV program integration is defined as the integration of one or more components of 
the HIV program (prevention, testing OR treatment) into a pre-existing program. 
Inversely a pre-existing program which falls under primary care being integrated into 
the HIV program. 
➔ If yes include 
  
    
2.      Does the study measure impact by comparing >1 model? 
 
Comparative models include 
 
- Case-control 
 
- Before and after 
 
                                                          
10 Dr Hebe Gouda, principal supervisor 
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- Comparing different types of integration 
- Qualitative report of changes following implementation  
➔ If yes include 
  
    
3.      Does the study suggest a metric for impact has been measured? 
➔ If yes include 
  
    
4.      Is the comparison performed post implementation of the model being tested? 
➔ If yes include 
  
    
5.      Has integration been applied in a primary care setting? 
 
- This does not include situations in which a randomised controlled trial has sampled 
patients from a primary care setting 
- Study is taking place in a specifically defined area 
➔ If yes include 
  
    
6.      Is the article primary research? 
➔ If yes include 
 
    
7.      Is the study being performed in a LMIC? 
 
- LMIC defined by the World Bank 
 
➔ If yes include 
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4.3.3 Data extraction 
A data extraction sheet was developed in Excel for relevant information to the research 
objectives stated in the introduction of this Chapter. It was then piloted with 10 randomly 
selected articles to be included in the analysis. Following the pilot, alterations to the 
extraction sheet were made. Box 2 below provides an overview of extraction criteria.  
4.3.4 Analysis and synthesis 
Analysis of the extracted results was performed to demonstrate the current state of methods. 
Key terms, concepts or definitions under each extraction criteria were identified and coded 
based on similar values. Analysis of the resulting extracted data was conducted by way of 
descriptive statistics. General trends were ascertained for the overall cohort of articles. 
Trends were then observed based on sub-group analysis of different HIV integration 
complexes, such as HIV/TB or HIV/ANC. Given small sample sizes and significant 
heterogeneity amongst studies no further statistical analysis was performed.  
4.4 Results 
The following section firstly provides the results of the review then information on the general 
cohort of included studies. Common characteristics are then provided by HIV integration 
complexes. 
4.4.1 Review results 
After removing duplicates 6613 hits were identified from the initial search. Based upon a 
review of titles and abstracts, 157 articles were included following the inclusion/exclusion 
criteria above. This relatively large decrease is primarily due to a large proportion of articles 
which did not provide two or more models of integration to be compared.  
After reviewing full articles 85 were included into the final study. Reviewing references 
included in these 85 yielded 13 new articles. In total 98 articles were included in the review. 
A flow diagram of the results can be seen in Figure 4.1 below. 
Data was extracted on the basis of year of publication, author, integration strategy, country, 
context, sample size (both of individuals and any higher cluster units), presence of clustering in 
the study, the study design, statistical or qualitative methods used to establish impact, indicators 
of impact, measurement and adjustment of bias, whether integration was overall positive, ex-post 
evaluation, and if the article was a review.  
 
Box 4-2 Information extracted from articles selected for inclusion during the review 
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Figure 4-3. Flow diagram for articles included in the review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
8245 papers identified through 
search terms 
6613 records screened on 
title/abs against selection 
criteria 
6613 records after duplicates 
removed 
 
1632 duplicates removed     
158 full texts assessed for 
eligibility 
 
85 studies meeting inclusion 
criteria based on full text 
 
73 references excluded 
including reviews 
13 articles included in 
snowballing 
98 articles included 
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4.4.2 General cohort of studies 
The articles included in the review had publishing dates ranging from 2003 to 2017, with 
publications peaking in 2012. Most articles (85%) were on studies which had been 
conducted in Sub-Saharan African countries, with 9% of studies focused on South-East 
Asia, 3% on Latin America and 2% on the Eastern bloc. One study included analyses from 
140 different countries. Of the 98 articles 93 were primary results while 5 were protocols for 
planned studies. These results can be seen in Table 4.1 below. 
Table 4.1. Summary statistics of full cohort of extracted articles from review, HIV integration 
complex by region under study 
  Region  
  SSA South East 
Asia 
LAC Eastern 
Europe 
Multiple 
countries 
Total 
HIV Integration 
Complex 
      
 TB 27(90%) -(-%) 2(7%) -(-%) 1(3%) 30(31%) 
 ANC 11(92%) 1(8%) -(-%) -(-%) -(-%) 12(12%) 
 PNC 1(100%) -(-%) -(-%) -(-%) -(-%) 1(1%) 
 Primary Care 13(87%) -(-%) 1(7%) 1(7%) -(-%) 15(15%) 
 Immunization 3(100%) -(-%) -(-%) -(-%) -(-%) 3(3%) 
 Substance use -(-%) 2(100%) -(-%) -(-%) -(-%) 2(2%) 
 Syphilis 1(100%) -(-%) -(-%) -(-%) -(-%) 1(1%) 
 Outpatient 2(67%) 1(33%) -(-%) -(-%) -(-%) 3(3%) 
 >2 programs 2(40%) 2(40%) -(-%) 1(20%) -(-%) 5(5%) 
 RHS & FP 17(85%) 3(15%) -(-%) -(-%) -(-%) 20(20%) 
 MNCH (ex ANC) 4(100%) -(-%) -(-%) -(-%) -(-%) 4(4%) 
 General 1(100%) -(-%) -(-%) -(-%) -(-%) 1(1%) 
 Nutrition 1(100%) -(-%) -(-%) -(-%) -(-%) 1(1%) 
 Total 83(85%) 9(9%) 3(3%) 2(2%) 1(1%) 98(100%) 
SSA = Sub-Saharan Africa, LAC = Latin America and the Caribbean, CRT = Cluster Randomised 
Trial, RCT = Randomised Control Trial, TB = Tuberculosis, ANC = Antenatal care, PNC = Postnatal 
care, RHS & FP = Reproductive health services and Family planning, MNCH = Maternal Neonatal 
and Child Health, - = no studies matching these criteria 
4.4.2.1 Integration complex 
Articles were grouped to determine common HIV integration complexes being evaluated. 
The breakdown of different complexes can be seen in Table 4.2 above. HIV with TB 
integration was the most common complex accounting for over 30% of the cohort. 
Reproductive and sexual health (RHS) studies were grouped with Family Planning (FP) 
studies and collectively made 20%. HIV integration in primary care made up just over 15%. 
Articles which discussed any component of HIV and MNCH integration collectively 
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accounted for over 17%; however, this was made up primarily of HIV/ANC complexes which 
accounted for 12% of the whole cohort. The remaining articles comprised less than 28% 
with no complex being more than 5%. Complexes included HIV integration with 
immunisations, drug/alcohol programs, NCDs, and syphilis.  
4.4.2.2 Study design 
As discussed above, one of the most important aspects in determining quality in comparative 
studies is the likelihood that the allocation of treatment and control is un-biased. Identified 
study designs of articles were grouped into before and after, case/control, difference in 
difference, cluster randomised trials, randomised control trials, qualitative studies, and 
others.  
As can be seen in table 4.2 below, before and after designs were the most common in the 
cohort comprising 37% of articles. This referred to studies which utilised a change towards 
integration over time to assess its impact. In these studies, the site or sites where the 
integration was applied used baseline results as a control to compare changes. Case-control 
studies used different locations for measuring integration and control. The selection of these 
controls, however, was not random. Additionally, baseline impact before integration was not 
measured. Case-control comprised 32% of all articles. Difference in difference used a mix 
of case-control and before and after study designs. Both case and control sites were 
measured at baseline then had their relevant changes measured post–integration. This 
design comprised 9% of all articles. Cluster randomised trials (CRTs) also employed a 
difference in difference type design, with the exception that case and control sites were 
randomly assigned. CRTs comprised 13% of all articles. RCTs made up 4% of all articles 
Qualitative studies were those stating the use of a qualitative methodology; however, only 
studies which suggested they were measuring a change post-integration were included. 
These comprised 8% of all articles. 
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Table 4.2.  Study designs used in empirical studies to evaluate integration, HIV integration complex 
by study design 
  Study Design  
  before 
and 
after 
case/co
ntrol 
Differen
ce in 
Differen
ce 
Proto
col 
CRT/RC
T 
Qualita
tive 
Whole 
Complex 
HIV Integration Complex 
 TB 14(47%) 12(40%) 1(4%) 2(7%) 1(4%) -(-%) 30(31%) 
 ANC 3(25%) 1(9%) 1(9%) 1(9%) 4(34%) 2(17%) 12(13%) 
 PNC 1(100%) -(-%) -(-%) -(-%) -(-%) -(-%) 1(2%) 
 Primary Care 5(34%) 5(34%) 2(14%) 1(7%) 1(7%) 1(7%) 15(16%) 
 Immunization 2(67%) -(-%) -(-%) -(-%) 1(34%) -(-%) 3(4%) 
 Substance 
use 
1(50%) 1(50%) -(-%) -(-%) -(-%) -(-%) 2(3%) 
 Syphilis 1(100%) -(-%) -(-%) -(-%) -(-%) -(-%) 1(2%) 
 Outpatient 1(34%) -(-%) 2(67%) -(-%) -(-%) -(-%) 3(4%) 
 >2 programs 2(40%) 1(20%) -(-%) -(-%) 2(40%) -(-%) 5(6%) 
 RHS & FP 4(20%) 5(25%) 1(5%) -(-%) 6(30%) 4(20%) 20(21%) 
 MNCH -(-%) 2(50%) -(-%) -(-%) 2(50%) -(-%) 4(5%) 
 General -(-%) 1(100%) -(-%) -(-%) -(-%) -(-%) 1(2%) 
 Nutrition -(-%) -(-%) 1(100%) -(-%) -(-%) -(-%) 1(2%) 
 Whole cohort 34(35%) 28(29%) 8(9%) 4(5%) 17(17%) 7(8%) 98(100%) 
CRT = Cluster Randomised Trial, RCT = Randomised Control Trial, TB = Tuberculosis, ANC = 
Antenatal care, PNC = Postnatal care, RHS & FP = Reproductive health services and Family 
planning, MNCH = Maternal Neonatal and Child Health, - = no studies matching these criteria 
4.4.2.3 Statistical methods and bias 
Study design and statistical methods are intrinsically linked. Design may be able to account 
for bias in some settings, however if appropriate statistical methods are not used then 
internal validity of the study may be compromised.  As can be seen in Table 4.3 below, all 
articles, excluding qualitative studies and study protocols, made use of descriptive statistics. 
This was to analyse the overall results of the study, to analyse baseline covariates for the 
two groups or both. Just under half of the studies used at least one method to account for 
potential bias or confounders related to systematic differences between treatment and 
control groups. This included using control covariates in assessing the outcome of 
integration (37%), using some aspect of randomisation in the study design (17%) or using a 
matching method (2%). Methods were not used exclusively. 
Most studies (78%) utilised a study design in which multiple higher-level units were studied. 
This translated to most studies using data in which clustering was a potential issue. This 
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was both in terms of potential bias from systematic similarities between groups and 
violations of regression model assumptions used to estimate the overall impact of 
integration. Just over 25% of studies in which clustering would be a potential issue used a 
statistical method to account for it. Methods included either estimating a regression model 
with cluster-robust standard errors or estimating an MLM. It should be noted that some 
difference in difference studies included MLMs although these were only to account for 
clustering effects of individuals over time. These are known as panel-data methods and do 
not account for geographical clustering unless explicitly included in the analysis. 
Table 4.3.  Summary statistics of full cohort of extracted articles, HIV integration complex by 
statistical technique and study design 
Complex Bias 
control 
(RCT or 
CRT) 
Bias control 
(multivariable 
regression) 
Multiple 
clusters in 
data 
Clustering 
and used 
cluster 
robust 
methods 
Ex-post 
TB 2(7%) 12(40%) 22(74%) 4(14%) 22(74%) 
ANC 4(34%) 3(25%) 10(84%) 6(50%) 2(17%) 
PNC 0(0%) 0(0%) 1(100%) -(-%) 1(100%) 
Primary Care 2(14%) 7(47%) 12(80%) 1(7%) 6(40%) 
Immunization 1(34%) 1(34%) 2(67%) 1(34%) 2(67%) 
Substance use -(-%) 1(50%) 1(50%) -(-%) 2(100%) 
Syphilis -(-%) -(-%) 1(100%) -(-%) 1(100%) 
Outpatient -(-%) -(-%) 2(67%) -(-%) 2(67%) 
>2 programs 2(40%) 2(40%) 4(80%) -(-%) 3(60%) 
RHS & FP 6(30%) 8(40%) 15(75%) 6(30%) 7(35%) 
MNCH 2(50%) 2(50%) 4(100%) 2(50%) 1(25%) 
General -(-%) 1(100%) 1(100%) -(-%) -(-%) 
Nutrition -(-%) -(-%) 1(100%) -(-%) 1(100%) 
Total 19(20%) 37(38%) 76(78%) 20(21%) 50(52%) 
CRT = Cluster Randomised Trial, RCT = Randomised Control Trial, TB = Tuberculosis, ANC = 
Antenatal care, PNC = Postnatal care, RHS & FP = Reproductive health services and Family 
planning, MNCH = Maternal Neonatal and Child Health, - = no studies matching these criteria 
4.4.2.4 Ex ante vs ex-post 
Ex-post evaluation is an important consideration in controlling bias. As can be seen in Table 
4.3 above, of the 98 studies extracted 50 were conducted ex-post, confirming assertions 
that this is a common theme in HIV integration evaluation. Ex-post was often described as 
retrospective. This included collection of data retrospectively such as post-policy 
implementation, or retrospective reviews of program data.  
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4.4.2.5 Measures of impact 
Measures of impact for policy can often be numerous and broad. Understanding the breadth 
of indicators for integration may help to understand its broad goals and trends in the way it 
is assessed. All articles looked at more than one primary indicator of impact. These 
indicators were grouped into process or outcome indicators as per Chapter 3. Process 
indicators involved improvements in service use or services generally while outcomes were 
concerned with measures of death, disease prevention or cost effectiveness. Articles which 
looked at more than one class of indicator were classified with both, however with emphasis 
on the primary indicator. Figures are quoted in text below and data are not shown. 
Overall 86% of studies included some measure of process while 32% of studies included an 
outcome measure. Of those articles including a process indicator, 73% used that indicator 
as the primary measure of integration effectiveness. Of the 32% including an outcome 
measure, 18% used that measure as the primary indicator of effectiveness. The remaining 
studies focused equally on both. 
4.4.2.6 System functions used to describe integration 
As discussed in Chapter 2 definitions of integration vary across the literature. This makes 
comparing studies of integration difficult even when they are as specific as HIV/TB 
integration in primary settings. Identifying context, processes, health system dissections and 
potential barriers may allow for improved comparability of studies. Processes throughout the 
reviewed literature are therefore presented below. Figures are quoted below in text and data 
are not shown.  
The primary health system function under evaluation was service use. The majority (88%) 
of all articles described integration being achieved primarily through physical location of 
integrated services. Remaining articles involved improving M&E activities and combining 
planning or budgeting. Within service use articles 90% involved evaluating different 
combinations of care cascade. Other specific service delivery functions included 
strengthening administrative networks (14%), increasing health provider knowledge or 
training (10%), and improving logistics networks (8%). The majority (93%) of articles used 
the term ‘integration’ as the descriptor. Other terms included linked, co-location, 
collaboration, integration through decentralisation and on-site/off-site HIV. 
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4.4.2.7 Effectiveness of integration 
Various integration models, complexes and modalities make describing the overall 
effectiveness of integration difficult. The effect of integration has also usually been measured 
across a broad range of indicators. Despite this the general trends for the primary indicators 
of impact are presented below. This is to provide an indication of the direction in which the 
study results for HIV integration, primarily service integration, are heading. To provide this 
general indication, overall reported outcomes of integration for each article were divided into 
positive effect, mixed or no impact/no statistically significant impact, or negative impact. This 
impact was only in relation to primary impact indicator/indicators as judged by either 
statement from the article’s author or inclusion in the outcome section of the abstract. Overall 
80% of articles analysed in this section reported a generally positive impact of integration, 
8% reported mixed or no significant findings, while 12% reported negative impacts of 
integration.  
4.4.3 Results by HIV complex 
The following section subdivides the results presented above by HIV integration complex. 
This is to demonstrate tendencies within each area of research important for informing how 
evaluation has been conducted. Integration complexes discussed include HIV/TB, HIV/ANC, 
HIV/RHS and family planning, and HIV/Primary care. All other complexes had insufficient 
articles available for review to include meaningful comparison. Details for all integration 
complexes relating to study design and statistical techniques can be seen in tables 4.2 and 
4.3 respectively. Figures for other indicators are quoted in text and data for these is not 
shown. 
4.4.3.1 TB 
Integration of HIV with TB services was a common combination due the natural history that 
the diseases share. As discussed in Chapter 2 HIV drives the incidence of TB and 
consequent mortality. Both diseases also share common control strategies due to 
similarities in treatment regimes, particularly in LMICs. It is unsurprising then that 30 articles 
[46, 67, 121, 196, 240-265] involving HIV/TB integration were included in the review making it 
the most frequently evaluated HIV integration complex. Most articles were focused on 
evaluating integration as characterised by physical location of services (26/30). The 
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remaining four studies looked at integration of M&E activities (1), planning and governance 
(2) and a composite of multiple functions (1).11 
As can be seen in Table 4.3 just over 47% of articles employed techniques to control for 
bias. This included two study protocols which were CRTs. The remainder used multiple 
regression with control variables. Most studies employed either a before and after (47%) or 
a case-control design (40%). Clustering was a significant issue across the HIV/TB cohort 
with multiple clusters present in 22 of the 30 articles. Only 4 of the 22 employed a measure 
to control for clustering, despite 11 of the 22 utilising regression. This represents 7 studies 
which were both clustered and using potentially problematic regression methods. Issues 
with study design and bias were potentially driven by reliance on ex-post evaluation which 
was performed for 74% of studies. 
As discussed in Section 2.5.1 impact for higher HIV/TB service integration was mainly 
positive with 24 of 28 studies indicating improved outcomes. This was measured primarily 
across process indicators with multiple indicators used across all studies. Indicators of 
impact involving increased or continued use of HIV treatment were used in 60% of articles, 
23% of articles using continued use of TB treatment, 27% using improved HIV testing, and 
10% using improved TB screening. Only 37% looked at impact measures involving 
mortality/morbidity.11 
4.4.3.2 ANC 
Integration of HIV and ANC services was a commonly studied complex representing 13% 
[114, 175, 266-274] of the cohort. This was likely due to ANC providing effective control 
opportunities for HIV. ANC is also a primary avenue for assessing the incidence/prevalence 
of HIV in the general population. All articles described integration as revolving around 
physical locations of services with one article also describing it in terms of strengthening 
linkages between ANC and HIV programs through HR training.11   
As shown in table 4.3, just over 88% of quantitative studies used some measure to control 
for bias. Five of these controlled for bias by randomising policy, with the remainder through 
multivariable regression. Clustering was an issue in 78% of studies, of which 21% employed 
a statistical measure for its control. The most common study design was CRT, one of which 
was a protocol [271], which altered its study design to result in the randomised control trial 
[270]. This consequently had a very low sample size of 12. Ex-post evaluation was used in 
                                                          
11 Data not shown 
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only two studies which likely influenced the relatively high proportion for study designs 
addressing selection bias.  
As discussed in section 2.4.2 the majority of completed empirical studies of HIV/ANC (82%) 
showed positive impacts for higher integration. All studies measured impact across multiple 
indicators, which primarily focused on processes as opposed to direct outcomes. This 
included 67% looking at a measure of new or continuing use of HIV treatment, 58% of HIV 
testing, 17% mortality and 25% relating to improved administration.12  
4.4.3.3 RHS and family planning 
Sexual health and HIV are inextricably linked given the primary pathway of HIV infection. A 
consequently common integration complex was HIV with RHS or family planning, of which 
twenty studies were identified.  This included seventeen [126, 275-289] articles which used 
the term ‘family planning’ with a further two being termed ‘reproductive’ [290, 291] and one 
‘sexual health’ [292]. Physical location of services was evaluated in 80% of articles, while 
20% evaluated strengthening linkages between programs through training and 
strengthening logistical networks.12 
As can be seen in table 4.3, 12 of the 20 used methods attempting to account for or control 
for bias. This included one article [281], which matched individuals attending different service 
delivery models. Matching was performed on very limited matching covariates but powered 
through a large sample size. Further methods for controlling bias included randomised 
design in six studies of which two were CRTs, while multivariable regression was used in 
five. Clustered designs were used in four studies however only the two CRTs used cluster 
robust methods. 
More integrated HIV and RHS/family planning resulted in positive primarily positive impact 
in fifteen of the twenty studies. The most common indicator for impact involved improved 
use of family planning. This was used in 65% of studies. Remaining studies used improved 
provider knowledge or competency (15%), improved HIV testing was used (10%), improved 
patient satisfaction (10%) and general service (10%).13 
                                                          
12 Data not shown 
13 Data not shown 
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4.4.3.4 Primary care 
HIV programs and services are often decentralised and integrated into primary care in 
general to improve coverage and use of HIV services. A total of fifteen HIV/primary care 
articles [112, 115, 276, 293-304] were extracted. All articles defined integration through 
physical location of services or programs. One study also defined it through strengthening 
of linkages within programs. The specific location described as primary care varied between 
health centres and hospitals.13 
As can be seen in table 4.3, Control for potential selection bias was attempted in nine of the 
fifteen studies, two through cluster randomisation and the remaining seven through 
regression adjustment. The two CRTs were for the same study; the initial study protocol 
[300] and the resulting published study [301]. Clustering occurred in twelve of the 15 studies. 
Only the two CRTs, however, included measures for control for clustering. This is despite 9 
of the remaining 10 studies utilising regression. Most articles used either a before and after 
or case control design.  
Generally positive impact was reported in eleven of the fifteen studies. Indicators of impact 
which were HIV treatment related were used in 27% of studies, while mortality was used in 
27%, and patient satisfaction/stigma was used in 33%.13 
4.5 Discussion 
Overall, this review establishes a gap in methods used to evaluate impact of HIV integration 
which account for clustering and bias. It also highlights the importance for further 
investigation given the generally positive performance of integration as a health system 
strengthening tool. This section provides a discussion on different issues uncovered by this 
comprehensive review.  
Six findings key to the evaluation of HIV integration in LMICs have been uncovered. These 
are: 1) there are a lack of methods used to control potential bias when gathering empirical 
evidence, 2) there are a lack of adjustment for the common situation of health policy 
clustering when evaluating impact, 3) ex-post evaluation is common in HIV integration, 4) 
integrated service delivery is the most common health system process evaluated, 5) there 
are a wide range of indicators used to describe the impact of HIV integration, most often 
process indicators, and 6) trends in study designs and methods used to perform evaluation 
differ by HIV complex. 
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4.5.1 Study design, statistical methods and potential bias 
Study design and statistical methods are essential to producing unbiased assessments of 
impact in empirical studies. They also dictate the reliability of the marginal benefits of policy 
and external validity of findings [74].  
4.5.1.1 Common use of study designs with potential bias 
The lack of study designs which account for selection bias common in empirical evaluation 
of HIV integration erodes confidence which can be placed in estimates of the policies effect. 
Few studies used randomisation to determine recipients of the integration policy [36]. 
Without randomisation it is possible to misattribute or miscalculate the effect of integration. 
The lack of randomisation may be due to limitations posed by evaluations being conducted 
ex-post. This presents an opportunity for other methods which are sufficiently flexible to 
control selection bias after policy has been implemented. 
Common study designs in articles included in the review also had inherent issues relating 
to other types of bias. The most common study design used was ‘before and after’. The 
frequent use of this design may be due to the relative ease of application. It allows the policy 
analyst to quickly and easily add an evaluation aspect to the implementation of policy without 
the need for extra planning [305]. Inherent in before and after design, however, are flaws 
which make using it as the basis of decision-making unadvisable [305].  
Health systems are dynamic organizational structures which function within a broader and 
even more complex national and global context [13]. Changes within each context are 
occurring constantly in response to stimuli internal and external to the health system. Before 
and after designs do not account for these changes. Using this design, it may be possible 
to misattribute changes to policy when they have occurred due to external factors. This is in 
addition to potential selection bias which this study design does not inherently account for. 
The heavy reliance of the empirical HIV integration literature on before and after design 
reduces confidence in the reliability of previous estimates of the policies impact. 
Another common study design was case-control. This refers to studies which compare the 
impact of health facilities where integration had either been applied or not applied, but not 
over time. Without measuring baseline indicators, it is difficult to ascertain the true effect of 
the overall policy change. Sites which applied integration may begin at a baseline that is 
inferior or superior to their comparator. The result is a biased marginal difference between 
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treatment and control groups in addition to potential selection bias. Results from these 
studies may misattribute the relative of effect of the policy [36].  
A sub-set of articles made use of designs which included both treatment and control groups 
followed from base-line to post-integration. By doing so time variant factors could be 
controlled, while comparing marginal benefits of integration from baseline [305]. These 
included articles classified as difference in difference studies which still did not account for 
selection bias. They also included all cluster randomised trials/randomised control trials.  
4.5.1.2 Cluster randomised trials and randomised control trials 
The most common study design used to account for selection bias in articles included in the 
review was cluster randomised trials. This involves randomising the site/health centre/district 
where policy is applied as opposed to the lower individual level whWhen evaluating policy, 
sites themselves are likely vary in relation to their ability to affect individual outcomes [306]. 
An example is HIV policies having differing effects in districts with differing HIV incidences:  
balance at the level of the individual may not be enough to provide causal comparisons. To 
provide appropriate balance and statistical power, sample sizes in CRTs need be enough 
to account for both individual and cluster level bias. The largest cluster sample size from the 
articles highlighted in this review was 18 clusters, which would be considered inadequate in 
many circumstances [138, 307].  
Gathering enough sample size for a CRT of integration hinges on the availability of enough 
health centres or higher facilities or districts which can be randomly assigned the policy. This 
is because integration almost exclusively applied to places as opposed to individuals, as 
discussed in Section 2.1.6. The use of CRTs when evaluating integration may be limited 
due to difficulty in attaining enough sample size.  
The ideal design for evaluating integration will involve effective randomisation. Even with a 
limited sample size CRTs will be preferential to designs which make no attempt to account 
for selection bias such as those discussed in the previous section. Given that enough cluster 
sample size is likely to be obtained for HIV integration, however, there is a space for using 
alternate pragmatic methods to evaluate impact in place or in concert with CRTs.  
4.5.1.3 Statistical methods for bias control 
A sub-cohort of studies controlled for confounding using statistical techniques such as 
multivariable regression. Using multivariable regression shows an improvement over 
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unadjusted means tests in relation to bias control [130]. However, potential bias between 
groups still may remain an issue [305]. As further elaborated in Chapter 5, models using 
regression without a method to implicitly create a counterfactual may be enough for 
correlation alone [308]. 
Regression adjustment models which are used to claim causality generally require a large 
purposefully selected variety of covariates, chosen with the pre-defined goal of establishing 
causality [154]. Both study aspects do not appear to have been achieved in the studies 
presented in this review. Without randomisation or a measure to demonstrate balance 
between treatment and control groups  correlation may be drawn [154].  
Using multivariable regression implies that a variety of control variables be available to 
include when estimating integration impact. Alternate statistical techniques which can utilise 
these variables are available, however, yet to be employed to evaluation of HIV integration. 
This presents an opportunity to use these techniques s to improve estimates of HIV 
integration impact and are explored further in Chapter 5. 
4.5.1.4 Clustering 
More than three quarters of studies in the review used designs involving clustered data. Only 
a quarter of articles in which a clustered study design was used incorporated methods which 
considered the structure of the data. Many of these articles, however, still used regression.  
This has two ramifications both of which erode confidence in the size and direction of 
estimates of HIV integration impact. Firstly, as indicated in Chapter 2 and further discussed 
in the following Chapter, implicit in the use of non-MLMs is the assumption that observations 
are independent of one another with homoscedastic standard errors [83]. This is clearly not 
the case when a study is utilising multiple clusters and can lead to incorrect estimates of 
impact. Secondly, by ignoring the clustered nature of the data, analysts are failing to account 
for cluster level bias which in turn reduces the reliability of outcome estimates [34].  
Two methods for accounting for clustering were identified in the review. These were Multi 
Level regression Models (MLMs) and use of cluster robust standard errors in standard 
regression. Correct use of both methods allows some assumptions about standard 
regression to be relaxed [160]. However, only using MLMs can the extra information of the 
cluster be incorporated into estimations of coefficients aside from standard error [83]. In 
contrast in the presence of intra cluster correlation, MLMs alone may not be sufficient even 
when indicators f clusters are incorporated into the model. Additionally, only specific sub-
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specifications of MLMs can control for cluster level bias without the inclusion of cluster level 
covariates [83]. Finally, only methods using MLMs can help reduce the likelihood of cluster 
level bias [33]. The lack of studies using cluster-robust methods, despite integration 
inherently being applied in clusters, is a lost opportunity for improved reliability in HIV 
integration impact estimation.  
6.1.1.1 Ex-post evaluation 
More than half of HIV integration evaluations reviewed here have been performed ex-post. 
Such evaluations describe difficulties in controlling how policy is applied. It is far better to 
plan for evaluation from the outset, particularly if control of policy application is possible. 
This is unlikely, given the inherent difficulties in randomising integration and its fixed 
application. 
Pragmatism is needed in health policy research. It is highly likely that the lack of appropriate 
methods to control for selection bias within the HIV integration literature is driven by the 
necessity to conduct evaluation ex-post.  Ex-post design may result in inadequate control 
for clustering if the selection of variables cannot be managed from the outset. 
Given the frequency with which ex-post design is used and the lack of methods accounting 
for bias and clustering, there is an opportunity for the use of methods to address the 
limitation associated with this type of study design/data when establishing causality in HIV 
integration research. 
4.5.1.5 ANC and TB 
Together ANC and TB integration strategies made up nearly half of all studies. This is likely 
due to the importance of these programs in most health systems, particularly in relation to 
HIV [62, 229]. This also likely due to specific links of HIV to each disease/service area, as 
discussed in previous Chapters [62, 229].  
The methods used in the ANC articles selected for review were the most robust in terms of 
bias and clustering. They were not, however, exhaustive. Randomised designs lacked 
cluster sample size while methods employing multivariable regression lacked demonstrable 
reductions in bias. TB studies had a less reliable standard of method. The two cluster 
randomised trials have at the time of writing yet to be completed. Even then the estimated 
cluster sample sizes remain small and similar problems around multivariable regression 
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were noted.  An opportunity exists for providing improved methods for evaluating the impact 
of these two complexes. 
4.5.2 Indicators, processes and outcomes 
As a secondary aspect of this review, indicators of impact, processes and general outcomes 
of the extracted articles were reviewed. This was to demonstrate the breadth and importance 
of these concepts across HIV integration in general.  
4.5.2.1 Indicators of impact 
Choosing a relevant and reliable indicator of impact is an important methodological issue in 
policy evaluation. Policy frequently has a variety of goals and a resulting variety of impacts, 
affecting a range of stakeholders [234]. Selecting effective indicators for policy hinges on 
understanding how these contextual factors may affect outcomes and ideas of success. 
Applying policy often has important unintended consequences or externalities. Most studies 
in this review took this into account by using a diverse range of indicators for impact. Given 
the imperative of integration of HIV it is unsurprising that many studies looked at the 
improved functioning of the HIV program to assess positive changes associated with 
integration through process indicators. Few studies used reductions in mortality or morbidity 
as indicators of impact. The limited inclusion of mortality/morbidity indicators has been noted 
in other systematic reviews [14]. This may be due to the inherent difficulties teasing out 
reductions in mortality from a complex integrated network such as an integrated health 
system [133, 208]. As discussed in Chapter 3, a targeted approach to selecting indicators, 
mapping indictors of improvements to structural system barriers, is needed. 
4.5.2.2 Definitions and modalities 
Articles extracted from this review evaluated a variety of modalities, almost all of which were 
termed integration. Based on the classification of system process provided by the theoretical 
framework in Chapter 3, the most common modalities related to integrated service delivery 
functions. The lack of empirical evidence of other health system functions such as 
governance may be due to difficulty in empirically measuring such processes as they are 
infrequently applied sub-nationally. This review also focused on primary care which may 
have excluded articles which did not specify or transcend more than one level of care. 
Within the service delivery class of integration modalities, integrated service delivery 
functions were most often achieved through physical location of services or programs, as 
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opposed to strengthening linkages between already co-located programs. Focus on location 
as the mechanism for providing integrated health services is likely due to the vertical nature 
of many HIV programs in LMICs [172]. The primary impetus around integration is to first 
provide services at the same location, then once these have been established, move to 
strengthen the linkages [172]. This finding is emphasised through the specific indicators 
selected for impact. As mentioned above, most impact measures focused on increased 
volume or availability of specific HIV health services. Few articles focused on service quality 
aspects such as patient satisfaction or quality of referral networks.  
4.5.2.3 Results of integration 
The high proportion of articles reporting mainly positive results highlights the likelihood that 
HIV integration in primary care, particularly related to service delivery, in LMICs is beneficial 
across a range of indicators. The variation in integrated functions and the variety of 
complexes makes the individual results about integration difficult to generalise. The current 
evidence suggests, however, that providing targeted linked health system components 
tends to promote improved performance of health system indicators, particularly those 
involved with HIV. Further discussion of the results of HIV service integration with TB and 
ANC services are provided in Chapters, 6, 7 and, 9. 
4.5.3 Limitations 
Several limitations of this review should be noted. Given the primary focus on methods for 
impact, many studies which simply discuss integration models without testing them will have 
been missed. This leaves for the potential that methods for evaluating integration, however 
under a different name, will not have been included in the review. While not directly related 
to this review’s primary goals, a full review of current HIV models employed throughout the 
world would be useful to the HIV integration debate.  
The difficulty in defining integration may also have meant missed articles which refer to 
integration with different terms or which describe an integration-like process but do not 
supply a name. An example of the former may be the decentralisation of HIV services, which 
may result in integrated primary services although without express articulation that the 
process was integration. An example of the latter may be the integration of HIV into 
immunization programs. Immunization programs in some contexts are being used as 
surveillance platforms for detecting HIV infections in children in high prevalence settings 
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[309]. Such articles, however, do not refer to the specific process with a name, even though 
it may be considered integration.  
Finally, on a practical note the diversity of integration terms, mechanisms and models meant 
that initial search terms had to be sufficiently broad to capture all available articles. This is 
an inefficient method for conducting a systematic review. However, it was necessary to 
capture the diverse ranges of articles and methods. This meant that the total number of hits 
to sort were relatively large compared to the number of included articles. Much of the 
subjectivity in selecting articles from such a broad search strategy was removed by using 
targeted selection criteria. 
4.6 Conclusions 
This systematic review was designed to highlight the current state of the methods used to 
evaluate the impact of HIV integration in primary care in LMICs. The findings suggest that 
there is limited use of methods to control for bias and clustering in empirical studies of HIV 
integration. This makes building a strong evidence-base for integration difficult. Designs and 
methods which fail to account for these common sources of bias weaken internal validity, 
causing doubt about the strength of consequent conclusions.  
Based on this review there is little use in the literature of evaluation methods that can 
account for selection bias and clustering, while most approaches are insufficiently flexible to 
be applied ex-post. This is likely as evaluating the impact of health policy relies strongly on 
available data as opposed to pre-planned trials. Ideally, improved data should be advocated 
for. When available, randomisation, incorporating a large sample, is the best method for 
controlling bias, particularly combined with MLMs. Failing this, alternate methods for 
controlling bias and clustering for evaluating integration as a health policy should be 
explored. A discussion of such methods is provided in the following Chapter. This is in the 
context of application to case studies representing the common limitations found during this 
review. 
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5 Quasi-experimental methods for controlling bias and clustering in ex-post HIV 
integration evaluation 
Chapters one through four of the thesis have identified key issues limiting the reliability of 
evidence arising from evaluation of integration also articulating the frequent use of methods 
which are inadequate to account for them. This Chapter explores quasi-experimental 
designs and statistical techniques which potentially address these issues. As discussed in 
the previous Chapter HIV integration evaluation has often been performed; with methods 
which fail to, or inadequately control for, selection bias, with methods which fail to, or 
inadequately control for clustering, and are reliant on evaluation after the implementation of 
policy. These issues present barriers to establishing a strong evidence-base for the 
development of health system strengthening and HIV integration. Appropriate methods 
which can account for these three issues are needed for evaluation.  
Given the frequent inability to effectively randomise policy, methods such as RCTs are not 
discussed here. Instead the Chapter focuses on quasi-experimental methods able to 
address issues of selection bias and clustering, also being flexible enough to be able to fit 
ex-post evaluation. 
The primary quasi-experimental approach explored in this thesis is conditioning using a 
Propensity Score (PS), constructed using Multi Level Models (MLMs). This technique allows 
control for selection bias incorporating important contextual information, which has been 
shown to be critical to the success of assessment of the impact of integration [43]. The 
approach also includes the use of a difference-in-difference estimation of policy outcomes 
where possible. While other quasi-experimental methods are capable of being used, MLM-
PS is likely the best fit for ex-post HIV integration evaluation and for the case studies 
presented in this thesis, as will be developed further below.  
Neither conditioning using PS nor MLMs are new. The application of PS followed by the use 
of MLMs in estimating policy outcomes is also not new. The use of a specific sub-set of 
MLMs, random effects models, to estimate the PS itself, however, are new. The MLM-PS 
approach was primarily developed by Arpino et al [34] and Li et al [32] and has only been 
applied, to the authors knowledge, to the field of education [310]. Its application to health 
policy and integration, as in this thesis, is novel.  
This Chapter explores theoretical and applied aspects of MLM-PS methods in general and 
compared to other quasi-experimental methods. Exploration and discussion of the methods 
are performed simultaneously. The chapter is limited to important study design aspects 
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relevant to MLM-PS and issues related to the available of data, used in case study Chapters 
7 and 8. 
5.1 Comparison of quasi-experimental methods 
As discussed in Chapter 2, a variety of quasi-experimental techniques can be used to 
establish causality/reduce selection bias if randomisation is not available [36]. It is argued in 
this thesis that PSs will be superior to other methods in the situation of HIV integration 
applied ex-post, particularly when application has been relatively arbitrary. This assertion is 
further discussed in this section. It should be noted that the discussion is only of bias 
reduction. Clustering is not considered as MLMs are capable of being incorporated into all 
techniques discussed below. 
Regression discontinuity will provide a strong basis for causality when individuals have 
received treatment at a pre-defined cut-off. While possible, it is unlikely that policy like 
integration will have been applied in this way [36]. Integration, like many health service 
policies, is inherently applied at the facility level or higher, necessitating that the unit of 
observation either be the facility or be an individual accessing a specific facility. In a similar 
fashion to sample size, in the case of CRTs described in the previous Chapter, it may be 
hard to apply the policy to sufficient facilities to reach sample sizes for robust measures of 
effect. If the unit of observation is the individual, it is likely unethical to mandate that specific 
individuals seek treatment outside of their normal facilities. This means that the fundamental 
mechanism for the establishment of a valid counterfactual in regression discontinuity is 
unavailable. 
Instrumental variables (IV) are the likely alternative to PS methods in HIV integration 
evaluation. As discussed in Chapter 2, they hinge on the ability to identify an appropriate 
instrument [154]. This in turn relies on the assumption of sufficient information on how policy 
has been applied. If the application of policy has been relatively arbitrary, as has occurred 
in the two case studies, selecting an instrument will be difficult. Weak instruments have been 
shown to increase bias in certain circumstances [155].  
IVs and regression discontinuity approaches have properties which make their use 
attractive. As discussed in Chapter 2, quasi-experimental methods  account for endogenous 
variables when estimating treatment effect. This may include omitted variables which have 
been measured, or those which are unmeasured or unmeasurable. As will be discussed 
below, a common assumption in PS analysis is that of no un-measured confounders [30]. 
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Regression discontinuity design and IVs are theoretically capable of consistent estimation 
of treatment effects in the presence of unmeasured confounders given certain assumptions 
[154].  
Establishing causality through multivariable regression is also reliant on there being no-
unmeasured confounders. It generally involves defining important covariates likely to affect 
estimates of policy outcome prior to policy implementation. It also generally involves a 
statement of intent, which can be referred to afterwards, prior to policy being implemented 
[30]. This thesis focuses on ex-post evaluation, which has been shown to be a common 
approach in HIV integration research. Given that multivariable methods for causality hinge 
on the ability to pre-plan analysis these two issues make such methods unlikely. Further 
benefits of PS methods over multivariable regression are discussed in Section 7.7 below.  
Given that other quasi-experimental techniques and designs are generally not able to be 
used for evaluating integration, conditioning on the PS is suggested as the most pragmatic 
method for evaluating HIV integration ex-post. This is with the caveat that PSs have strong 
limitations and are reliant on important assumptions. The key limitation of PSs is the 
requirement they be based on measured covariates. Consequently, they can only be used 
to claim causality with the assumption of no unmeasured confounders. This makes the use 
of PSs controversial. PSs, however, are argued to be useful as the next best alternative 
from standard multivariable analysis, given the inability to randomise and use alternate 
quasi-experimental designs. 
5.2 Analysis using the PS 
Broadly a PS analysis can be broken into four steps. These are: PS estimation, conditioning 
on the PS, measuring bias/balance between treatment groups post-conditioning, and 
estimation of treatment effect. Each of these steps is elaborated below. 
5.2.1 Propensity score estimation 
The PS is used to create a comparison group for a given treatment. It is constructed from a 
control group which may contain similar individuals to the treatment group but are potentially 
dissimilar at an aggregate level. Construction and application of the PS theoretically allows 
the two groups to differ only in having received treatment [311]. Creating the PS itself involves 
performing a regression based on covariates of participant treatment assignment or 
covariates that also influence measured outcome [311]. Using these covariates regression 
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is performed with a dummy variable for receiving treatment [1 = treatment, 0 = control] as 
the modelled dependant variable. Once estimated a fitted regression for each observation, 
or individual, is performed, resulting in predicted probabilities. These values form the PS, 
ranging from 0 to 1, and can be defined as the individual probability of treatment assignment 
conditional on observed covariates [153].  
5.2.2 Conditioning on the propensity score 
Once the PS has been constructed, it can be used with various techniques to condition the 
data. This is with the goal of removing potential biases present between treatment groups. 
Common techniques include matching, weighting, stratification and adjustment [312].  
Matching is based on a treatment observation being matched as closely as possible to a 
control observation with a similar PS [151, 152]. Once matched the sample is restricted to 
only matched observations. Weighting involves estimating treatment effects using 
probability weights based on the PS. Different weighting estimators are available for 
estimating different treatment effects, as discussed further below [150]. Weighting may also 
involve augmentation of weights to counter the effect of extreme weight values.  
Stratification involves grouping observations into different strata based on the PS and 
estimating a weighted outcome [311]. It is assumed that PSs within each strata are 
sufficiently similar to provide unbiased comparison following weighting. Finally, adjustment 
involves using the PS as a covariate in a standard multivariable regression when 
determining treatment effects [311]. This approach potentially avoids problems of 
dimensionality, however, is infrequently applied as it has limited benefits [313]. 
5.2.3 Bias reduction 
A critical step both before and during conditioning is observing reduction of bias in observed 
covariates [312]. This is to measure the level of similarity between treatment and control 
group prior to estimation of treatment outcomes, creating balance between groups. Bias can 
be tested via several methods, some of which are specific to the conditioning technique 
used.  
Rosenbaum and Rubin [30] suggest two methods: testing for statistically significant 
differences in covariate distribution; and testing the standardised bias of covariates [30]. If 
covariate distributions do not differ within pre-defined limits of the methods, treatment and 
control groups are assumed to be sufficiently similar for causal comparison based on 
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measured covariates. This is also known as covariate balance. This hinges on the 
assumption that no important covariates have been missed, or that they are accounted for 
by proxy [30]. 
Balance is checked at different points and in different ways for the various conditioning 
techniques. Prior to conditioning, balance is checked on the entire un-conditioned sample. 
Following conditioning, balance is checked for matching only on matched pairs. For 
weighting it is checked on the entire weighted sample. For stratification it is checked within 
each stratum. Covariate adjustment is not readily able to check balance [312].  Checks on 
the specification of the PS, however, may be conducted. These involve standard regression 
diagnostics [312], which are not readily comparable to balance checks of other techniques. 
5.2.4 Treatment effect estimation 
Following conditioning on the PS and measurement of bias, unbiased impacts of treatment 
effects can be estimated. This involves selecting an appropriate statistical model to test the 
difference between treatment and control groups with reference to the primary outcome 
variable [151, 311, 314].  
Different approaches are used depending on conditioning technique. Matching involves 
outcome models only incorporating matched observations. If the same observation is used 
multiple times, as is the case with ‘matching incorporating replacement’, frequency weights 
and consequent statistical control for repeated observations must be included [311]. 
If weighting is used, outcome models must incorporate probability weights. Stratification 
involves estimating outcomes within each stratum and if appropriate providing control for 
observations clustered into strata [315]. Finally, covariate adjustment involves the 
incorporation of the PS as a covariate in the outcome estimation model [311]. 
5.3 Counterfactual framework and the Propensity Score 
The following section describes the theoretical basis for claims of causality using the PS. It 
is generally derived from the Neyman Rubin [76-80] causal framework fitted for the use of 
PS. Comparison to a common causal estimand is used in evaluating treatment effects in 
randomised control trials. Two common estimands of treatment effects using the PS are 
highlighted. In doing so common assumptions associated with PS analysis are discussed.  
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Here the general mechanisms by which conditioning on the PS can create an unbiased 
estimate of treatment effect are discussed. The PS itself can be defined as a score assigned 
to each individual sample observation which indicates its propensity for being included in 
the treatment group [150, 153]. It can be formally notated as:  
e(X) = Pr( Z= 1 | X)                  (1) 
That is the conditional probability e(X) of being in treatment group Z = 1 conditional on 
covariate vector X. Estimation of the PS allows the construction of a potentially valid 
counterfactual. Through conditioning on the PS potential biases may be reduced so as to 
provide a comparison of treatment and control groups ceteris paribus14 [150]. 
When using data that is unlikely to have selection bias, for example through random 
treatment assignment, effect estimation is achieved using a general estimand. One such 
estimand is the population average controlled difference (ACD) [150, 153]. This defines the 
difference in the means of a given outcome Y in two groups with balanced covariate 
distributions. It can be presented formally as: 
πACD = Ex [ E(Y |X, Z = 1) - E(Y |X, Z = 0)],                    (2) 
where the expected value Ex is with respect to the marginal distribution of X in the combined 
population. This highlights the possibility of potentially unbiased estimators when covariates 
are balanced between those receiving treatment (Z=1) and those not (Z=0). 
When non-random treatment assignment is present modification of the ACD is required. 
One such method is conditioning using the PS. Modification through the PS relies on several 
key assumptions. The first is the Stable Unit Treatment Value Assumption (SUTVA) which 
states that the outcomes for each individual observation are unaffected by the treatment 
assignments of other observations [150, 153]. If this assumption holds, each unit has two 
possible outcomes Y(z) for z=0,1, which relate to the two potential treatments. Only one 
outcome or each unit, however, is observed [150, 153]. The observed outcome Y can be 
expressed as: 
Y = Y(1)Z + Y(0)(1-Z)               (3) 
Assuming SUTVA a common causal estimand used in a PS is the population average 
treatment effect (ATE). Noted formally as: 
                                                          
14 With all else being equal 
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πATE = E [Y(1) – Y(0)]                 (4) 
where the ATE is defined as the expected value of Y for observations assigned to the 
treatment minus the control groups. Causal effect estimation from observed data are 
identified by assuming no unmeasured confounders, also known as unconfoundedness, 
where treatment is effectively randomized within cells defined by the values of observed 
covariates [150, 153]: 
(Y(0), Y(1)) ⊥ Z|X.                 (5) 
Under unconfoundedness, Pr(Y(z)|X) = Pr(Y|X,Z=z), so the causal estimand πATE equals the 
descriptive estimand πACD:  
πATE = E[Y(1) – Y(0)] = Ex[E(Y|X,Z=1) - Ex[E(Y|X,Z=0)]= πACD            (6) 
Comparisons of this type require sufficient overlap to be assumed, 0 < e(X) < 1, which relates 
to the study population being restricted to covariate values which there can be both 
treatment and control units. If this is not the case data cannot support inferences on outcome 
comparisons under the two group assignments. Treatment assignment mechanisms which 
satisfy both overlap and unconfoundedness are termed strongly ignorable [150, 153]. 
A further common causal estimand is the Average Treatment Effect on the Treated (ATET), 
presented formally as: 
πATET = E [(Y(1) – Y(0))|Z=1]                 (7) 
It differs from the ATE by restricting expected values of Y to the treatment group.  As per 
the ATE it is identified by assuming unconfoundedness as per (5). The assumption of 
common support is relaxed depending on conditioning technique [316].  
The case studies presented in this thesis make use of this general framework to construct 
counterfactual scenarios for estimating the impact of HIV service integration. The statistical 
methods used to construct the counterfactuals are discussed below. Both case studies make 
causal comparisons of both ATE and ATET. 
5.4 Propensity scores with clustered data 
Recently, interest has grown in extending the PS methodology to data that has a clustered 
or hierarchical structure [82]. This implies that individual observations within a data set are 
clustered into higher level units. For example, in the HIV/ANC case study women, the 
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individual unit of observation, are clustered into the districts in which they live and are able 
to receive ANC. These districts are further clustered into regions.  
Clearly women residing in the same district may systematically differ from those of other 
districts. Given this clustering many of the assumptions of classical regressions analysis are 
violated [317]. Individual observations may cease to be independent of each other and 
standard errors may not be homogenous across clusters.  
PS strategies which consider clustered data are relatively new. A systematic review of PS 
methods with clustered data [82] noted that some studies attempt estimation of the PS, 
and/or potential outcomes individually within each cluster[82]. This may be used to model 
multisite randomised trials.  
Inherent in this study design is a treatment assignment mechanism that can be applied 
within each individual cluster [33]. This strategy provides two clear limitations. Firstly, the 
inclusion of cluster level covariates in the PS becomes impossible. Secondly entire clusters 
that are close to or entirely treatment or control may be excluded from analysis.  
Kim and Steiner [318] suggest methods to overcome these limitations when treatment 
assignment has been at a cluster level. They suggest creating homogenous clusters through 
grouping observations based on cluster level covariates. Propensity scores and treatment 
effects may then be estimated within these super-clusters. This approach however is reliant 
on observed level 2 covariates and cannot account for unobserved characteristics which 
pre-defined clustering, such as national/subnational level, may have.  
Several other studies suggest estimating the PS only at the cluster level using cluster level 
covariates [319, 320]. This approach removes the possibility of using individual level 
covariates in the estimation of the PS. 
5.4.1 Multilevel estimation of the propensity score 
Other more novel approaches have attempted to estimate PSs or treatment effects on 
pooled data using MLMs [32, 34, 82, 310, 321-329]. MLMs recognise the assumption violations 
of single level regression in the presence of clustered data.  
As discussed above clustered data has a clear hierarchical structure such as individuals 
grouped by geographical location where the higher unit is termed the cluster.  Broadly 
defined MLMs take into account hierarchical data structures by modelling standard errors at 
both the individual and cluster level [317].  By introducing a term to represent each cluster, 
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cluster level effects can be added into the MLM. This may include both observed covariates 
at the cluster level and unobserved effects associated with the cluster. The use of these 
models has been shown to be more effective in reducing bias, when compared to simpler 
models, when dealing with clustered data [32, 34, 317].   
Clustering has been accounted for, using MLM at different stages of the PS analysis. Studies 
either estimate an MLM for the PS or more commonly estimate a single level model of the 
PS but use a MLM for estimation of outcomes. Several studies perform both of these steps 
in what is known as a doubly robust estimation of causal effects [330]. Doubly-robust 
methods have been shown to be pragmatic when dealing with a relatively arbitrary treatment 
assignment as only one of multiple model specifications need be correct [32]. Applying 
doubly robust estimations, however, can still never account for misspecification of a model. 
Several simulations are performed in the literature to test the differences between different 
MLM estimation strategies. Arpino et al [34] and Li et al [32] test different multilevel 
estimations of the PS in the presence of a weighted estimator for treatment effects. Both 
studies suggest that estimations of the PS which consider clustering result in a greater 
reduction in bias than naive models. They note, however, that when also performing a 
multilevel estimation of outcomes, bias can be reduced across all propensity estimation 
models.  
Similar conclusions were drawn from a simulation by Leite et al [33]. Here it was noted that 
overall bias was reduced when accounting for clustering in either estimation of the PS or 
when estimating treatment effects or both. This simulation also compared different 
conditioning strategies but found little differentiation in terms of bias reduction.  
Rickles and Seltzer [325] test different specifications of the PS under different conditioning 
techniques and find that bias within their study is not affected by different estimation 
strategies of the PS. A reduction in bias does occur when the conditioning strategy accounts 
for clustering. This is achieved through matching within clusters where possible.  
Overall through the simulations performed by Arpino et al [34], Li et al [32], Leite et al [33] 
and Rickles and Seltzer [325], it is clear that accounting for clustering at one of the stages of 
a PS study will reduce bias when compared to models which do not account for clustering.  
Where possible accounting for clustering in more than one step may provide a greater 
opportunity to reduce cluster-related bias. This is due to the two chances which doubly-
robust estimation provides for correctly specifying a statistical model [330]. These different 
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methods, in relation to different MLMs and using examples from case studies, are further 
discussed below. 
As highlighted in Chapter 4 treatment assignment in HIV integration evaluation is often 
clustered. PS methods used to evaluate the impact of HIV service integration may be 
improved through the inclusion of MLM’s. These are in line with the availability of key 
attributes within available data. This discussion is extended below to the real-life examples 
drawn from the case studies used in this thesis. 
5.5 Case study data summary 
Data used to evaluate the impact of integration is drawn from different sources for the two 
different case studies. Below a summary of key attributes of the data are provided. It is 
limited to points relevant to discussion of the analysis strategy for each case study in 
general. A full description of each data set is provided in the case study Chapters 6 and 7. 
5.5.1 Case study data overview 
The data used to evaluate the impact of HIV service integration is taken from Peru. As 
mentioned in the literature review there exist dual models of integration [partial and full 
integration] in Peru at different locations.  
As stated in Chapter 2 the application of the integration pilot has been at the cluster level. 
Consequently, many but not all districts are restricted to having purely treatment (fully 
integrated) or control (partially integrated) observations. This treatment assignment is 
relevant when considering the statistical methods used.  
Each data set has included key criteria for PS conditioning. These criteria are: variables to 
indicate partial or full integration models, variables to measure the impact of these models, 
a relatively large pool of control observations and, a rich set of covariates observed for both 
treatment and controls [150].  
5.5.2 Summary of HIV/ANC data 
To observe the impact of HIV/ANC service integration in Peru the thesis utilises cross-
sectional household and individual surveys conducted as part of the Demographic and 
Health Survey (DHS) series [331].  
The unit of observation for this case study is women who have received ANC from a public 
primary facility within the available time period (2001 – 2013). Determining if women have 
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received ANC from partially or fully integrated clinics has been achieved by cross 
referencing MINSA reports [84, 92], Census data [332] and DHS data [95, 197, 200-203, 333, 
334]. Fully integrated clinics have been identified based on their district and the health 
centres which each woman has attended.  
Districts in Peru are the lowest level of administrative area. Accessing primary health 
facilities in Peru requires that the patient’s residence is located within the district to which 
the health facility pertains. A patient presenting at a health facility has their national ID 
checked to ensure that they reside in the health facility catchment area. If not, they are 
directed to their appropriate health establishment [207]. Districts are further clustered into 
regions. There are three levels within the data; individual women (level 1), districts (level 2) 
and regions (level 3). Regions are limited to only those having at least one treatment 
observation for greater comparability. 
Data has been progressively collected over all years in the 2001-2013 period. A key variable 
isolated from the DHS data are the year of interview. Due to insufficient observation within 
each year observations are grouped into three time periods: pre-integration, post integration 
1 and post-integration 2. Details on this grouping are found in the following Chapter. It is 
important to note that DHS is a repeated cross-sectional survey. Observations are repeated 
random draws over years and are not followed over time. 
To assess if full integration has impacted essential service use, an outcome variable has 
been isolated from the DHS data. This binary variable indicates whether a respondent has 
received an HIV test during their ANC check. This is the primary outcome variable of interest. 
Two other secondary binary variables measuring HIV knowledge are tested in the case 
study Chapter.  
Key covariates used to estimate the PS have been isolated through a review of the literature 
as well as the availability within the dataset. District covariates have been isolated from 
further MINSA data and added to the overall data set based on district. These covariates 
form the PS and are further discussed in Chapter 6. Covariates have been isolated as level 
1 characteristics, such as age or SES and level 2 characteristics such as district level HIV 
incidence. Cluster variables have also been available, such as the district and region in 
which each woman lives.  
5.5.3 Summary of HIV/TB data 
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To observe the impact of HIV/TB service integration in Peru this thesis utilises routine 
surveillance data collected by the Ministry of Health National Tuberculosis Program (MINSA 
NTP) [335-352]. This data has been made available from the MINSA from 2009 onwards only 
for select areas within the Peruvian capital, Lima. The NTP only collects data aggregated at 
the facility level. The unit of observation is consequently the health facility. This is further 
restricted to only primary facilities. The data details health facility by name. Defining which 
health facility is partially or fully integrated has been achieved by cross referencing names 
of facilities with MINSA reports.   
Health facilities only serve the district to which they pertain [207]. The data are therefore 
clustered at the district level. It is restricted to two health administrative areas within Lima. 
Health administrative areas are groups of districts managed as a sub-directory of Lima’s 
national public health administration. Lima contains 5 administrative areas; one of the two 
studied contains all health centres considered fully integrated. As with the HIV/ANC case 
study the data has a 3-level structure; Health facility (level 1), district (level 2) and health 
administrative area (level 3). 
Two primary outcome variables have been isolated from the data. These are the ratio of 
newly confirmed TB patients being offered a HIV test, and the ratio of TB patients offered a 
HIV test who receive the results of that test. As further detailed in Chapter 7 the first variable 
is treated as continuous while the second is transformed into a binary variable below/above 
90% test return ratio. These variables have only been included in routine data collection 
from 2013 so their analysis is restricted to this year. A third binary outcome variable 
measuring TB death rates/incidence is also tested. This is included as a secondary indicator 
of outcome and is available yearly from 2009 onwards. 
Key covariates have been selected through a review of the literature as well as the 
availability within the dataset. These have included demographic and health system 
indicators taken from the NTP databooks and other sources such as the MINSA and the 
INEI [353, 354]. They are at both health facility and district level.  
5.6 Application of MLM-PS 
The following section discusses the plan used in both case studies to generate 
counterfactual scenarios using MLM-PS. This approach expands on the four steps above 
and approximates the approach used by Garrido et al [75]. This subdivides PS analysis into 
seven steps.  
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The first step is to review the data and its appropriateness for the PS conditioning technique 
based on the key criteria. As discussed in the previous section both data sets are shown to 
be appropriate based on the presence of key characteristics, variables and covariates. The 
remaining six steps are discussed below.  
5.6.1 Identification of covariates for use in PS 
Following cleaning of the data, the second step for PS modelling is to identify covariates 
which may be used to construct the PS. This involves reviewing key literature and observing 
covariates which have correlations to the treatment and/or outcome [355].   
As will be discussed below not all covariates which have been identified are appropriate for 
inclusion in the PS estimation. No set rules exist on which covariates should be included 
aside from those which may influence proper estimation of the true PS. Proper estimation 
of the PS is detailed in Steps 3 and 4 below. It has been suggested that covariates which 
are correlated either with the treatment or outcome variable may help to properly estimate 
the PS [311, 356]. This point, however remains controversial as there is disagreement as to 
whether covariates which affect only outcomes should be included in estimating the PS. 
Given, however, such variables may still influence the true estimation of treatment affects 
they are included in this thesis. 
Importantly both data sets have been identified as having a clearly defined clustered 
structures. A key component of the PS analysis is to therefore account for this clustered 
structure. This is through both recognition of the violation of classical regression 
assumptions of independent observations and isolation of cluster (district) level covariates 
which may be relevant to the construction of the PS. 
5.6.2 Estimation of the propensity score 
The third step is to estimate the PS itself. Within the two case studies a single regression 
model is presented for the estimation of the PS. This is the model which is most relevant in 
terms of bias reduction and assumptions. Despite this, a variety of estimations have been 
tested; these are presented as a component of Chapter 8. The current Chapter is restricted 
to the common model generally used and compared in the case study Chapters (6 and 7).  
5.6.2.1 Propensity score for HIV/ANC case study Chapter  
As discussed above, data used for the HIV/ANC case study follow a three-level clustered 
structure. This incorporates individual observations, pregnant women attending ANC, who 
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are clustered in to districts, which are clustered in to regions. Each unit belongs to one of 
two groups for which covariate balanced comparisons are of interest. These groups are 
defined by a 1) treatment: having received ANC from a fully integrated health centre and 2) 
control; having received ANC from a partially integrated health centre.  
The standard model for estimating a PS is a naive model which has no link to cluster/district 
membership [32, 34]. This model can be shown formally as: 
Logit (ehjk) = β0 + γ1U1jk… γqUqjk + β1X1hjk…βpXphjk                     (8) 
Where h are pregnant women attending ANC during pregnancy (h = 1...H), in district j (j = 
1....J) in region k (k = 1….K). Where ehjk is the individual propensity score describing the 
binary likelihood of receiving treatment (Z = 1) or control (Z = 0).  X1hjk…Xphjk are covariates 
for each pregnant woman which need to be balanced between treatment and control groups. 
U1jk… Uqjk are district covariates which also need to be balanced. In the standard PS model 
district level covariates may be used however are modelled at pregnant woman level with 
no variance within districts.  
With the standard model, district level covariates are assigned individually to each unit within 
the cluster and variance of zero across the cluster. In the presence of clustering of individual 
units, such as in to districts, further assumptions of homoscedasticity of error variance and 
individuality of units are likely violated. Additionally, in the presence of clustering, measured 
variables associated with cluster membership are likely affecting treatment assignment and 
outcome thus violating assumptions of unconfoundedness. The proper inclusion of these 
variables necessitates a model which allows variation between clusters [32, 34]. 
Given the clustered structure of the data a PS model is estimated to account for the 
assumption violations. This is a mixed effects logistic regression. It is a 3 level model 
containing fixed effects at level h and random effects at levels j and k. This model can be 
presented formally as: 
Logit (ehjk) = β0 + δk + δjk + γ1U1jk… γqUqjk + β1X1hjk…βpXphjk               (9) 
Where h are pregnant women attending ANC during pregnancy (h = 1...H), in district j (j = 
1....J) in region k (k = 1….K). Where ehjk is the individual propensity score describing the 
binary likelihood of receiving treatment (Z = 1) or control (Z = 0).  X1hjk…Xphjk are covariates 
for each pregnant woman which need to be balanced between treatment and control groups. 
U1jk… Uqjk are district covariates which also need to be balanced. δk is a random intercept for 
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each region drawn from a normal distribution δ𝑘~ N(0, σ
2
𝑅). δjk is a random intercept for 
each district drawn from a normal distribution δ𝑗𝑘~ N(0, σ
2
𝐷 ). Continuous covariates district 
level covariates and are modelled as random slopes drawn from normal distribution 
  β𝑈~ N(0, σ
2
𝑈).  
This model allows the violated regression assumptions to be relaxed by modelling standard 
errors at both the individual and cluster levels. The use of this model implies that unknown 
structures are affecting individual covariate distributions affecting treatment and/or control. 
Importantly, it also correctly models cluster level covariates allowing their inclusion in the PS 
[32, 34]. 
5.6.2.2 Propensity score for HIV/TB 
As with the previous case study a mixed effects logistic regression is used to estimate the 
PS. In contrast with the previous case study, it involves only two levels: health facility which 
are clustered into district. A third level; health administrative area is omitted from the 
estimation of the PS due to a lack of treatment observations in one of the two areas. This 
violates the condition of conditional logistic regression and causes issues with collinearity 
between treatment and cluster variables. Observations are pooled over health 
administrative areas. Each health facility belongs to one of two groups for which covariate 
balanced comparisons are of interest. These groups are defined by a 1) treatment: as a full 
spectrum of TB and HIV services available and 2) control; having a full spectrum of TB 
services but only HIV testing available. The two-level mixed effects estimation is presented 
formally as: 
Logit (ehj) = β0 + δj  + γ1U1jk… γqUqjk + β1X1hjk…βpXphjk         (10) 
Where h in this case study represents health facilities (h = 1...H), in district j (j = 1….J), in 
health administrative area k (k = 1…K). Where ehj is the individual propensity score 
describing the individual binary likelihood of receiving treatment (Z = 1) or control (Z = 0). 
The PS is conditional on health facility covariates X1hjk…Xphjk and district level covariates 
U1jk… Uqjk. β0 is a constant. δj is a random intercept for each district j drawn from a normal 
distribution δ𝑗~ N(0, σ
2
𝐻𝐷). Continuous district level covariates are estimated as random 
slopes drawn from a normal distribution  β𝑈~ N(0, σ
2
𝑈).  
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5.6.2.3 Fixed and random effects 
Different iterations of MLMs are available for incorporating cluster structure in regression. 
Mixed or random effects, which incorporate random coefficients to model cluster 
membership, have been described above. An alternative is the use of fixed effects or in the 
case of binary dependant variables also known as conditional logit models [160]. These 
models may incorporate cluster membership as a fixed effect. Using the TB/HIV case study, 
an example may be: 
Logit (ehj) = β0 + Dj + β1X1hj...βnXnhj                                            (11) 
Where h in this represents health facilities (h = 1...H), in district j (j = 1….J), in health 
administrative area k (k = 1…K). Where ehj is the individual propensity score describing the 
individual binary likelihood of receiving treatment (Z = 1) or control (Z = 0). The PS is 
conditional on health facility covariates X1hjk…Xphjk .U1jk… Uqjk from model (10) are not used 
as the term Dj  absorbs information at this level [32, 34]. 
Modelling clusters in the estimation of PS in this way has been argued to be able to 
incorporate unmeasured contextual or cluster level information into the PS estimation [32, 
34]. This may aid in controlling of bias. Using fixed effects, however, may prove problematic 
and is not pursued in this thesis; as the inclusion of district dummy variables may result in 
confounding with main effects in the model. Although highly data specific, through simulation 
it has been shown that the latter option produces greater reductions in bias [32, 34].  
A further issue relating to evaluation of a health policy such as integration is that treatment 
is frequently applied at the cluster level. For example, all studies identified in Chapter 4 
which were clustered also had cluster level treatment assignment. This results in various 
clusters which contain only treatment or control observations. Fitting the above fixed effects 
logistic model to either of the case study data sets when estimating the PS is hindered by 
collinearity between the dependent variable, in this case treatment and some clusters. This 
may mean estimating an incorrect model, modelling only at a higher cluster level, or 
dropping observations. None of these three options is ideal. Instead models incorporating 
random effects for district membership are used in the case study Chapters. Further 
iterations using a mix of fixed and random effects at different cluster levels are performed 
and discussed in Chapter 8. 
5.6.3 Balance diagnostics and areas of common support 
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The fourth step involves testing if the PS has produced a greater balance of covariates 
between treatment and control groups. Specifically, this involves observing balance of the 
distribution of the observables between treatment and control, and whether sufficient overlap 
of similar PSs between groups is present, known as common support [357].  
5.6.3.1 Balance 
Balance checks are applied to observe covariate distributions before and after conditioning 
on the PS. Standardised bias is used to test balance between covariates used to estimate 
the PS and PS itself. Standardised bias is calculated for continuous covariates, such as the 
PS, as the difference in mean between treatment and control groups divided by the pooled 
standard deviation, for each covariate, or the PS itself. In the case of binary or categorical 
covariates the difference in proportions between treatment and control is used [358]. A 
standard cut off of 20% or less standardised bias is used to indicate balance [29]. 
A second balance check is to observe differences between treatment and control groups 
using a covariate specific means test such as a t-test or chi-squared. Balance is achieved if 
there is no statistically significant difference at the 95% level, in means of the PS or 
covariates between groups [153, 359].  
Both balance tests are used with matching, weighting or stratification. In the case of 
covariate adjustment balance diagnostics may involve the goodness-of-fit of the PS model 
or observing the presence of extreme values of the PS [313].  
5.6.3.2 Common support 
The area of common support is observed through frequency distribution of the PS between 
treatment and control observations [75]. Generally, for estimations of the ATE common 
support should overlap most observations. ATET requires, more generally, that sufficient 
treatment and control observations are available for a valid comparison [316]. When PSs 
have not achieved balance, lack a sufficient area of common support or do not reduce 
randomness of treatment assignment, re-specification of the PS is pursued. Aside from 
inclusion of novel covariates, various methods may be used to re-estimate the PS. These 
include disuse of less critical covariates, re-categorising covariates, such as changing 
continuous to categorical covariates, including interaction terms between covariates or 
including higher order terms or splines. Covariates altered in one of these ways may have 
different distributions across treatment and control groups enabling balance [75].  
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5.6.4 Conditioning on the propensity score 
The fifth step of the analysis conditions the data based on the PS. All conditioning technique 
methods have their individual strengths and weaknesses. In general, the decision on 
technique should be made on a case-by-case basis. Conditioning techniques are compared 
in terms of their ability to produce a valid counterfactual [32]. 
Matching provides a potentially balanced distribution of covariates by pairing treatment to 
control observations based on the PS. The sample is then restricted to only matched pairs. 
Under a correct specification of the PS treatment assignment can be considered strongly 
ignorable thus providing an unbiased estimation of causal effects.  
Building upon Section 5.4.1 the outcome Yhjk is observed. This section describes 
conditioning techniques using labelling from case study 1. This is the probability of subject 
pregnant woman h in district j in region k having received a HIV test during ANC. However, 
this model is analogous to case study 2 with the exception that the highest-level region j, is 
not present in PS estimations.  Consequently, when conditioning based on matching: 
?̂?ℎ𝑗𝑘 = ?̂?ℎ𝑗𝑘
1  - ?̂?ℎ𝑗𝑘
0                                                          (12) 
where ?̂?ℎ𝑗𝑘
1   indicates the outcome for unit h in cluster j, in higher cluster k, who has received 
treatment Z=1. This can be considered analogous to (4) with the assumption that matching 
has created a potentially unbiased estimator.  Various matching specifications may be used 
depending on the data. They include one to one, or one to many, matching. They may 
include a calliper, or limit on the distance that any pair of observations may be on the PS 
[314]. They may also include the use of replacement whereby observations may be used 
repeatedly to match similar observations in their alternate group. Matching produces an 
ATET. It is reliant upon strong common support as limited matched pairs can affect external 
validity of results.  
Secondly, Inverse Probability (of treatment) Weights are estimated. Two weights are utilised 
each estimating a different treatment effect. The IPW estimates ATE while the IPW ATET 
estimates the ATET. The individual weights are calculated as: 
𝐼𝑃𝑊 𝐴𝑇𝐸ℎ𝑗𝑘 =  [
𝑍ℎ𝑗𝑘
?̂?ℎ𝑗𝑘
+  
1 − ?̂?ℎ𝑗𝑘
1− ?̂?ℎ𝑗𝑘
]                                                                    (13) 
𝐼𝑃𝑊 𝐴𝑇𝐸𝑇ℎ𝑗𝑘 =  𝑍ℎ𝑗𝑘 + (1 − 𝑍ℎ𝑗𝑘) [
?̂?ℎ𝑗𝑘
1−?̂?ℎ𝑗𝑘
]                                                   (14) 
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Where Z is a binary indicator of treatment and e is the individual PS. Each weight is used to 
estimate outcomes as per (4) and (7) respectively, with the difference being the population 
which are being estimated. 
?̂?ℎ𝑗𝑘  𝐴𝑇𝐸 𝐼𝑃𝑊 =  [
1
𝑛
𝑍ℎ𝑗𝑘𝑌ℎ𝑗𝑘
?̂?ℎ𝑗𝑘
−
1
𝑛
 
(1−𝑍ℎ𝑗𝑘)𝑌ℎ𝑗𝑘
1−?̂?ℎ𝑗𝑘
]                                                (15)  
?̂?ℎ𝑗𝑘𝐴𝑇𝐸𝑇 𝐼𝑃𝑊 =  [
𝑍ℎ𝑗𝑘𝑌ℎ𝑗𝑘
𝑍ℎ𝑗𝑘
−  
(1−𝑍ℎ𝑗𝑘) 𝑌ℎ𝑗𝑘?̂?ℎ𝑗𝑘(1−?̂?ℎ𝑗𝑘)
(1−𝑍ℎ𝑗𝑘) ?̂?ℎ𝑗𝑘(1−?̂?ℎ𝑗𝑘)
]                                   (16)  
ATE and ATET weights differ in that they estimate treatment effects for different populations. 
As ATE provides estimates for the entire population it requires greater common support 
across the entire PS. Outcomes using the ATET weight are restricted to treatment 
observations and those most like them. Common support may be relaxed to ensuring that 
the distribution of PSs at least lies roughly within the control distribution [316]. As with 
matching, various specifications around weighting may be used, the most common of which 
is weight augmentation. Weights are trimmed to reduce the likelihood that extreme values 
are increasing bias of estimated outcomes. Values above a certain percentile will be 
censored to the highest value of the previous percentile [315]. 
Thirdly, treatment effects are estimated using the PS as an adjusting covariate. 
Consequently, the PS is an unbiased estimator and treatment assignment is ignorable 
based on the PS in that:  
?̂?ℎ𝑗𝑘 = ((?̂?ℎ𝑗𝑘
1  - ?̂?ℎ𝑗𝑘
0  ) | ?̂?ℎ𝑗𝑘)                                                    (17) 
where ?̂?ℎ𝑘
1   indicates the outcome for unit k in cluster h who has received treatment Z=1 and, 
?̂?ℎ𝑘 is the PS for unit k. Fewer specifications are available for PS adjustment. The utility of 
adjustment has been discussed in situations where treatment assignment is known and 
dependent on many covariates. Here covariate adjustment has the benefit over standard 
multivariable regression by collapsing covariates into a single score thus needing fewer 
estimated parameters. Covariate adjustment is less commonly used in health policy. This is 
due to balance checks for the technique being less developed and less comparable with 
other conditioning techniques.  
The choice of conditioning technique is dependent on several factors: the desired treatment 
effect estimation, the specifics of the data, the specification of the PS in relation to common 
support, SUTVA and unconfoundedness, and the relative ability of the different techniques 
to reduce bias. An increasingly common practice is to use several techniques/specifications 
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and compare their bias reduction. The results obtained from such specification tests should 
be presented to demonstrate variations in estimated treatment effect because of differing 
specifications. 
Caliendo et al [150] have suggested that simple one to one matching with calliper can often 
produce the least biased results in samples with relatively small numbers of controls [150]. 
This however is in the face of data sets which are relatively simple. Matching likely increases 
bias as the number of matched observations increases, particularly in samples with large 
numbers of dissimilar observations [156].  
Covariate adjustment is useful when a large array of covariates needs to be included in the 
PS. By reducing these covariates to a single value fewer parameters need to be estimated 
when estimating treatment effects. The standard balance checks described above are not 
available when using covariate adjustment. This is a key limitation to the use of this 
conditioning technique. 
The case studies presented in this thesis make use of ATET weighting. As will become clear 
in the following Chapters, ATET is the most appropriate measure of treatment effects for the 
given data. Weighting is also most able to balance covariates based on the PS, as will be 
demonstrated in Chapter 8. All conditioning techniques however are compared in Chapter 
8.   
5.6.5 Estimation of treatment effects 
Following conditioning on the PS outcomes are estimated using a second regression, the 
assumption being that following conditioning a potentially unbiased estimator has been 
created. To estimate outcomes Li et al’s [32] recommendations are followed and augmented. 
The estimation of the average treatment effects, conditional on the PS, is approached 
through the use of the doubly-robust (DR) estimator. Given variations in the data between 
case studies, different outcome model strategies have been pursued. These are elaborated 
below.  
5.6.6 Outcome models for HIV/ANC  
Outcomes for the HIV/ANC case study are modelled as the estimated effect of full integration 
on the likelihood of HIV testing during ANC. As the data has a repeated cross-sectional 
design, changes in outcome may change over time. Individual observations, however, are 
not followed over time.  Observations are grouped into three time periods based on the year 
in which they have received the ANC check. These are: pre-intervention (2000-2005), post 
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intervention 1 (2006-2010), and post intervention 2 (2011-2014). For each potential outcome 
model an interaction term of treatment and time period is included [130]. 
The doubly-robust estimator used for the HIV/ANC case study includes multiple levels to 
account for district and region level bias associated with outcome estimation. The outcome 
model is a mixed effects model. Random intercepts are estimated for each higher level as 
per (9). This model however does not include random slopes. 
The random effects outcome model has the form: 
Logit(Yhjk) = β0 + δjk + δk + β1Zhjk + γ1Thjk + (βγ)11ZhjkThjk,                      (19) 
Where h are pregnant women attending ANC during pregnancy (h = 1...H), in district j (j = 
1....J) in region k (k = 1….K). Logit(Yhjk) is the likelihood of receiving a HIV test during ANC, 
weighted as per (16). δk is a random intercept for each region drawn from a normal 
distribution δ𝑘~ N(0, σ
2
𝑅). δjk is a random intercept for each district drawn from a normal 
distribution δ𝑗𝑘~ N(0, σ
2
𝐷 ). Zhjk is a binary variable indicating treatment group Z = 0,1. Thjk is 
a categorical variable indicating time period T = 0,1,2. ZhjkThjk is an interaction of treatment 
and time categories.  
Similar models are used to estimate treatment effects on the remaining outcome variables 
for the HIV/ANC case study. A variety of alternate specifications are also tested in the 
Chapter 8.  
5.6.7 Outcome models for HIV/TB 
The HIV/TB case study differs from the previous case study in that three outcome models 
use different specifications. The two primary indicators are only available for a single time 
period; thus, time is not included. These two models also differ as the distribution of the 
outcome to be modelled is continuous for the first outcome and binary for the second. The 
third outcome is also binary. Doubly-robust estimators are used for all three outcome models 
incorporating three levels. 
The model for the first outcome is presented formally as: 
Yhjk = β0 + δk + δjk + β1Zhkj + ehkj                                            (20) 
Where h in this case study represents health facilities (h = 1...H), in district j (j = 1….J), in 
health administrative area k (k = 1…K). Where Yhjk is the marginal percentage of TB positive 
patients, weighted as per (16) receiving an HIV test in health facility h, in district j, in health 
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administrative area k, in treatment group Z. Zhjkα is an indicator of treatment where Z=0,1. 
δj is a random intercept for each health administrative area j drawn from a normal distribution 
δ𝑗~ N(0, σ
2
𝐻𝐴𝐴). δjk is a random intercept for each district drawn from a normal distribution 
δ𝑗𝑘~ N(0, σ
2
𝐷 ). 
The model for the second outcome is presented formally as: 
Logit(Yhjk)= β0 + δk + δjk + β1Zhjk                                          (21) 
Where h in this case study represents health facilities (h = 1...H), in district j (j = 1….J), in 
health administrative area k (k = 1…K). Where Yhjk is the binary estimation of the likelihood 
of a health facility to have >90% of HIV test results, weighted as per (16). Zhjk is an indicator 
of treatment where Z=0,1. δj is a random intercept for each health administrative area j drawn 
from a normal distribution δ𝑗~ N(0, σ
2
𝐻𝐴𝐴). δjk is a random intercept for each district drawn 
from a normal distribution δ𝑗𝑘~ N(0, σ
2
𝐷 ). 
 
The model for the third outcome is presented formally as: 
Logit(Yhjk)= β0 + δk + δjk + β1Zhjk + γ1Thjk + δhjk                                (22) 
Where h represents health facilities (h = 1...H), in district j (j = 1….J), in health administrative 
area k (k = 1…K). Where Yhjk is the log likelihood of a health facility to have >10% of TB 
deaths/TB incidence, weighted as per (16). Zhjk is an indicator of treatment where Z=0,1. Thjk 
is a continuous variable for time in years. δj is a random intercept for each health 
administrative area j drawn from a normal distribution δ𝑗~ N(0, σ
2
𝐻𝐴𝐴). δjk is a random 
intercept for each district drawn from a normal distribution δ𝑗𝑘~ N(0, σ
2
𝐷 ).δhjk is a random 
intercept for each health facility δ𝑗𝑘~ N(0, σ
2
𝐻𝐹  ), as health facilities are followed over time. 
5.6.8 Robustness of results 
The seventh step is an exploration of how alternate model specifications may have affected 
results. This involves presenting a full gamut of results from scenarios differing at key points 
from the final model presented in each case study [360]. It also involves testing the sensitivity 
of the overall PS models to different forms of bias. 
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5.6.8.1 Robustness through alternate model specifications 
To ensure that variability and bias have largely been accounted for in the analysis, results 
are presented with altered specifications. These include addition or removal of covariates 
used in estimating the PS, a mix of MLMs to estimate the PS, the use of different conditioning 
techniques and their specifications, and a mix of MLMs to estimate outcomes following 
conditioning on the PS. Specifications are presented as results of their relative reductions in 
bias and estimations of outcomes 
5.6.8.2 Sensitivity analysis 
To test the assumption of unconfoundedness a sensitivity test as suggested by Rosenbaum 
is applied [361]. This is a common procedure for testing the sensitivity of the specification of 
the PS and the ramifications if key confounding variables have been excluded [150]. It is 
unable to directly test if there are unmeasured confounders associated with PS. It is, 
however, able to simulate the effects of a theoretical unmeasured confounder if it were 
present. The test involves simulating a confounder with differing strengths into the data. 
Changes in outcomes are then compared, with dramatic change indicating that the overall 
PS model is vulnerable to incorrect estimates in the presence of a strong confounder. This 
procedure is currently the standard for sensitivity testing with a PS, however has several 
limitations related to the analysis performed in this thesis. Firstly, it is only currently able to 
be performed on matched pairs [362]. There is little current guidance on applying the test to 
weighting on the PS; the primary technique used in both case studies. Additionally, it is 
unclear how well this technique performs in multilevel settings where an implicit assumption 
of bias due to clustering has been made. Despite these limitations the method is used and 
explored in Chapter 8.  
5.7 Conclusions 
This Chapter explored the use of MLM-PS to potentially address common issues relating to 
HIV integration. Three key conclusions are made around the method. Firstly, PSs are 
appropriate for potential endogeneity when evaluating HIV integration, when other quasi-
experimental methods may not be. This is due to PS’s flexibility in relation to ex-post 
evaluation and relatively arbitrary treatment assignment. Secondly, an augmentation of the 
standard PS method, MLM-PS, can be used to incorporate important information into the 
PS when clustered data are present. This involves correctly modelling clustered 
membership and the inclusion of cluster level covariates important in PS estimation. Thirdly, 
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the conditioning technique used in MLM-PS most appropriate for the case study data is 
‘weighting’. This is determined based on matching having been shown to increase bias in 
situations with complex data, while covariate adjustment with the PS loses some potential 
benefits derived from balance checks. The following three Chapters employ and explore 
MLM-PS methods’ ability to reduce bias when estimating the potential causal impact of HIV 
integration.  
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6 Case study 1: MLM-PS applied to HIV/ANC service integration in Peru 
This Chapter is an exploration of Multilevel Propensity Score Models (MLM-PS) through the 
application of the method to a case study of integrated HIV/ANC services in primary facilities 
in Peru. The aim of the Chapter is firstly to explore the use of MLM-PS methods in a situation 
where HIV integration has been non-randomly assigned to different clusters, thus mimicking 
common situations found during the systematic review in Chapter 4. It is secondly aimed to 
attempt causal estimate of the context specific impact of HIV/ANC service integration, in 
doing so filling the gap in the literature highlighted in Chapter 2. This gap refers to a lack of 
evaluation of HIV/ANC service integration using methods accounting for potential selection 
bias and clustering, in general and in Peru. 
This Chapter begins by describing the context in which HIV service integration has been 
implemented. It then describes the data used and the different variables and indicators 
selected for assessing integration. Biases at both the individual and cluster levels, between 
different integration policy groups, are demonstrated. This is followed by the application of 
MLM-PS, where these biases are shown to have been sufficiently reduced to allow causal 
comparison, contingent on assumptions made around the use of Propensity Scores (PS). 
Results for full integration are estimated. Following this, a discussion on the implications of 
both the use of the methods and findings are presented. 
6.1 HIV/ANC service integration in Peru 
As discussed in Chapters 1, 2, and 3, in 2005 two models of HIV service integration were 
implemented in Peru. They involved 1) the integration of a full suite of HIV services into 
primary health facilities or 2) the partial integration of HIV services into primary facilities. A 
description of services available in each model can be found in Table 1.1.  
This case study compares the relative impact of full vs partial integration on one primary and 
two secondary outcome variables. The primary variable is increased use HIV testing. 
Secondary variables relate to stigma and knowledge about HIV:  the likelihood of pregnant 
women describing witchcraft or supernatural means as causing HIV; and the likelihood of 
pregnant women knowing that treatment for HIV is available.  
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6.2 Data overview: Cross sectional data drawn from the Demographic and Health 
Survey series 
The following section describes the data which has been used to evaluate the impact of 
HIV/ANC service integration in Peru. This involves the use of cross-sectional household and 
individual surveys conducted as part of the Demographic and Health Survey (DHS) series 
are used [363].  
Peru has participated in the DHS program since 1988 under the direction of the Instituto 
Nacional de Estadisticas (National Statistics Institute - INEI). The surveys are designed by 
drawing sampling units from the National Census, which is also conducted by the INEI. A 
stratified, two-staged random, clustered sampling scheme is employed to produce national, 
urban/rural, climatic zone and regionally representative samples [331].  
A total of 12 waves, until the date of analysis (2015), have been undertaken. For the 
purposes of the thesis, the eight most recent waves are utilised: 2004-06[333], 2007-08[334], 
2009[200], 2010[201], 2011[202], 2012[203], 2013[95] and 2014[197]. Waves are limited to 
these years due to key variables being excluded from the survey until the 2004-06[333] wave.  
Survey respondents were women aged 15-49. The household response rates have been 
consistently above 93% for all surveys used in the analysis. The 2004-2006, 2007-2008, 
2009, 2010, 2011, 2012, 2013 and 2014 waves surveyed 19,090; 22,558; 24,212; 22,947; 
22,517; 23,888; 22,920; and 24,872 respondents, respectively.  
The eight waves of DHS data have been combined into a single data set. Observations with 
non-sense values have been removed. These have included respondents who have 
birthdays outside of the 15-49 range or respondents whose most recent child was born 
before 2005.  Given that these observations comprise less than 1% of the overall sample it 
is unlikely that they will have influenced results.  
Respondents were surveyed regarding ever-born children. Those who were pregnant or had 
a live birth within the preceding five years were then are asked about MNCH services which 
they had received. Participants were asked if they had received ANC at their last birth or 
pregnancy. If the answer was ‘yes’ they were then asked several questions regarding the 
type and quality of their last ANC check.  
Further information has been added to the pooled data set. This has included key variables 
relating to the district where each observation resides. This data has been sourced from the 
National Census [332] and a MINSA national surveillance report [364] and is publicly 
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available. It is restricted to years prior to the implementation of integration. This is due to 
availability. As is further described below, DHS data provides a unique district code, which 
has been used to cross reference district level data sets to add district level variables to the 
overall data. Further details on the survey are available elsewhere [363]. The publicly 
available dataset was obtained through online resources. The data was anonymous, with 
no identifiable information on the survey participants.  
6.2.1 Defining the relevant sample in HIV/ANC 
This case study evaluates the impact of HIV service integration into ANC.  The sample is 
restricted to women who have received ANC in the relevant years. The treatment, full 
integration, has only been applied to primary health facilities in Peru.  The sample is 
restricted to women who have attended ANC at public primary health facilities, which can 
be health centres or health posts. These differ in the availability of different services and 
personnel. Both offer a full spectrum of ANC including HIV tests.  
Not all pregnant women may present for an ANC check.  Bias may be introduced into the 
study by restricting the sample to women who received ANC. This, however, is unlikely given 
that ANC 1 + check coverage in Peru is over 95% for the respective years of interest [197].  
Women in the DHS are asked about ANC, but only about their most recent birth.  It is unlikely 
that the same woman has been sampled multiple times within each wave. Across waves 
however there is potential for the same woman to have been sampled.  
6.2.2 Defining treatment and control groups 
The primary variable of interest in this case study is whether a pregnant woman visited a 
partially or fully integrated primary health facility for her ANC check. Identifying which of 
these was attended was undertaken by observing the district in which each woman resides.  
Districts in Peru are the lowest level of administrative area [207]. Accessing primary health 
facilities in Peru requires that the patient’s residence is located within the district to which 
the health facility pertains. A patient presenting at a health facility has their national ID 
checked to ensure that they reside in the health facility catchment area. If not, they are 
directed to their appropriate health establishment [207]. Hence, pregnant women were 
deemed to have visited a fully integrated or partially integrated facility based on the district 
in which they lived.  
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This aspect of the Peruvian health system also helped to counteract potential spill over 
effects which could occur between districts located close to one another. Spill over from 
women attending private clinics is counteracted through a key question in the DHS. Women 
are asked to describe the facility they attended in terms of being a public (MINSA) clinic, 
public (other) or private. 
Not all primary health establishments within a district may be fully integrated. However, full 
integration is restricted to health centres, but not health posts, within each district. Within all 
fully integrated districts sampled, all health centres have received full integration. Full 
integration is defined as pregnant women attending health centres, but not health posts, 
within fully integrated districts. Women participating in the DHS define whether they have 
attended a health centre or health post for ANC. 
The DHS does not identify observation districts by name, only by code. However, the INEI 
publishes standard codes for region, province and district which are used in all surveys, 
including the national census and the DHS [354]. These codes have been cross referenced 
with the DHS data to identify each observation’s district by name. The national HIV program 
has also published several reports on the status of the HIV epidemic and the program’s 
consequent response [84]. These reports have detailed all health establishments which can 
be considered fully integrated. The documentation details the name of the health centre and 
its location by district. Consequently, the DHS data has been cross referenced with the HIV 
program reports to isolate fully integrated and partially integrated districts. This sample has 
been restricted to compare only treatment and control observations observed in regions 
where the treatment has been applied.  
As stated in Section 5.6.7 integration has been implemented at the cluster level. Many, but 
not all, districts are restricted to having purely treatment [fully integrated] or control [partially 
integrated] observations. This cluster level treatment assignment is relevant when 
considering the statistical methods used. 
6.2.3 Defining outcome variables 
To assess the impact of fully integrated health facilities an outcome variable has been 
isolated from the DHS data. This variable indicates if a respondent had received an HIV test 
during their ANC check. It originates from the following DHS question: “Did you receive a 
HIV test during ANC check?” Responses to this question include: ‘Yes’, ‘No’ and ‘Don’t 
Know’. Values recorded as ‘Don’t Know’, comprising less than 1% of responses, have been 
126 
 
removed for clarity. The outcome variable has been coded 0 for ‘No’ and 1 for ‘Yes’ thus 
becoming a binary variable. 
HIV tests during ANC are technically available at both partially and fully integrated primary 
health facilities [365]. This variable is appropriate for showing differences in service use 
between the two models of integration. As discussed in Chapter 3, receiving an HIV test 
during ANC is highly relevant to Peru given the concentrated state of the HIV epidemic within 
the country.  
A further two outcome variables are isolated. Both are related to women’s knowledge and 
attitudes relating to HIV. As mentioned above, HIV testing as part of ANC is coupled with 
pre and post–testing information sessions. It is possible because of these information 
sessions that knowledge may be improved around HIV and stigma associated with the 
disease may be mediated [366]. Consequently, the following variables are used: 1) 
knowledge of HIV prevention activities, and 2) measures, misconceptions and consequent 
stigma involving HIV.  
The evaluation has been conducted ex-post. Questions isolated for measuring integration 
have been restricted only to those available in the data. The first is drawn from the question: 
‘Is there anything which can be done to prevent HIV?”. This question is not ideal for 
representing the broad range of aspects which encompass knowledge of HIV. Interpretation 
of the question may be broad and include ideals of fatalism as well as knowledge. 
Regardless, responses are ‘yes’, ‘no’ or’ don’t know’. Responses are dichotomised to ‘yes’ 
or ‘no/don’t know’.  
The secondary outcome variable is drawn from the question: ‘Do you believe that HIV can 
be caused by witchcraft or supernatural means?’ As with the knowledge measure this 
question is not ideal to evaluate stigma. HIV stigma is reflected through a broad range of 
perspectives. It may be represented in ways that don’t require a belief in the supernatural. 
Regardless responses include ‘yes’, ‘no’ or ‘don’t know’. Responses are dichotomised into 
‘yes/don’t know’ or ‘no’.  
Measuring outcomes relating to knowledge or attitudes is also difficult when not following 
individuals over time. This is due to potential directionality issues. Such issues along with 
those relating to data collection discussed above, the knowledge/attitudes-based outcomes 
are not considered primary outcomes and results from these are considered cautiously. 
6.2.4 Selective assignment of integration 
127 
 
As mentioned above, health centres have been fully integrated non-randomly. It is possible 
that treatment and control groups systematically differ from one other. Consequently, when 
evaluating impact based on the raw data, potential biases may occur. This bias is driven by 
individual characteristics and based on the district and region where each woman resides.  
Districts can differ dramatically in Peru [354]. For instance, within Lima, two bordering 
districts, La Molina and Villa Maria del Triunfo, are the most affluent and the most destitute 
districts in the country respectively [354]. This may translate into differences in demand, 
accessibility and acceptance for key services [367]. They may also represent differing levels 
of resources available at health centres/districts. Measuring the outcome of impact between 
fully and partially integrated groups, without taking individual and higher- level 
characteristics into account, may result in incorrect inferences.  
6.2.5 Potential confounding factors 
Relevant potential confounders have been identified through a review of the literature on 
common correlates associated with increased use of HIV tests, HIV and ANC in Peru, and 
the HIV service delivery models. Key covariates have also been selected based on 
availability and associations within the dataset. A key covariate, 2005 district HIV incidence, 
has been added to the data-set from national surveillance data [364]. PSs are used to control 
for selection bias which rely on key measured covariates. Covariates shown to have limited 
effect, be collinear with other covariates, or which have problems due to inappropriate data 
collection are not included. A description of the covariates reviewed from the data for 
inclusion in the PS can be seen in the Table 6.1below. Table 6.2 shows a justification for 
the use of each covariate in potentially estimating the PS.
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Table 6.1. Descriptions of covariates in estimating the propensity score in HIV/ANC 
Variable Definition 
Region If the mother resides in (1) Lima, (2) Loreto or (3) Moquegua regions 
Year Indicates year mother was surveyed ranging from 2007 to 2012 
Age Indicates mother’s age in years 
Education Mother's education attainment: (1) None; (2) Incomplete Primary; (3) Complete Primary; (4) Secondary or more 
Wealth Wealth quintiles derived using principal components analysis based on household assets, pre-completed within 
the DHS 
At least one ANC check given by 
a doctor 
(0/1) if a mother received her ANC check from a doctor 
Has health insurance  (0/1) if mother has any type of medical insurance 
Language/Ethnicity Ethnic background of the observation based on language spoken, collapsed original variable labels into (0) 
Spanish speakers (1) Other 
District The district to which the observation pertains 
District level HIV incidence 
Region 
Rate of HIV infection per 100,000 population 
 
The region in which the observation pertains, supersedes the district level 
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Table 6.2. Rationale for covariates potentially used to estimate propensity score in HIV/ANC 
Variable Rationale 
Year and wave Important due to differences which may have occurred over time and relates to year in which ANC check was performed 
Age Participants may systematically differ in their attitudes and knowledge towards different health seeking behaviour by 
age. This covariate has also shown to influence ANC use in Peru [88]. 
Wealth Health seeking behaviour can often be tied to access, which may in turn be affected by wealth [368]. This covariate has 
also been shown to be significantly associated with ANC coverage and HIV incidence in Peru [88]. 
Education Education levels have been shown in various settings to have an effect on health seeking behaviour. Education has 
also been shown to be significantly associated with ANC coverage in Peru. 
Has health insurance Identified in the DHS. Having health insurance is theorised to be correlated to health seeking behaviour.  
Region The integration intervention has been implemented in only 4 regions. By including region specific covariates it may be 
possible to control for systematic differences which are present across different regions. Important in identifying 
clustered structures within the data. Used to model potential systematic similarities which observations may share by 
region. 
At least one ANC check 
given by a doctor 
This covariate has been identified in the DHS. This covariate is being used to control for health system specific 
characteristics which may have an affect on health seeking behaviour. 
District  Important in identifying clustered structures within the data. Used to model potential systematic similarities which 
observations may share by district. 
District HIV incidence 
 
When integration has been applied it has been noted that one of the district selection criteria for full integration has been 
a higher HIV incidence 
Language/Ethnicity Evidence has shown that patients may receive sub-optimal service based on their ethnicity, also on their ability to speak 
the country’s official language 
130 
 
 
6.2.6 Clustering 
For this case study, the base unit of observation is women who have attended ANC. As 
mentioned above women are only able to receive ANC from health centres in the district in 
which they live [207].  Districts are further clustered into the four regions from which data has 
been drawn. As mentioned above an important district level covariate has been added to 
the data: district HIV incidence per 100,000 district residents [364]. Both district membership 
and district covariates are considered when evaluating impact in this case study. 
6.2.7 Time periods 
Integration was implemented in 2005. Consequently, it is possible to follow changes in key 
outcome indicators before and after integration. The data used for this analysis has a 
repeated cross-sectional design. Year of interview for each observation is available, so 
changes in outcome can be observed over time. Insufficient sample size per individual year 
has meant that observations have been grouped into 3 time periods. These are pre-
integration, post integration 1 and post integration 2.  
Pre-integration refers to all years before integration. Post integration 1 refers to the time 
directly following integration up until 2010. Post integration 2 refers to 2010 and onwards. 
The cut-off date between post integration 1 and 2 has been selected as it coincides with 
dramatic changes in the structure of the HIV financing mechanism within Peru. During this 
period the percentage of HIV financing coming from external funders, namely the Global 
fund for AIDS, Tuberculosis, and Malaria (GFATM), has been reduced [91, 194].  
6.2.8 Analysis 
The analysis of this data has been primarily performed using Stata. Data was originally 
available in Excel, Stata and SPSS formats. All formats have been converted to Stata format 
and combined. A sample of Stata code used is available as Appendix 4. 
6.2.9 Ethics 
Research ethics approval was obtained for the use of the secondary de-identified data. 
Notification of approval can be found in Appendix 1.  
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6.3 Descriptive statistics 
To provide a general overview of the sample and explore potential biases between treatment 
groups descriptive statistics are provided below. This includes descriptions of the whole 
sample of data, by partial and full integration model, and across outcome variables. 
6.3.1 Baseline description of whole sample 
Table 6.3 below presents descriptions of covariates across full sample of pregnant women 
attending ANC. A total of 7,470 women are included. They comprise 180 treatment 
(attending a fully integrated facility for ANC) and 7,290 control (attending a partially 
integrated facility) observations. Just over half of women (57.5%) had some form of health 
insurance. Most (45.3%) were aged 25-34. The remainder of the sample was 15-24 (31.9%) 
and 35-49 (23.1%). More than half of the sample was from the poorer wealth tercile (54.6%), 
with the remainder being equally split between the two-remaining wealth terciles.  
Most women had received at least one other substantive test during ANC (87.5%) and most 
received their ANC test from a doctor or obstetrician (86.6%). A majority (83%) of women 
spoke Spanish as their first language. A roughly even split of women were sampled from 
each time period. A roughly even split of women were also sampled from the four regions 
with the most (33%) from Lima and the Least (14%) from Moquegua. The average district 
HIV incidence was 1.04 cases per 100,000 population (5.7 SD) for the sample. 
6.3.2 Covariates by integration model 
To demonstrate potential systematic differences between women attending fully and 
partially integrated facilities, comparison based on descriptive statistics are provided, shown 
in Table 6.3. Frequencies and differences for covariates are observed by treatment group 
and statistically significant differences are tested using t-tests and chi-squared tests. 
Summarising in this way may help to inform further steps in the analysis by gaining an overall 
picture of the data and potential correlations while also quantifying biases between the 
treatment and control groups. 
Women receiving ANC checks by time-period were lowest in the pre-intervention and post-
intervention 2 periods for both groups. The average age for both groups was 28. No 
statistically significant differences were found between groups for age at the 95% level. Most 
women attending both partially and fully integrated groups had secondary education. A very 
low percentage of women (2.24%) had no education in both groups.  
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Women differed significantly in levels of wealth between attending fully and partially 
integrated facilities. The wealthier quintile had the highest proportion of women from the fully 
integrated group. The partially integrated group was more evenly distributed between the 
quintiles except for the richest quintile which had the lowest sample numbers.  
Slightly more women had health insurance in the fully integrated group. More women in the 
fully integrated group (61.06%) had their ANC check by a doctor than the partially integrated 
group (46.97%); however, this was not statistically significant. Most women from both groups 
had at least one other test during ANC. While almost all women in the fully integrated group 
lived in Lima (71%), less than half of the partially integrated group resided there (40%). 
Women in the partially integrated group were less likely to have Spanish as their first 
language. These differences between partially and fully integrated groups were statistically 
significant. 
Fully integrated districts had a statistically significant higher incidence of HIV. This is most 
likely due to the implementation of full integration in high incidence areas. The highest 
incidence of HIV was found in the capital, Lima, and the jungle state Moquegua. High HIV 
incidence districts and observations, though, were not restricted to fully integrated areas. 
Some districts within partially integrated areas also had high HIV incidence allowing for 
comparison.
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Table 6.3. Population characteristics of pregnant women by partially and fully integrated health facilities in Peru (2002-2014) 
Covariate All Sample Partially integrated Fully integrated p* 
Region %  %  %  
Apurimac 1,705 22.54%  1,678 23.00% 9 5.00%  
Lima 2,525 33.37%  2,330 40.00% 128 71.11% *** 
Loreto 2,245 29.67%  2,206 30.30% 29 16.11% *** 
Moquegua 1091 14.42%   1,076 14.70% 14 7.78% *** 
    100.00%     100.00%   100.00%   
Time Period          
Pre-intervention 2000 26.43%  1956 26.80% 44 24.40%  
Post-intervention 1 3367 44.50%  3287 45.10% 80 44.40%  
Post-intervention 2 2199 29.07%   2047 28.10% 56 31.10%  
    100.00%     100.00%   100.00%   
Age          
15-19 634 8.49%  619 8.49% 15 8.33%  
20-24 1728 32.13%  1689 23.17% 39 21.67%  
25-29 1800 24.10%  1755 24.07% 45 25.00%  
30-34 1582 21.18%  1540 21.12% 42 23.33%  
35-39 1033 13.83%  1011 13.87% 22 12.22%  
40-44 540 7.23%  525 7.20% 15 8.33%  
45-49 153 2.05%   151 2.07% 2 1.11%  
    100.00%     100.00%   100.00%   
Education          
No education 205 2.74%  203 1.26% 2 0.44%  
Primary 2,316 31.00%  2,275 27.43% 41 23.89% * 
Secondary 3,822 51.16%  3,709 55.51% 113 61.06%  
Higher 1,127 15.09%   1,103 17.90% 24 14.60%  
    100.00%     100.00%   100.00%   
Wealth          
Poorest 2,255 30.19%  2220 30.45% 35 19.44% ** 
Poorer 1,823 24.40%  1803 24.73% 20 11.11% *** 
Middle 1,591 21.30%  1545 21.19% 46 25.56%  
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Richer 1,214 16.25%  1160 15.91% 54 30.00% *** 
Richest 587 7.86%   562 7.71% 25 13.89% *** 
    100.00%     100.00%   100.00%   
At least one ANC check given by a doctor/obstetrician     
No 4,188 53.08% 4,118 55.13% 70 38.94%  
Yes 3,462 46.92% 3,352 46.97% 110 61.06%  
    100.00%   100.00%   100.00%   
Has health insurance        
No 3,274 43.27% 3,093 42.42% 85 47.22%  
Yes 4,292 56.73% 4,197 57.57% 95 52.78%  
    100.00%   100.00%   100.00%   
Woman received at least one other common test during ANC     
No 933 12.49% 915 12.55% 18 10.00%  
Yes 6,537 87.51% 6,357 87.20% 162 90.00%  
    100.00%   100.00%   100.00%   
Ethnicity based on primary language 
Quechua/other 1268 16.76% 1,167 16.01% 5 2.77% *** 
Spanish 6298 83.24% 6,123 83.99% 175 97.22%  
  100%  100%  100%  
Mean district HIV incidence    
 12.62 (18.11) 12.52  (18.13) 22.42  (17.59) *** 
        
    100.00%   100.00%   100.00%   
Total 7,470   7290   180     
*p<0.1, **p<0.05, ***p<0.01, Data are drawn from the Peruvian DHS, years 2002-2014
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6.3.3 Descriptive statistics of primary outcome variable 
Descriptive statistics and associations of integration model and covariates with primary 
outcome variable are provided in Table 6.4 below, for the outcome variable: pregnant 
women having received a HIV test during ANC. This is to help inform covariates which may 
confound naïve estimations of integration impact. Comparing naïve outcomes between 
treatment groups is also analogous to performing a case-control study. As discussed in 
Chapter 4, this is a common occurrence in the empirical integration literature. This measure 
is provided here for the purposes of comparison, to estimates derived from the application 
of MLM-PS. This includes difference between groups measured before and after integration, 
mimicking a non-panel-data difference in difference design. Frequencies and averages are 
provided, and t-tests and chi-squared tests are used to estimate statistically significant 
differences.  
Across the whole sample an average of 67% of women received an HIV test during ANC. 
Fully integrated groups showed a statistically significant higher percentage of tests (78.33%) 
compared to the partially integrated (66.72%) group. This represents a marginal difference 
of 11.61%. The percentage of HIV tests by integration group over intervention periods can 
be seen in Figure 6.1 below. The overall percentage of women receiving tests across the 
whole sample increased from the pre-intervention period continuing to increase until the 
second post-intervention period. The initial increase in both groups is most likely due to 
expansion of the HIV program from 2005 onwards including expansion of coverage and 
quality of services [195].  Testing in the fully integrated group was significantly higher prior 
to the intervention (p<0.1) and in the second post-intervention period (p<0.1) when 
compared to the partially integrated group. When controlling for time using logistic 
regression, women attending fully integrated facilities are 66% (statistically significant at p < 
0.05) more likely to have received a HIV test than the partially integrated group. 
As can be seen in table 6.5 below, amongst both fully and partially integrated groups a 
higher percentage of HIV tests during ANC were performed in the Lima region. The 
percentage of tests performed between different age groups were roughly similar except for 
the 45-49 age group which had a lower percentage of women receiving tests than other 
ages. Urban mothers with secondary or higher education were more likely to receive a test.  
HIV testing was also inversely proportional to wealth.  Between treatment and control groups 
women with secondary education (p<0.1) and in the richest wealth quintile (p<0.05) in the 
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fully integrated group were more likely to receive a HIV test compared to similar women in 
the partially integrated group.  
Women were more likely to receive a HIV test during ANC if they had their ANC check from 
a doctor/obstetrician, had insurance, had at least one other ANC check, and had the final 
say on their own health, but these findings were not significantly different between treatment 
and control groups. This was with the exception of women who had insurance in the fully 
integrated group, who were more likely to receive an HIV test than similar women in the 
partially integrated group. Higher HIV incidence districts were associated with increased 
testing for the whole sample and by integration group. 
Among the whole sample 87% of women believed there were preventative activities which 
could be used against HIV. This was the same for both women attending fully and partially 
integrated facilities, with the difference not being statistically significant. Among both fully 
and partially integrated facilities 11% of women believed witchcraft could cause HIV, the 
difference also not being statistically significant.  
Figure 6-1. Unadjusted difference in HIV test usage between fully and partially integrated 
observations by intervention period (data drawn from Peruvian DHS 2002-2014) 
 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Pre-intervention Post-intervention Post-intervention 2
P
e
rc
e
n
ta
ge
 o
f 
p
re
gn
an
t 
w
o
m
e
n
 r
e
ci
e
vi
n
g 
H
IV
 t
e
st
 
d
u
ri
n
g 
A
N
C
Control Treatment
137 
 
Table 6.4. Associations of population characteristics with increased likelihood of receiving a HIV 
test during ANC, Peru (2002-2014) 
Outcome HIV test during ANC (No/Yes) All 
sample 
total P 
 Yes 2,465   
 No 5,005   
Education  < primary 1,201 2,521   
> Secondary 3,804 4,949 *** 
Language/ Other 355 1,172 
 
Ethnicity Spanish 4,650 6,298 *** 
Region  Apurimac 715 1,687 
 
 
Lima 2,055 2,458 
 
 
Loreto 1,453 2,235 
 
 
Moquegua 782 1,090 *** 
Wealth groups 0 2,242 4,078 
 
1 1,258 1,591 
 
2 1,505 1,801 *** 
Other test during ANC No 218 933 
 
Yes 4,787 6,537 *** 
ANC by professional No 288 1,002 
 
Yes 4,717 6,468 *** 
Has insurance No 2,093 3,178 
 
Yes 2,912 4,292 * 
HIV incidence (district) ϯ No HIV Test 0.5557 1.9655 *** 
HIV Test 1.1867 2.8758 
Ageϯ No HIV test 29.514 7.6294 *** 
 
HIV test 28.6409 6.9811 
Language/ethnicity No HIV test 355  *** 
 HIV test 4650   
*p<0.1, **p<0.05, ***p<0.01, Data are drawn from the Peruvian DHS, years 2002-2014, ϯ = 
continuous covariate 
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Table 6.5. Differences in increased likelihood of receiving a HIV test during ANC across population 
characteristics by partially and fully integrated health facility in Peru (2002-2014) 
Has received Received HIV 
Test 
Control (no) Control 
(yes) 
Treatmen
t (no) 
Treatmen
t (yes) 
p 
Full Sample  2,426 4,864 39 141 *** 
Education < primary 1,173 2,478 28 43  
 > Secondary 3,691 4,812 113 137 >1 
Ethnicity 0 354 1,167 1 5 
 
 1 4,510 6,123 140 175 *** 
Region Apurimac 712 1,678 3 9 
 
 Lima 1,947 2,330 108 128 
 
 Loreto 1,433 2,206 20 29 
 
 Moquegua 772 1,076 10 14 *** 
Wealth groups 0 2,205 4,023 37 55 
 
1 1,221 1,545 37 46 
 
2 1,438 1,722 67 79 *** 
Other test 
during ANC 
No 212 915 6 18 
 
Yes 4,652 6,375 135 162 >1 
ANC by 
professional 
No 712 
(29.35%) 
286 
(5.88%) 
2 
(5.13%) 
2 
(1.42%) 
 
Yes 1,714 
(70.65%) 
4,578 
(94.12%) 
37 
(94.87%) 
139 
(98.58%) 
** 
Has insurance No 1,060 
(43.69%) 
2,033 
(41.8%) 
25 
(64.1%) 
60 
(42.55%) 
 
Yes 1,366 
(56.31%) 
2,831 
(58.2%) 
14 
(35.9%) 
81 
(57.45%) 
>1 
HIV incidence 
(district) ϯ 
No HIV 1.17057 2.8947 1.7444 2.0561 ** 
HIV 
     
Ageϯ HIV test 28.6492 6.9855 28.3546 6.8464 >1 
Language Other 813 354 4 1 *** 
/ethnicity Spanish 1,613 4,510 35 140  
*p<0.1, **p<0.05, ***p<0.01, Data are drawn from the Peruvian DHS, years 2002-2014, ϯ = 
continuous covariate
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6.3.4 Summary of descriptive statistics 
The results above demonstrate that statistically significant differences exist between 
partially and fully integrated groups. These are at both the individual and cluster level. In 
addition, various factors are statistically significantly associated with increased HIV testing. 
This is both in the pooled sample and when controlling for treatment. Naïve estimates of the 
impact of full integration, as provided above, suggest that higher integration is significantly 
associated with improved HIV testing. However, such comparisons without controlling for 
the important confounders highlighted in this section may not represent full integration’s true 
effects. Causal comparison based on the data requires adjustment for bias prior to impact 
of HIV service integration being estimated. 
6.4 Methods used to estimate impact of full integration 
The following section provides details of the specifications of MLM-PS in the estimation of 
the PS. This includes specifications of conditioning the data based on the PS, measure 
common support and balance post-conditioning, and estimate outcomes post-conditioning. 
This section differs from the previous Chapter by discussing specifics relating to practical 
aspects of this case study. A theoretical explanation MLM-PS is available in Chapter 5. 
6.4.1 Estimation of the propensity score 
To balance confounders between treatment and control groups a PS is constructed to 
balance fully and partially integrated observations. The PS is constructed using observations 
across all time periods. When observing outcomes pre and post treatment using a PS, it is 
common to include only baseline covariates [356].  This is to balance policy groups before 
integration has been applied. This allows a more balanced sample to be followed over the 
course of intervention [36]. This relies however on following the same observation over time, 
which is not the situation for this case study. 
Instead covariates used in the PS are those across all time periods. District HIV incidence 
is provided at a single time point prior to integration as it is the only available measure. As 
discussed in Chapter 5 a mixed effects model is used to estimate the PS. This includes fixed 
effects as person level covariates, random intercepts for both district and region, and 
random slopes estimated for the district level covariate HIV incidence. The PS model is 
presented below:  
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Logit (PSkjk) = β0 + δk + δjk + γ1incjk + β1eduhjk + β2wealthhjk + β3agehjk + β4anchjk + β5profhjk 
+ β6inshjk (23) 
Where h are pregnant women attending ANC during pregnancy (h = 1...H), in district j (j = 
1....J) in region k (k = 1….K). PShjk indicates the individual PS for receiving treatment. β0 is 
the constant. δk is a random intercept for each region drawn from a normal distribution 
δ𝑘~ N(0, σ
2
𝑅). δjk is a random intercept for each district drawn from a normal distribution 
δ𝑗𝑘~ N(0, σ
2
𝐷 ). inc is a district level continuous variable indicating the district HIV incidence 
per 100,000 population, estimated as a random slope with a distribution 𝑖𝑛𝑐 ~ N(0, σ2𝑖𝑛𝑐 ). 
edu is a binary variable indicating education, wealth is a categorical variable indicating 
wealth terciles, age is a continuous variable for woman age in years, anc is a binary variable 
indicating if another common ANC test is performed during ANC check, prof is a binary 
variable indicating if ANC is performed by a doctor/obstetrician or other health worker and, 
ins is a binary variable indicating if the woman has health insurance. 
The PS itself can be defined as individual probability of having received ANC from a fully 
integrated health centre.  
6.4.2 Conditioning on the propensity score 
To improve covariate balance between treatment and control groups, they are conditioned 
based on the PS. As highlighted in Chapter 5, various conditioning techniques can be used 
to create a valid counterfactual. The technique tested with the available data and best able 
to improve covariate balance between treatment and control groups, ATET weighting, is 
used.  
6.4.3 Common support and balance 
Testing the assumption of common support is performed by a visual inspection of the PS 
through kernel density and box plots. Following observation of common support, balance 
diagnostics are performed to ensure previously highlighted biases have been removed post 
conditioning on the PS. As with the descriptive statistics this includes measuring statistically 
significant differences. The difference being that post-conditioning is measured on the 
inverse probability weighted sample. This is performed using t-tests and chi-squared pre 
and post conditioning. Standardised bias is also tested as discussed in the methods 
Chapter. Sufficient covariate balance is achieved if the t-test for equality of means is not 
rejected. A p-value cut-off is set at no greater than 0.05. Standardised bias less than 20% 
is used to describe a balanced sample as per Rosenbaum and Rubin [29]. 
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6.4.4 Outcome estimation models 
Three similar models are used to estimate the three measured outcomes incorporating PS 
derived probability weights. All three models are mixed effects differing only in the modelled 
outcome. Doubly-robust estimators are used to provide a double chance of controlling for 
bias associated with clustering [32]. Each model also contains a time-treatment interaction. 
Each outcome model, weighted on the inverse of treatment assignment, is estimated as per 
(19), Chapter 5, Section 5.6.6. 
6.5 Results 
The following sections presents results based on the estimation of the PS. These include 
common support of the PS, balance pre-post PS conditioning and outcomes incorporating 
probability weights. 
6.5.1 Common support 
Firstly, a visual inspection of the range of the PS between treatment and control using box 
plots. Figure 6.2 shows that treatment observations lie within the upper and lower bounds 
of the control observations suggesting common support has been achieved. Next 
observation of the weighted PS is performed through kernel density plots. ATET weights 
require only that sufficient overlap is obtained with the treatment group as results are limited 
to the treatment group and to control observations like them. The distribution of the PS is 
much more similar between groups post weighting.  
 
Figure 6-2 Propensity score box plot by treatment group
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6.5.2 Balance diagnostics 
Table 6.7 shows the distribution of covariates pre and post weighting, between treated and 
control groups. Several covariates were shown to have significantly different means before 
conditioning. Following weighting all statistically significant differences become non-
significant, thus indicating that these covariates have been successfully balanced between 
treatment and control groups. Standardised bias is also used to assess balance. Prior to 
weighting all covariates sit outside the common range for acceptable bias. Following 
weighting all covariates also reduce standardised bias to within the acceptable range 
Interestingly the covariate measuring age sees a large increase in bias following 
conditioning. This may be due to strong similarities prior to weighting. Bias levels between 
groups for age, however, remain within acceptable levels post-weighting.  
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Table 6.6. Bias between women attending fully and partially integrate health facilities pre- and 
post-weighting on the PS 
Covariate Weighted Treated Control %bia
s 
%redu
ction in 
Bias 
t-test 
(t) 
p>t 
District HIV Incidence Unweighted 1.7499 0.9594 32.5 
 
3.99 0 
 
Weighted 1.7499 1.5298 9.1 72.1 0.96 0.339 
Education Unweighted 0.7611 0.6600 22.4 
 
2.83 0.005 
 
Weighted 0.7611 0.7434 3.9 82.5 0.38 0.706 
Language/Ethnicity Unweighted 0.9722 0.8399 46.5 
 
4.83 0 
 
Weighted 0.9722 0.9972 -8.8 81.1 -1.86 0.064 
*Lima District Unweighted 0.7111 0.3196 85 
 
11.13 0 
 
Weighted 0.7111 0.7028 1.8 97.9 0.17 0.867 
*Loreto District Unweighted 0.1611 0.3026 -34 
 
-4.1 0 
 
Weighted 0.1611 0.1602 0.2 99.4 0.02 0.983 
*Apurimac district Unweighted 0.0777 0.1476 -22.2 
 
-2.62 0.009 
 
Weighted 0.0777 0.0863 -2.7 87.8 -0.29 0.774 
Age (in years) Unweighted 28.911 28.929 -0.3 
 
-0.03 0.973 
 
Weighted 28.911 27.734 16.6 -6303.3 1.57 0.117 
Lower income wealth 
group 
Unweighted 0.2555 0.2119 10.3 
 
1.41 0.158 
 
Weighted 0.2555 0.2342 5 51.2 0.46 0.649 
Middle/upper income 
wealth group 
Unweighted 0.4388 0.2362 43.8 
 
6.3 0 
 
Weighted 0.4388 0.4477 -1.9 95.6 -0.16 0.87 
Received at least 1 
other test during ANC 
Unweighted 0.9 0.8744 8.1 
 
1.02 0.306 
 
Weighted 0.9 0.8848 4.8 40.7 0.45 0.652 
ANC provided by 
doctor/obstetrician 
Unweighted 0.9777 0.8631 43.3 
 
4.47 0 
 
Weighted 0.9777 0.9738 1.5 96.5 0.24 0.812 
Has Health Insurance Unweighted 0.5277 0.5757 -9.6 
 
-1.29 0.199 
 
Weighted 0.5277 0.5218 1.2 87.6 0.11 0.912 
Data drawn from the Peruvian DHS 2002-2014, *Regions here are included only for illustrative 
purpose 
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Following weighting significant differences between treatment and control groups have been 
removed. Potential confounders between the two groups are sufficiently balanced to enable 
a causal comparison based on measured confounders at both individual and district level. 
6.5.3 Outcome estimations 
Results from the three outcome variables are presented in Table 6.8 below. Following 
weighting full integration causes a 123% (51% - 196% 99%CI) log odds increase in the use 
of HIV testing. This was with a p-value of 0.001 indicating statistical significance at a 95% 
and 99% level.  
Despite the positive finding, the breadth of estimated confidence intervals suggest that the 
true value lies within quite a broad range. At worst, however, when using the estimates 
generated by this exercise it can be said that full integration is no worse than partial 
integration.  
Knowledge of methods to prevent HIV shows almost no difference between treatment 
groups with a 1% reduction in knowledge related to full integration. Full integration also 
appears to result in more stigma (54%). Both findings, however, are not statistically 
significant and sit within CIs incorporating positive and negative bounds. Full integration is 
therefore assumed to have no marginal benefit on knowledge or attitudes over partial 
integration.  These outcomes are evaluated as secondary indicators of full integration and 
should be treated with caution. As an initial analysis, however, it may be assumed that at 
baseline integration results in no worse knowledge/stigma. 
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Table 6.7. Estimated causal impact of full integration post weighting on the PS across all outcome indicators 
Outcome Log likelihood SD t p 95% Confidence 
intervals 
Received HIV test during ANC 1.238 0.371 3.34 0.001 0.510 1.966 
Believes something can be done to prevent HIV -0.01 0.814 -0.01 0.99 -1.606 1.586 
Believes HIV can be caused by witchcraft 0.547 1.847 0.3 0.767 -3.074 4.168 
SD = Standard Deviation, Results estimated using Peruvian DHS data (2002-204) 
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6.6 Discussion 
The goal of this Chapter was to explore the use of MLM-PS and attempt causal estimation 
of full HIV service integration impact. Two important results are derived from this study. 
Firstly, bias at multiple levels between treatment groups can demonstrably be reduced 
following the use of the MLM-PS. Secondly, higher HIV service integration has a strong 
causal effect on the increased use of HIV testing, shown following application of MLM-PS. 
Discussion of these findings is presented below.  
6.6.1 Application of MLM-PS 
The primary objective of this thesis was to explore the use of pragmatic alternatives to 
randomisation and other methods which were limited due to issues posed by HIV integration. 
Using MLM-PS, estimated HIV testing during ANC increased dramatically and significantly, 
caused by higher integration. Prior estimates which did not control for bias underestimated 
its full effect. Controlling for bias and clustering estimates a 123% increase in the use of HIV 
tests, which is 57% more than naïve estimates; a compelling difference for policy makers. 
Application of MLM-PS in this Chapter has shown to overcome evaluation issues posed by 
integration. Despite the identified data limitations, it has allowed bias reduction at multiple 
levels when conducting evaluation ex-post using a common source of nationally 
representative cross-sectional data. This has ramifications for measuring impact of 
integration and other similar health policies. 
Within the integration literature quasi-experimental methods have been suggested as a 
pragmatic alternative to randomisation [133]. This, however, has generally excluded PSs.  
A similar situation is found for quasi-experimental methods relating to health policy in 
general [28, 369]. A recent systematic review finds that PSs, in this field, are used with much 
less frequency than other quasi-experimental methods [370]. This is likely due to the limited 
scope of endogeneity which PSs can address. Despite this PSs applied in this case study 
have provided a demonstrable reduction in bias, where other techniques may not, given the 
limitations posed by data and study design. The frequency with which ex-post evaluation 
occurs in HIV integration may be indicative of trends in general integration and health policy. 
Including PSs in the barrage of quasi-experimental methods which can be applied to 
integration and other health policies is beneficial to improving estimated impacts from 
evaluations limited by study design and data.  
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PSs have not previously been applied to measure the impact of integration but applied to a 
limited degree to other health policies [370]. The novel application of MLMs in estimation of 
the PS has not been explored generally in health policy. Given the findings from this case 
study the inclusion of MLMs in PS studies may be warranted due to the manner in which 
many health policies are applied and measured. As an example, PSs have successfully 
been used to evaluate impact of health insurance cards on increased use of essential 
services [371]. Here outcomes of the policy are measured at an individual level. Multiple 
individuals, however, reside in the same household and are therefore subject to similar 
contextual information, such as household SES, which may influence their decision to 
access care. The PS applied in this example controls differences between individuals, 
however ignoring household characteristics which are stated to likely affect outcomes [371]. 
Based on the research presented in this case study the inclusion of household information 
is both important and feasible through MLM-PS.  
PSs have also shown to be useful in controlling differences for policy applied fixed to the 
cluster level, similarly to integration. Two examples are; a health financing policy applied to 
purposively selected health facilities compared to similarly matched control facilities [372] 
and, a community based newborn package applied at the level of the district matching 
individuals within control districts [373]. In both examples’ PSs are used to demonstrably 
reduce individual level biases, however, both do not account for contextual information. This 
may misattribute the effect of the policy as context has been shown to affect outcomes of 
polices like integration applied to fixed locations [43]. The demonstration that MLMs can be 
added to the PS is important for evaluating policies applied at a cluster level. 
Large, nationally representative, repeated cross-sectional surveys such as the DHS are 
increasingly used to evaluate health and other policy impact [374]. As demonstrated in this 
case study, MLM-PS is a useful tool to evaluating clustered policies ex-post, using DHS and 
other similar surveys. Such surveys often draw observations from a large geographic area 
[331]. They often also include a wide array of variables including descriptions of the area 
observations are drawn from [331]. This improves the likelihood of identifying treatment and 
control observations but also increases the likelihood of inclusion of contextual information 
from the survey itself or from outside sources. PSs have previously been used to evaluate 
health and other policy impact using the DHS [375-379], including when the policy has been 
applied at the district level [373]. Large national surveys such as the DHS, or others such 
as the world mental health survey, rely on stratified sampling often at the district level. This 
allows nationally representative population estimates but also presents the opportunity for 
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including information at the cluster level into estimations of the PS when district level bias is 
a possibility. MLM-PS and data sources such as the DHS may be a potent combination for 
improving estimated impacts of policy into the future. 
6.6.2 Comparison to other empirical studies 
As demonstrated in Chapter 4 there is a gap in the HIV/ANC service integration research of 
strong study designs. This study fills that gap by approaching the evaluation of integration 
using a combination of impact evaluation techniques. The positive effect of higher integration 
of HIV with ANC has been explored in other studies and is discussed in Chapter 4. As with 
the case study presented in this Chapter, prior research has generally found positive effects 
for higher integration.  
This Chapter is the first evaluation performed on HIV/ANC service integration in Peru. Other 
empirical HIV/ANC studies, identified through the systematic review, have been in Africa in 
generalised epidemic countries or in India. Comparing results from this case study to other 
empirical literature is therefore difficult given the dramatically different contextual factors 
which have been shown to influence perceived benefits of integration [43]. Similarities may 
be found however, along different dissections of integration, as per Chapter 3.  
Frequent in the literature are evaluations on service delivery models of integration similar to 
this case study: full integration vs. partial integration. These show generally positive results 
for higher integration albeit with different indicators than the case study, reflecting different 
barriers to optimal system performance. In Zambia in response to programmatic barriers 
leading to a loss to follow up of both testing and treatment of HIV positive women, partially 
and fully integrated HIV services are compared [267]. Standalone clinics previously offering 
only CD4 testing and referral are fully integrated to provide a full array of HIV services along 
with laboratory couriers to expedite results and community-based follow up. Full integration 
is associated with an increase in the proportion of pregnant HIV+ women receiving CD4 
counts in addition to both increased initiation of HIV treatment and increased infant testing 
for HIV after birth. Here improved care is driven by the physical location of services as with 
the Peruvian case study. CD4 counts also improved suggesting full integration can influence 
testing as with Peru, albeit of a different class. The inclusion of activities over and above co-
location of services, however, may have influenced improved uptake. This reflects the likely 
benefits of fully integrated services across the care cascade, however also the importance 
of context specific application of integration. 
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In Kenya low coverage for PMTCT services due to verticality of stand-alone programs was 
addressed by randomising 12 ANC clinics to have a full spectrum of PMTCT or referral of 
HIV positive women to HIV services [270, 273]. A similar study in Nigeria randomly assigned 
12 secondary and primary facilities to have all HIV services or only HIV testing with referral 
to CD4 testing and treatment [266]. This was in part due to a shortage in trained staff in rural 
Nigeria. Both studies showed improvements in treatment enrolment, treatment initiation and 
infant testing at fully integrated sites. Both studies show improvements in patient outcomes, 
however, for different reasons. Higher integration effect is reflected primarily on indicators 
later in the treatment cascade, such as treatment and infant follow-up, than those of the 
Peruvian case study. Despite this they provide a clear indication that for the purposes of 
systems planning, providing ANC and HIV together provides a demonstrable improvement 
in key service provision modalities of HIV control. 
Few studies have looked at HIV testing for pregnant women during ANC, excluding CD4 
tests, as an outcome indicator. The only example is from rural India [380]. Here, to scale up 
HIV screening among pregnant women in ANC the PMTCT program was integrated with 
MNCH services in primary clinics, reflecting partially vs non-integrated models. As with Peru 
testing was integrated into primary clinics with referral to higher facilities for other services 
with training nurses in counselling and testing activities. Differing from Peru training 
administrative managers and capacity building of health staff in the district was performed 
along with outreach activities. When comparing non-integrated and partially integrated 
models, HIV screening was found to increase from 55% to 79% (p<0.001). Such a robust 
improvement is in line with the findings presented in this current case study.  
The results from this case study provide a basis for the use of integration as a health system 
strengthening tool in Peru. In the context of a concentrated HIV burden, integration may be 
used to increase the effectiveness of ANC-based HIV testing and the HIV program in 
general. Policy makers in Peru desiring an increase in HIV testing coverage may consider 
full HIV service integration into ANC as an effective platform for achieving this, particularly 
in urban, medium-high HIV incidence areas. It appears that integration may achieve the 
program-strengthening mechanisms discussed in Chapter 3.  
These findings may also be considered by policy makers outside of Peru, while considering 
the unique context. This includes the nature of the HIV epidemic, the baseline characteristics 
of the treatment group, the coverage and structure of the national ANC program, and the 
structure of the primary care program in general.  
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6.6.3 Caveats and limitations to the study 
A variety of methods and specifications can be used to attempt to remove selection bias 
from secondary data, although they should be the most appropriate for the strengths and 
weaknesses of the data. A variety of alternate approaches are identified in Chapter 8. 
Several limitations of this case study are noted. Firstly, in using PS analysis for claiming 
causality, an assumption of no-unmeasured confounders is made [30]. This is a common 
weakness of any PS study and has been attempted to be addressed by utilising a broad 
spectrum of available covariates in estimation of the PS, including district and region 
membership. Additionally, various specifications and an iteration of a common sensitivity 
analysis are performed in Chapter 8.  
Secondly, as more complex methods are used in estimation of the PS, conditioning, and 
estimation of outcomes, potential researcher bias can occur [156]. This has been addressed 
here by first estimating the PS and conditioning technique before estimating outcomes. 
Regardless, outcomes estimated using different specifications of the PS are presented in 
Chapter 8. PSs and methods have been used based on their relative ability to reduce bias 
in the sample. The final method chosen is that which most reduces imbalances.  
Thirdly, the relatively limited information about the integration itself is a potential weakness. 
Potential heterogeneity of treatment may be affecting overall outcomes. Attempts have been 
made, in part, to account for this by controlling for clustering. This will only allow similarities 
in treatment within those districts and not at the individual health centre level.  Results 
obtained from this study should consider this potential heterogeneity.  
6.7 Conclusions 
The aim of this Chapter was to explore MLM-PS as applied to national cross-sectional data. 
This was achieved by applying the method to a case study of HIV/ANC integration in Peru. 
MLM-PS was shown to reduce demonstrable bias at multiple levels. It is therefore concluded 
to be feasible and appropriate for reducing bias when estimating integration impact using 
clustered national cross-sectional data. Un-weighted data was shown to underestimate the 
impact of full integration. This estimate of impact however was demonstrated to be 
potentially biased. The difference in weighted and un-weighted estimate suggest that the 
inclusion of MLM-PS when bias and/or clustering is present has important ramifications for 
policy makers seeking information on integration effectiveness.  
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A further aim was to estimate outcomes of higher integration of HIV/ANC in Peru. Outcomes 
estimated post-weighting showed full integration to cause increased HIV testing. Thus, 
suggesting that integration is a sound health system strengthening policy in the country.  
Results drawn from this chapter are important for informing health system structuring in 
Peru. Also having important ramifications for evaluating HIV integration as they have 
demonstrated the feasibility of MLM-PS when using common cross-sectional data. The 
following Chapter extends the use of MLM-PS to routine surveillance data.  
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7 Case study 2: application of MLM-PS to HIV/TB service integration in Peru 
This Chapter is the second case study of impact evaluation of HIV service integration in 
primary care. The previous case study demonstrated that MLM-PS can reduce biases at 
multiple levels when comparing HIV/ANC integration models. This Chapter extends the 
exploration of MLM-PS by applying it to an alternate HIV integration complex: HIV/TB. The 
case study relies on data which fundamentally differs to that used in the previous Chapter. 
The data are drawn from the national routine surveillance system, a common theme in 
empirical HIV integration evaluation. The data and case study face the common limitations 
to HIV integration evaluation: non-random assignment of integration, clustered data and 
relying on ex-post evaluation. This type of data also poses distinct challenges discussed 
further below. 
The Chapter firstly aims to explore the use of MLM-PS through application to national 
surveillance data. It secondly aims to estimate the impact of HIV/TB service integration. It 
builds upon methods described in Chapter 5 and uses indicators for impact which have been 
discussed in Chapter 3. It begins by describing the context in which HIV/TB service 
integration has taken place and the different models being evaluated. It then describes the 
data used and the different variables and indicators selected for assessing integration. Next 
it describes potential biases associated with non-random treatment assignment. Details of 
the estimation of the PS, specifics on the conditioning techniques, and reduction in bias 
following conditioning are then provided. Impact of higher integration is then estimated. This 
is followed by a discussion of the implications of the results and the benefits/limitations of 
the approach taken.  
7.1 HIV/TB service integration in Peru 
As discussed in Chapter 1, 2, and 3, in 2005 HIV service integration has been implemented 
in Peru. This involved the integration of a full suite of HIV services into primary health 
centres. Previously HIV treatment had been available only at regional hospitals and other 
higher-level facilities.  
Two service delivery models, partial and full integration, have been available post 2005. In 
the partial integration model, a patient presenting for TB would be able to receive a full suite 
of TB services, including HIV testing if confirmed positive for TB. If the HIV test returned 
positive, the TB patient would be referred to a higher facility for HIV confirmatory testing and 
ART treatment. In the full integration model, a patient presenting for TB would be able to 
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receive a full suite of TB procedures including HIV testing if confirmed positive for TB. If this 
HIV test returned positive, the TB patient would be able to receive a confirmatory test and 
ART treatment at the same facility. A comparison of service delivery models can be found 
in Table 1.1. The relative impact of these two service delivery models is evaluate here.  
7.2 Routine surveillance data overview 
Data informing the case study has been collected by the Peruvian Ministry of Health 
(MINSA) National Tuberculosis Program (NTP) [335-352]. The MINSA routinely collects 
information on health service indicators at the health establishment level. This data 
collection process is conducted individually by different MINSA programs, such as the NTP 
or the HIV program. Each program supplies monthly information aggregated to quarter year 
periods on epidemiological and service use indicators to MINSA. Data books from the NTP, 
checked and verified by relevant NTP personnel, have been made available from 2008 to 
2013.  
The data was only able to be provided for two health administrative areas of the capital city, 
Lima.  This data cannot be considered nationally representative. It is, however, of relevance 
given that over a quarter of the Peruvian population reside in the capital and a majority of 
the country’s TB and HIV incident cases occur there [84]. The administrative areas (Central 
Lima and East Lima) are both highly urbanised with comparable population sizes. Both have 
districts which include a breadth of socio-economic indicators. Both also have a mix of 
districts with relatively high and low HIV and TB incidence. Only some districts in Central 
Lima have fully integrated HIV/TB facilities [353, 354]. 
The data collection process involves manual collection of individual patient information in 
paper form. This information is de-identified and then aggregated at the health facility level. 
It is then provided to health district officials for reporting. Each health facility in the NTP data-
books is identified by name.  
Data-books provided by the MINSA were collated into a single spreadsheet for this research. 
Formats across books have been standardised. Non-sensical values have been removed, 
such as health facilities with zero patients (less than 1% of all observations). Data on 
demographic and health system characteristics have been added to the spreadsheet 
manually, as detailed below [84, 353, 354, 381-383].  Quality control measures have been 
undertaken. 
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7.2.1 Defining the relevant sample  
Here the sample isolated from the data and relevant to evaluating the impact of integration 
is described. The data used is only available aggregated at the health establishment level; 
which is the primary sampling unit for this Chapter. Study years are restricted to 2008 – 
2013.  Baseline data, however, is not available for analysis.  Only primary facilities have 
been included in the analysis. In Peru, these are both health posts and health centres.   
Facilities are differentiated based on the relative size of the population which they serve. 
Data has been made available for 210 health facilities, 137 of which are primary facilities. 
7.2.2 Defining treatment and control groups 
Defining which health facility is partially or fully integrated has been based on the health 
facility’s name. As mentioned in the previous Chapter all primary health facilities which can 
be considered fully integrated in Peru have been listed by the MINSA [84, 92, 94]. All health 
facilities in the NTP data-books have also been named. By cross referencing these two data 
sources it has been possible to indicate if the NTP health establishment was partially or fully 
integrated. The 137 primary facilities available within the data contain 12 fully integrated 
facilities and 125 partially integrated.  
7.2.3 Defining outcome variables in HIV/TB 
To assess if integrated primary health facilities have influenced service delivery three 
outcome variables have been identified from the NTP data. The first two are primary 
indicators while the second is considered secondary as discussed in Chapter 3. The first is 
the primary health facility’s ratio of HIV tests offered for confirmed TB positive patients. This 
ratio has been constructed from two key variables included in the NTP data-books: gross 
number of confirmed TB positive cases; and gross number of confirmed TB positive cases 
who have received a HIV test. It is not appropriate to compare direct gross numbers of tests 
between health facilities. Health facilities in Peru vary on key characteristics, including the 
size of the population which they serve. The HIV testing rate has been constructed by 
dividing the total number of TB positive cases offered a HIV test by the total number TB 
positive cases for each primary health facility15. This variable is non-normally distributed, 
censored, and truncated, as such is transformed into a binary variable indicating whether a 
health facility is above or below a 90% test return rate. 
                                                          
15 HIV /TB test Ratio = Total TB positive receiving HIV test / Total TB positive 
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The second outcome variable is the health facilities’ ratio of returned HIV test results for TB 
patients. As discussed in Chapter 3, patients often do not receive the results of their HIV 
test despite having taken the test. This can be due to a variety of both health system and 
patient factors. Knowing HIV status is critical for patient survival and control of the disease. 
The variable indicating test ratio return is constructed by dividing the number of returned 
tests by the total number of patients receiving a test16. This is only available for 2013.  
Study results may potentially be biased if some TB positive patients receive an HIV test 
without being recorded as having this done by the NTP, for example from other programs. 
Given that HIV tests are only available free for at risk groups such as confirmed TB cases, 
it is highly unlikely that other areas of the health facility are providing HIV tests to confirmed 
TB cases. Additionally, patients infrequently present at a health facility for suspected HIV, 
rather they present for symptoms related to opportunistic infections caused by HIV, so it is 
much more likely that a HIV/TB case would present first to the TB program. Consequently, 
the potential bias is not likely to have an effect on the study outcome. This is also only 
available in 2013. 
The third outcome indicator is the TB mortality ratio. The mortality ratio is used as a crude 
measure for the performance of the HIV/TB program complex. This variable is measured for 
multiple years: 2008-2013. Results drawn from this indicator should be considered with 
caution. Firstly, TB deaths may not be directly HIV related. Secondly, TB death is a broad 
measure and it is difficult to assign differing performance to integration alone as per Chapter 
3. Thirdly, a relatively low number of deaths in the intervention period makes results highly 
variable. The measure itself is constructed based on two variables: the total number of TB 
deaths and the total TB incident cases. Both variables are restricted to a given year17. This 
variable has a non-normal distribution and is transformed into a binary variable indicating 
above and below 10% death rate per health centre. 
7.2.4 Non-random integration 
As mentioned above health facilities have been non-randomly fully integrated. Evaluating 
outcomes between fully and partially integrated facilities without taking this into account will 
be potentially biased, as is the case with HIV/ANC integration dealt with in Chapter 6. Biases 
may be both at the level of the health facility itself or higher district levels. Potential baseline 
                                                          
16 HIV/TB Test return ratio = Tot TB positive with returned HIV test/Tot TB+ receiving HIV test 
17 TB death rate = Tot TB deaths / Tot TB positive 
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confounding factors are balanced between fully and partially integrated groups before 
evaluating their impact. This involves use of a MLM-PS which takes into account individual 
and cluster level characteristics. It also involves the use of doubly-robust methods when 
evaluating outcomes. 
7.2.5 Clustering 
Individual observations, health centres, are clustered based on their district. Districts are in 
turn clustered into health administrative areas: Central and East Lima. Clustering is included 
as an important aspect of the overall analysis in both PS and estimation of outcomes.  
7.2.6 Potential cofounding factors 
To improve balance of confounding factors between treatment and control groups key 
covariates have been selected through a review of the literature as well as the availability 
within the dataset. These have included demographic and health system indicators taken 
from the NTP data-books and other sources including the MINSA and the INEI [353, 354, 364]. 
Covariates have been provided at the level of the health facility and of the district in which 
the facility is located. Table 7.1 below provides a description of covariates while Table 7.2 
provides the rationale for their inclusion in the PS.  
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Table 7-1. Descriptions of covariates potentially used to estimate propensity score in HIV/TB case study 
Variable Description Source Variable Type Rationale 
Year (Only 
available for 
secondary 
indicator) 
The year which the 
observation 
corresponds to 
NTP 
data-
books 
Ordinal Used to account for time variant factors which may influence service use. 
District The district and sub-
district which each 
health facility belongs 
to 
INEI 
District 
level 
reports 
and NTP 
data 
Categorical Given that multiple health facilities are present in different districts, this 
covariate may be used to control for systematic differences which may be 
present within each district. 
District 
poverty 
Percentage of district 
living in poverty. 
Dichotomised into 
poor and middle class.  
INEI 
District 
level 
reports   
Dichotomous Poverty is associated with TB and HIV incidence and TB mortality in Peru 
[384]. Poverty may also have an effect on health seeking behaviour. 
District 
health 
expenditure 
per person 
Public health 
expenditure per 
person by district. 
Dichotomised into low 
and medium 
spending.  
INEI 
District 
level 
reports   
Categorised It is theorised that the relative amount of health expenditure within a given 
district will influence the availability of key services and the likelihood those 
services are used. 
Population 
size served 
Size of population 
which health facility 
serves 
NTP 
data-
books 
Continuous It is theorised that population size may influence the quality of services 
offered at different health facilities. 
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Health 
centre 
attendance 
Number of patients 
seen by the health 
facility in a year 
period. For propensity 
score estimation this is 
taken only from 2008. 
NTP 
data-
books 
Continuous It is theorised that attendance may influence the quality of services offered 
at different health facilities. 
HIV 
prevalence 
The HIV prevalence 
per 100,000 
population within the 
given district in 2005 
MINSA 
Surveilla
nce data 
Continuous The HIV prevalence is theorised to have an effect on health seeking 
behaviour amongst participants attending different health facilities. 
TB 
Prevalence 
The prevalence per 
1,000 health centre 
population served 
NTP data Continuous The relative number of TB confirmed cases is theorised to have an effect on 
the functioning of the health facility and on health seeking behaviour for 
those attending the facility. 
District 
density of 
health 
centres per 
person sq. 
km 
District health centres 
per person per square 
km.  
INEI 
District 
level 
reports   
Continuous Used to approximate access and the relative distance that patients need to 
travel to access health services. 
Size of TB 
program 
Approximated from 
the number of patients 
screened for 
respiratory symptoms 
based on the  
 Continuous It is theorised that the relative size of the TB program within each district will 
affect the likelihood that key services are available and used. 
Health 
district 
The health district 
which each health 
facility and 
consequent district 
belongs to.  
NTP 
data-
books 
Dummy 
variables 
This variable describes the health district in which each health facility and 
district pertains. 
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7.2.7 Time periods 
Not all outcome variables are available for all years of the study period. Many HIV/TB 
specific indicators have only been included as standard surveillance from 2013 onwards. 
This results in impact being assessed for different outcomes over different periods of time. 
Indicators assessing the improved testing relating to integration were evaluated for 2013. 
The indicator assessing TB related mortality was evaluated for 2008-2013.  
For the outcome measured over multiple years, the data provided is in panel data format: 
repeated observations of the same health facility over time. Panel data methods are used 
when estimating the impact of higher integration on TB death. The period for which data are 
available does not fall over the pre-integration period, however, only several years following 
integration. Estimates of impact do not account for baseline differences between treatment 
and control groups for any of the variables. This is important when considering the benefit 
estimated for integration and is further discussed below.  
7.2.8 Analysis 
All data has been reviewed and cleaned using Microsoft Excel. Data was then converted 
and transposed into STATA. All further data analysis was conducted using STATA [385]. 
7.2.9 Ethics 
Research ethics approval was gained for use of secondary de-identified data. Details can 
be found in Appendix 1.  
7.3 Descriptive statistics 
This section provides descriptive statistics of the overall sample and by treatment group. 
Describing the data in this way gives an idea of the sample in general and highlights potential 
bias  in relation to baseline distributions of covariates between treatment and control groups 
[150].  
7.3.1 Baseline description of whole sample 
To describe the overall sample, frequency or averages are provided for each covariate.  As 
only a single PS is estimated, values for covariates which change over time are provided as 
an average over all years.  
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As can be seen in table 7.2, the overall sample contains 137 health facilities; 12 fully 
integrated and 125 partially integrated. Average population size served was 18,018 
Peruvians per facility. The average number of patients per 1,000 population seen was 129. 
The number of patients presenting for respiratory related symptoms per 1,000 population 
was 11 while TB incidence per 1,000 population was 0.62. The average district population 
size was 449,221 residents with a large SD (379,044). Average district size was 86 km2. 
Dividing population by size produced an average population density of 9,072 residents per 
km2.  
Average number of health facilities per district was 17. The consequent number of people 
per health facility/km2 was 1,765. District HIV incidence per 100,000 residents was 3.017, 
with an average of 17% of the population living in poverty. Average public health expenditure 
in 2002 by district was 94 USD.  
7.3.2 Covariates by integration model 
As can be seen in table 7.2, district populations of partially integrated facilities were double 
the size of fully integrated facilities. Despite this, fully integrated facilities generally served 
larger populations than partially integrated facilities. This is most probably due to almost 
double the number of health facilities per district in the partially integrated group.  
Partially integrated facilities generally saw more patients, had more patients presenting for 
respiratory related illness and had more TB incident cases per 1000 population. HIV 
incidence was almost double, however, in fully integrated districts. Fully integrated districts 
were also denser.  
Partially integrated clinics had lower health spending and consequent higher population per 
health facility/km2. Twice the proportion residents in partially integrated districts were living 
in poverty. All differences between fully and partially integrated facilities, except HIV 
incidence, were significant at the 99% level. HIV incidence was significant at the 95% level.  
Based on these descriptions, significant differences exist between treatment and control 
groups.  Thus, a comparison of the two groups may be subject to selection bias. Consequent 
adjustment is needed prior to estimating the effects of full integration. 
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Table 7.2. Health facility level characteristics by partially and fully integrated facilities in Central and East Lima, Peru 2013/2014 
Covariate All sample Partially integrated Fully integrated 
 
Health facility covariates N mean SD* N mean SD N Mean SD p 
Size of population health facility 
serves 
137 18,018.09 19,998.35 125 15,083.5 17,378.76 12 48,586.78 2,0561.53 *** 
Health centre population 
adjusted patients seen/1000 
137 129.737 59.341 125 132.337 58.836 12 102.645 60.310 *** 
health centre population 
adjusted respiratory patients 
seen/1000 
137 11.263 7.984 125 12.006 7.903 12 3.522 3.524 *** 
Health centre population 
adjusted TB incidence/1000 
(2008) 
137 0.628 0.386 125 0.663 0.384 12 0.27 0.176 *** 
* SD = Standard Deviation, *p<0.1, **p<0.05, ***p<0.01. Data drawn from MINSA NTP surveillance data 2013/2014 
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Table 7.3. District level characteristics by partially and fully integrated facilities in Central and East Lima, Peru 2013/2014 
District covariates N Mean SD N mean SD N Mean SD p 
District population size 137 449,221.7 379,044 125 475,101 386,017.5 12 179,645.2 98,515.61 *** 
District number of health facilities 137 17.1313 11.1887 125 18.184 11.0813 12 6.166667 4.44835 *** 
District size in km2 137 85.8839 74.8561 125 92.9232 74.6243 12 12.55833 8.6512 *** 
District HIV incidence per 
100,000 population 
137 3.0175 3.2854 125 2.833 3.27297 12 4.939167 2.87724 ** 
District Density (district 
population per km2/100,000) 
137 9072.239 6552.881 125 8346.322 6219.531 12 16633.88 5145.389 *** 
Percent of district living in 
poverty 
137 17.4167 8.7272 125 18.192 8.625932 12 9.341667 4.9953 *** 
No. of people per health facility/ 
km2 
137 1765.032 3500.135 125 1329.391 2789.741 12 6302.963 6254.037 *** 
District public health expenditure 
per person in USD 2002 
137 94.6899 73.4919 125 88.0481 70.5911 12 163.875 69.8615 *** 
* SD = Standard Deviation, *p<0.1, **p<0.05, ***p<0.01. Data drawn from MINSA NTP surveillance data 2013/2014, INEI district level 
reports and MINSA Surveillance data 
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7.3.3 Descriptive statistics of outcome variables 
As can be seen in table 7.4, for the overall sample 64% of TB incident cases were offered a 
HIV test. Treatment and control centres had a 65% and 63% testing ratio respectively, 
indicating a 2% marginal improvement for full integration. This difference was not statistically 
significant. For the overall sample, 53% of health facilities had a HIV test return ratio over 
90%. The ratio differed between fully integrated facilities (84%) and partially integrated 
(50%) and was statistically significant. This represented a 34% difference compared to the 
integration model. The secondary outcome measure (TB death) was measured yearly from 
2009-2013 equalling 822 time-facility observations: 72 treatment and 750 control. A TB 
death ratio less than 10% was found in 90% of the overall sample. A smaller percentage of 
fully integrated facilities (82%) had lower death ratios compared to partially integrated (91%). 
This was statistically significant.  
Ordinary least squares and logistic regressions are used to demonstrate significant 
associations depending on the outcome variable. This is using both univariable and, 
bivariable associations with treatment, where control = 0 and treatment = 1, used as a control 
variable. Associations with the secondary outcome variable are not shown. This is to mimic 
case-control studies found to be prevalent in Chapter 4, for comparison to MLM-PS. Using 
these methods full integration was not statistically significantly associated with improved 
testing; however, it was associated with a greater than 90% return rate of HIV tests. Fully 
integrated centres were 150% (p = 0.054) more likely to return HIV tests. Overall unadjusted 
differences paint a mixed picture on the effectiveness of full integration. The primary testing 
measures indicate both no difference and a highly statistically significant improvement for 
full integration. Without adjustment, however, biases are likely affecting these estimations. 
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Table 7.4. Summary of statistics of all outcome indicators by fully and partially integrated 
health facilities in Central and East Lima, Peru 2013 
Variable All sample Treated Control 
 
Outcome N Mean/ 
frequency 
(%) 
N Mean/ 
frequency 
(%) 
N mean/ 
frequency 
(%) 
p 
% of TB incident 
cases offered HIV 
test 
111 0.636076 12 0.6515 99 0.6342 0.8212 
> 90% of HIV tests 
having result 
returned to patient 
137 73(53%) 12 10(84%) 125 63(50%) 0.029 
< 10% death ratio of 
TB incident cases in 
calendar year 
822 740(90%) 72 59(82%) 750 681(91%) 0.017 
p values based on t-tests and chi-square tests, Data drawn from MINSA NTP surveillance data 
2013/2014 
Descriptive statistics and associations are provided for covariates used in the estimation of 
PS and primary outcome variables in tables 7.5 and 7.6 below.  All outcome variables are 
ratios; however, only the HIV testing ratio is roughly normally distributed. The remaining two 
outcomes are transformed into binary variables. 
As can be seen in Table 7.5 below, within the overall sample statistically significant 
associations with HIV testing ratio include health facility population-adjusted respiratory 
incidence and total health facility population. There remain significant when controlled for 
treatment. Significant outcomes associated with more than 90% test return ration are total 
facility population and district population. When controlling for treatment, district population 
becomes non-significant while district population density becomes significant. All covariates 
were statistically significantly associated with reduced TB death ratio. When controlling for 
treatment district, HIV incidence becomes non-significant.  
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Table 7.5. Associations of improved rate of HIV tests for TB patients with district and health facility characteristics in Central and East Lima, Peru 2013 
Covariate 
 
Univariable Bivariable 
HIV test for TB patients’ rate N Coefficient 95% CI p Coefficient 95% CI p 
treatment 111 0.0173 -0.1341, 0.1687 
    
Percentage of district living in poverty 111 -0.0032 -0.0085, 0.0021 
 
-0.0029 -0.0089, 0.0029 
 
District HIV incidence 111 0.0086 -0.0062, 0.0235 
 
0.0097 -0.0057, 0.0251 
 
District density per health centre per km2 111 -7.2E-07 -1.36E-05, 1.21E05 
 
-6.5E-07 1.49E-05, 1.36E05 
 
Health facility population adjusted number of health 
centre consultations 
111 -0.0131 -0.0951, 0.0688 
 
-0.0105 -0.0943, 0.0732 
 
Health facility population adjusted number of patients 
presenting with respiratory symptoms 
111 -0.0055 -0.0114, 0.0004 * -0.0055 -0.0119, 0.0008 ** 
Total population served by health facility 111 -133.025 -250.2482, -15.8014 ** -133.445 -263.1115, -3.7792 ** 
District public health expenditure per person in USD 2002 111 0.0004 -0.0001, 0.0010 
 
0.0004 -0.0002, 0.0011 
 
District population size 111 1.73E-08 -1.02E-07, 1.36E07 
 
3.77E-08 8.82E-08, 1.64E07 
 
Number of Health facilities in district  111 -0.0001 -0.0040, 0.0038 
 
0.0002 -0.0039, 0.0045 
 
District size in km2 111 -0.0003 -0.0010, 0.0003 
 
-0.0005 -0.0012, 0.0002 
 
District Density (district population per km2/100,000) 111 3.52E-06 -3.85E-06, 1.09E05 
 
5.45E-06 -2.71E-06, 1.36E05 
 
* SD = Standard Deviation, *p<0.1, **p<0.05, ***p<0.01. Data drawn from MINSA NTP surveillance data 2013, INEI district level reports and MINSA Surveillance 
data, Bivariable= treatment as control covariable 
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Table 7.6. Associations of improved likelihood of >90% rate of returned HIV tests for TB patients, with district and health facility characteristics in Central and East 
Lima, Peru 2013 
Returned HIV test result rate >90% Univariable Bivariable 
 
Covariate N Log 
likelihood 
95% CI p Log 
likelihood 
95%CI p 
Treatment 137 1.5934 0.045, 0.0352 ** 
   
Percentage of district living in poverty 137 -0.0120 0.542, -0.0508 
 
0.0003 -0.04, 0.0408 
 
District level HIV incidence 137 0.0340 0.518, -0.0692 
 
0.0138 -0.0917, 0.1195 
 
District density per health centre per km2 137 5.42E-05 0.302, -0.00001 
 
1.14E-05 -0.0001, 0.0001 
 
Health facility population adjusted number of health 
centre consultations 
137 0.0795 0.784, -0.4889 
 
0.1796 -0.4072, 0.7665 
 
Health facility population adjusted number of patients 
presenting with respiratory symptoms 
137 0.0159 0.466, -0.0268 
 
0.034 -0.0122, 0.0803 
 
Total population served by health facility 137 -1324.18 0.006, -2266.289 *** -1116.15 -2084.111, -148.1911 ** 
District public health expenditure per person in 2002 USD 137 -0.0006 0.786, -0.0052 
 
-0.0024 -0.0076, 0.0026 
 
District population size 137 -8.7E-07 0.059, -0.1.77E-06 * -6.8E-07 -1.6E-05, 2.42E06 
 
Number of Health facilities in district 137 -0.0198 0.201, -0.0501 
 
-0.0105 -0.0422, 0.0212 
 
District size in km2 137 0.0006 0.775, -0.0038 
 
0.002417 -0.0023, 0.0071 
 
District Density (district population per km2/100,000) 137 -2.8E-05 0.291, -7.97E-04 
 
-5.8E-05 -0.0001, -1.9E-07 ** 
* SD = Standard Deviation, *p<0.1, **p<0.05, ***p<0.01. Data drawn from MINSA NTP surveillance data 2013, INEI district level reports and MINSA Surveillance 
data, Bivariable= treatment as control covariable 
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7.3.4 Descriptive statistics summary 
The data presented in this section demonstrate that full integration has mixed results on the 
different outcome variables. Comparisons without appropriate control, however, are likely to 
be biased as various confounding factors have been demonstrated to exist between both 
treatment and control groups and associated with the outcome variables. Differing from the 
previous case study, many more confounding covariates have been included at the cluster 
level. However confounding covariates are demonstrated to exist at both levels.  
7.4 Methods 
The following section provides a description of the specifications used to estimate the PS 
and condition the data based on the PS, and identifies the models used to estimate 
outcomes. Focus is placed on the practical aspects and decisions made during the analysis 
needed to create balance between treatment groups.  
7.4.1 Estimation of the propensity score 
To help improve covariate balance between treatment and control group a PS is estimated 
[29]. As with the previous case study, a mixed effects model is used to include cluster effects 
[32]. To balance covariates between treatment and control groups several iterations of the 
PS are performed. This has included log transformations, categorisation and interaction 
terms of some covariates.  
Facility level covariates are modelled as fixed effects while non-categorised district level 
covariates are modelled as random slopes. Random intercepts are estimated for district only 
as discussed in the methods Chapter. The final mixed effects model for the PS is presented 
below:  
Logit (PShj) = β0 + δj + γ1HIVj + γ 2PoFaKmj + β1consulhj + β2resphj + β3TBinchj + β4povhj + β5exphj + 
(ββ)67povhjexphj                                                                                                         (24)   
Where h represents health facilities (h = 1...H), in district j (j = 1….J), in health administrative 
area k (k = 1…K). Where ehj is the individual propensity score describing the individual binary 
likelihood of receiving treatment (Z = 1) or control (Z = 0). The PS is conditional on health 
facility covariates X1hjk…Xphjk and district level covariates U1jk… Uqjk. β0 is a constant. δj is a 
random intercept for each district j drawn from a normal distribution δ𝑗~ N(0, σ
2
𝐻𝐷). HIV is 
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district HIV incidence modelled as a random slope with a distribution β𝐻𝐼𝑉 ~ N(0, σ
2
𝐻𝐼𝑉 ) 
while PoFaKm is the population per facility/km2 modelled as a random slope with a 
distribution β𝑃𝑜𝐹𝑎𝐾𝑚 ~ N(0, σ
2
𝑃𝑜𝐹𝑎𝐾𝑚). Consul, is the number of consultations by health 
centre population; resp, is the number of patients presenting with respiratory symptoms; 
TBinc, is the facility adjusted TB incidence; pov, is a binary variable indicating district 
population percentage above and below a set threshold; exp, is a binary variable indicating 
district per capita health expenditure above and below a set threshold; pov exp, as an 
interaction term between pov and exp.  
7.4.2 Conditioning on the propensity score 
Measured covariates between treatment and control groups are balanced by conditioning 
using the PS. As with the previous case study various specifications are available for 
conditioning samples using a PS. The specification which provides the greatest overall 
balance, with the least assumptions for the given data, ATET weighting [316], is used. This 
is further explored in Chapter 8. For the two-primary outcome indicators a single weight is 
provided to each facility. For the third outcome model which varies over time the same 
weight is provided to each individual facility per time point.  
7.4.3 Common support and balance 
Following estimation of the PS, balance is assessed between treatment and control groups. 
Distribution of the PS is observed using kernel density plots and box plots. Common support 
is ascertained through a visual inspection of the PS. Comparisons of individual covariates 
are made using t-tests and chi-squared tests and reduction in standardised bias. General 
bounds are set for balance for each of the balance tests prior to weighting. Covariates are 
assumed to be balanced if they have a p value and standardised bias greater than 0.05 and 
less than 20% respectively [29]. 
7.4.4 Outcome estimation models 
Outcomes are estimated with three different models incorporating probability weights based 
on the PS. As suggested by Li et al [32] a doubly-robust estimator is used to allow two 
chances to control for clustering using random intercepts estimated for both districts and 
health districts. The two primary outcome models restrict analysis to a single time period; 
however, the analysis of TB death incorporates a random coefficient for health facility and a 
fixed effect for time to control for temporal changes. The models used to estimate outcomes 
can be seen formally as model (20), (21) and (22) in Chapter 5. 
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7.5 Results 
This section presents results based on the estimation of the PS, balance post-conditioning 
and outcome models incorporating probability weights.  
7.5.1 Common support 
A visual inspection of the PS suggests common support has been achieved. Figure 7.2 
below demonstrate common support given the significant overlap in PS between treatment 
groups.  
Figure 7-1 Box plots of propensity score by treatment group
 
Important in assessing common support for PS weighting for ATET is that treatment 
observations roughly fall within the control area of support, as is the case for the estimated 
PS [316]. As with the previous Chapter ATET weights require only that sufficient overlap is 
obtained with the treatment group as results are limited to the treatment group and to control 
observations like them. The distribution of the PS is much more similar between groups post 
weighting. Robustness of these assumptions is explored in Chapter 8.  
7.5.2 Balance diagnostics 
Table 7.7 shows the distribution of covariates pre- and post- weighting, by treatment and 
control group. The difference in mean covariate values is imbalanced based on p-values 
prior to weighting. Post-weighting, all such imbalances are removed. Standardised bias by 
covariate is also assessed. Following weighting almost all covariates lie well below 20% 
bias. Three covariates are slightly over 20% (20.6% maximum). All three covariates, 
however, show a large reduction in bias. Given the removal of biases based on p-value the 
sample is considered balanced.  
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Table 7.7. Covariate bias between partially and fully integrated health facilities, pre-post, weighting, 
measured by p-value and standardised bias in Central and East Lima 2013 
Variable Weighting Treated  Control %bias t     p>t    
  
Mean Mean 
   
District HIV incidence Unweighted 4.9392 2.833 68.3 2.15 0.033 
 
Weighted 4.9392 4.8086 4.2 0.1 0.925 
District Health centres per 
100,000 pop (natural log)  
Unweighted 8.2041 5.9811 169.1 5.08 0 
Weighted 8.2041 7.8965 20.4 0.53 0.604 
Health centre population 
adjusted consultations 
Unweighted 1.0265 1.3234 -49.8 -1.67 0.098 
Weighted 1.0265 0.8677 20.6 0.54 0.594 
Health centre adjusted number 
of patients presenting for 
respiratory symptoms 
Unweighted 3.5226 12.007 -138.6 -3.67 0 
Weighted 3.5226 3.2666 4.2 0.15 0.884 
TB incidence per pop (Sq) Unweighted 1.5652 2.4588 -132.3 -3.79 0 
Weighted 1.5652 1.7146 -20.1 -0.46 0.649 
District public health 
expenditure per person in USD 
2002 
Unweighted 163.88 88.048 108 3.56 0.001 
Weighted 163.88 170.93 -10.1 -0.2 0.844 
Percentage of district living in 
poverty 
Unweighted 0.5833 0.784 -43 -1.57 0.118 
 
Weighted 0.5833 0.6404 -12.2 -0.24 0.815 
Health Expenditure categorical Unweighted 0.4166 0.128 66.4 2.7 0.008 
Weighted 0.4166 0.474 -13.2 -0.24 0.817 
Poverty and health expenditure 
interaction term 
Unweighted 0.4166 0.0404 96.5 4.94 0 
Weighted 0.4166 0.474 -14.7 -0.24 0.817 
Data for analysis drawn from MINSA NTP surveillance data 2013, INEI district level reports and 
MINSA Surveillance data, Bivariable= treatment as control covariable 
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Based on the removal of bias post-weighting, it may be assumed that causal comparisons 
of treatment effect weighting on the PS may be made [32]. This demonstrates the feasibility 
of MLM-PS in reducing biases.  
7.5.3 Outcome estimations 
Following successful demonstration of improved covariate balance, inverse probability 
weighted outcomes are estimated. Results for three indicators are presented in Table 7.8. 
The first primary outcome, rate of HIV testing for TB patients, showed a small negative 
statistically significant impact for full integration. This translates to a 6% reduction in testing 
ratio associated with full integration. The second primary outcome, Log odds ratio of >90% 
ratio of returned HIV tests, shows a strong and statistically significant improvement with full 
integration. The third outcome, TB deaths per incidence, shows a marked reduction with 
integration. This relationship was also statistically significant. 
Table 7.= 
Outcome Coefficient/lo
g likelihood* 
SE z p 95% CI 
% of TB incident cases offered 
HIV test 
-0.0625 0.0089 -6.98 0 -0.08 -0.0449 
> 90% of HIV tests having result 
returned to patient 
1.5114* 0.0411 36.69 0 1.4306 1.5921 
< 10% death ratio of TB incident 
cases in calendar year 
0.9617* 0.0744 12.93 0 0.8159 1.1076 
SE = Standard Error, CI = Confidence Interval 
7.6 Discussion 
The aim of this Chapter was to further explore the feasibility of MLM-PS by estimating causal 
effects of full integration over partial integration on HIV/TB program functions. It differed from 
the previous case study through the data used, which was drawn from the national 
surveillance system. Three key results are obtained from the case study.  
Firstly, the use of MLM-PS methods is capable of balancing potential confounders using 
routine surveillance data with the inclusion of important cluster level variables. Secondly, 
higher HIV/TB service integration appears to have a very small but statistically significant 
negative effect on the rate of HIV tests given to TB patients. Finally, despite this reduction, 
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for those who do receive a HIV test the likelihood that a more integrated facility will have 
greater than 90% chance of providing test results is significantly higher. These results are 
further discussed below. 
7.6.1 Application of MLM-PS on routine surveillance data 
As with the previous case study, MLM-PS demonstrably reduce biases between treatment 
and control groups. Controlling for biases through weighting led to different estimated 
impacts from other common methods. Biases were demonstrated at both health facility and 
district level prior to outcomes estimation. Weighting the data using MLM-PS allowed 
incorporation of covariates at multiple levels. Importantly, and differing from the previous 
case study, more than half of covariates were measured at the cluster level. Reliance on 
higher level covariates is not ideal, as many covariates are averages of lower level 
covariates which implies a loss of information. In a practical sense, however, the ability to 
rely on cluster covariates has important ramifications for using routine surveillance data to 
estimate policy impact.  
Routine surveillance systems are a convenient and pragmatic source of data which can be 
exploited to evaluate impact of programs and policies [386]. Most national surveillance 
systems have arisen as a method for monitoring population changes in infectious disease 
burdens [386], so it is a natural extension to use them to monitor impact of programs around 
disease focused programs such as DOTS or integration [387]. They have characteristics 
which make them useful for policy impact evaluation. Surveillance systems generally have 
information collected at sub-national levels, then aggregated at a regional or national level. 
This implies measurement across a broad range, with sufficient decentralisation to be 
sensitive to policy changes. Most health systems make surveillance a routine M&E process, 
making data readily available. There may also be less of a barrier to access for government 
officials seeking to use the data to evaluate policy. National surveillance data also has 
various limitations. For the purposes of evaluation, it is often criticised of being low quality, 
with frequent inconsistent descriptions of indicators across geographic areas, or limited in 
the scope of information collected [387, 388]. If these issues can be overcome, however, 
national surveillance systems are a powerful source of data for evaluating natural policy 
changes. 
As with the previous case study policies such as integration are unlikely to be randomised 
necessitating the use of quasi-experimental methods such as PSs for potential claims of 
causality. PSs rely on a broad range of covariates. As discussed above a key limitation of 
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using routine surveillance data with PSs however, is the scope of covariates often included 
in the data set [389]. Surveillance data are generally focused on collecting key performance 
indicators [386]. Other information, such as individual patient characteristics necessary for 
estimating the PS may not be within the scope of data collection. There may also be ethical 
constraints around colleting individual characteristics such as SES within a national data 
collection system. Controlling bias in non-randomised studies relies on a broad range of 
covariates, depending on the technique used [36]. A key benefit of routine surveillance data 
are that it frequently explicitly defines locations from where data are collected. As 
demonstrated in this case study, by using district as a link to data outside of the routine 
surveillance system, covariates may be added allowing PSs to be used. 
Adding covariates using geographic location implies potential bias at multiple cluster levels.  
When health policies are administered at a level higher than the individual, such as the 
health facility or district, aggregate differences between treatment groups may affect 
estimations of outcomes. For example measuring impact of transport subsidies to specific 
districts on TB treatment success rates [390]. Potential differences by district are considered 
likely to affect outcomes [390]. Consequently, similar treatment and control districts are 
matched based on urban and rural location, to receive the policy or control, controlling for 
individual person differences using multivariable regression. Matching on only a single 
cluster covariate will likely miss important cluster level confounding factors. Given the 
concession that district variables are likely effecting outcomes, this evaluation would benefit 
from including district variables estimation of impact. As demonstrated in this case study this 
can be achieved by incorporating outside data at the cluster level using MLM-PS. The 
feasibility of MLM-PS expands the possibilities of routine surveillance data to evaluate 
impact of important health policies applied at cluster level such as integration, which are 
unable to be randomised or are evaluated ex-post.  
The use of MLM-PS on routine surveillance data are critical to integration of HIV/TB. This 
type of data appears to have frequently been used to evaluate HIV integration impact of 
HIV/TB. Of the 30 studies of HIV/TB impact reviewed in Chapter 4, 22 were ex-post analysis, 
most often described as retrospective evaluation of program data. By linking routine 
surveillance data with other data sets at both individual and cluster level, reliability of 
estimates of impact may be improved.  
7.6.2 Study outcomes 
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Full integration resulted in a small negative yet statistically significant impact for the rate of 
HIV testing for TB patients. Unfortunately, limitations in the data do not allow parallel 
comparison of treatment and control groups before and after the implementation of 
integration. A small difference result may have been expected if average testing ratios were 
very high in both groups. This, however, is not the case. As demonstrated above, average 
testing was only 64% for the overall sample.  
The ratio of returned HIV tests showed a marked improvement with full integration. It is 
surprising that integration resulted in no difference in the testing ratio but did lead to 
improved return rates of tests. It is possible that the importance of patient knowledge of 
results is reinforced by health personnel who work in integrated settings [391]. Personnel 
who are aware of both the importance of HIV and TB comorbidities and that testing is free 
and available at their facility may take extra steps to ensure results are returned. Inadequate 
training around integrated services has resulted in poor testing results in several settings 
[117]. The importance of this indicator should be emphasised in relation to population control 
of HIV, with TB patients being aware of their HIV status being vital to preventing further 
spread of the disease [392]. Despite this, HIV results are not universally provided to the 
patient. Full integration does clearly improve the rate of returned tests. 
The reduction seen in the TB death ratio associated with full integration is supported by 
previous research [240, 243, 257, 259, 260, 265, 393, 394]. Despite the encouraging result, this 
outcome should be interpreted with caution. The PS rests on the assumption of no un-
measured confounders. Given the relative size of the TB epidemic and program in Peru in 
relation to HIV, it is difficult to conceptualise full integration of HIV as the sole mechanism 
for improved TB death ratios. All available confounders were utilised in the PS, but one 
suspects that a much greater variety would be influencing TB deaths in a concentrated HIV 
setting [43]. This includes patient, health facility and district level factors. PS models have 
been built to account for differences in HIV/TB service integration models. Integration 
process indicators such as rates of testing and returned tests are more valid in relation to 
the estimated model. Despite this, it is conceivable that network-like effects of full integration 
allow more effective functioning of the TB program. This may include improved staffing, staff 
training and staff attitudes, less variability in the availability of timely medications through 
strengthened logistic networks and strengthened outreach and promotional activities [210]. 
It is also important to note that the statistical model used to estimate integration impact on 
TB deaths, as with the previous statistical models, does not cover the time period prior to 
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integration. Different baseline (before integration) values of TB deaths between integration 
models may in part account for differences seen between the two groups.  
7.6.3 Comparison to other empirical studies 
As with the HIV/ANC case study this is the first evaluation of HIV/TB integration in Peru. As 
identified in Chapter 4 most other empirical studies have been performed in Africa in high 
HIV settings. A single study in Guatemala was undertaken in a context where the HIV 
epidemic was concentrated with a large TB epidemic. Here, in response to a high proportion 
of deaths in co-infected patients, HIV and TB services were integrated in a rural hospital. 
Integration involved treatment made available at the same facility, training of hospital staff 
on co-infection and HIV/TB-specific nosocomial infection measures. The pre-integrated 
facility provided all TB services but only HIV testing on specific referral. Patients using 
integrated services were more than three times more likely to initiate ART and showed lower 
mortality rates [265]. This demonstrates that a similar model of integration (full vs partial) 
may be successful in improved outcomes in concentrated HIV settings. Integration in this 
setting focused on improving clinical outcomes for co-infected patients, differing from the 
Peruvian case study.  
All other studies comparing fully, and partially integrated models were performed in 
generalised epidemic countries in Sub-Saharan Africa. Mixed results were shown across a 
variety of indicators. Some positive results were found. In South Africa, due to a lack of 
initiation of ART among TB patients, ART was integrated into TB clinics, already offering 
HIV testing and counselling in a similar fashion to the Peruvian case study. This integration 
model showed improvements in completion of TB treatment and continuation of HIV 
treatment [257]. Some other partial vs full integration studies showed mixed results: Ansa et 
al [241] compared three integration models in Ghana (fully integrated (all services available), 
partially integrated (all TB service available, HIV testing only) and referral (all TB services 
available, referral for all HIV services). Here HIV screening for TB patients was associated 
with higher levels of integration. HIV treatment-related indicators, however, showed mixed 
results associated with higher integration, with no clear indication on optimal service delivery 
models.  
Some partial vs full integration studies found no benefit with higher integration. In two 
districts of Rwanda in response to high TB mortality, a high proportion of TB patients who 
were unaware of their HIV status, and in response to WHO guidelines, full integration of HIV 
services into TB clinics was implemented [121]. Prior to this, only HIV testing was available. 
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No statistically significant improvements were found for higher integration for HIV testing 
and treatment related indicators. In Botswana, Schwartz et al [258] noted poor mortality 
outcomes for TB patients may be associated with distally located ART services. TB clinics 
that only offered HIV testing were compared to clinics that also offered ART for TB patients 
with a low CD4 count. No difference in mortality was found between clinics with timely 
initiation of ART.  
Consequently, while previous literature has shown primarily positive results for HIV/TB 
integration, a mixed picture is painted for partial vs. full integration. Some actors in the field 
have noted that integration through service co-location alone may not be sufficient to provide 
the benefits of integration [255]. This fits with previous literature and the Peruvian case study.  
7.6.4 Caveats and limitations to the case study 
The methods used in this case study are used to create a measure of balance between sets 
of non-ideal data from divergent policy groups. The approach has implications for policy 
analysis at the sub-national and national level. It represents an improvement in bias control 
over other simpler methods discussed in Chapter 4, if tools such as randomisation are not 
feasible. As with any study using scientific methods, strong conclusions drawn from its 
results should be subject to research replication. The results of this study do add weight to 
most previous findings around HIV/TB service integration.  
Several limitations of this case study are noted. General limitations on PS analysis, which 
also apply to this study, have been discussed in Section 6.9. Lack of baseline data are 
unable to be addressed within the data set so conclusions should take into account the 
possible differing baseline levels of success prior to integration. The TB death rate is 
suggestive, particularly if assuming the effects of full integration would not be immediate. 
Little can be done, unfortunately, on the relatively small sample size.  This becomes a caveat 
when interpreting results.  
7.7 Conclusion 
This Chapter aimed at exploring the feasibility of MLM-PS using routine surveillance data. 
The data differed from that of the previous case study as it relied more heavily on the use of 
cluster level covariates. This was likely to reflect a common theme with this type of data 
when used for policy evaluation. The method was explored through application to a case 
study of HIV/TB integration.  
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MLM-PS proved to reduce bias at multiple levels. It can therefore be concluded to be feasible 
when applied to national surveillance data when evaluating HIV integration. This is an 
important consideration given that many HIV/TB integration studies have frequently relied 
on secondary data drawn from routine surveillance systems. 
A second aim was to estimate the impact of higher HIV/TB integration across multiple 
indicators. The results from these analyses showed mixed results for higher integration. This 
suggests that higher integration has little effect on HIV testing rate, however a stronger 
causal effect on the rate of returned HIV tests. These results differed somewhat from the 
previous empirical literature. However strong limitations to the data likely affect impact 
measures, namely the inability to measure impact at baseline.  
The two case studies performed for this research demonstrate that the use of MLM-PS is 
feasible in line with key limitations present in HIV integration evaluation. The use of MLM-
PS relies on various assumptions. To test these assumptions and demonstrate that the least 
biased estimates of impact possible, given the limitations of the data, have been provided, 
exploration of the methods should be performed. The following Chapter is a practical 
exploration of MLM-PS, describing the use of various iterations of the method.  
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8 Exploration of the robustness and sensitivity of results drawn from case studies 
The following Chapter is an exploration of the robustness and reliability of the methods used 
to establish the impact of HIV integration in the preceding two chapters. Both case studies 
have approached impact evaluation with a similar methodology, conditioning data on a PS 
to create a counterfactual for potentially unbiased estimation of integration. Such analysis, 
as with any PS analysis, involves decisions at various steps throughout the analysis process 
which may influence estimated outcomes.  
It is increasingly important and common in PS analysis to explore the ramifications of 
different specifications of the overall PS model [150, 151, 153, 395]. Doing so provides a 
measure of transparency to the analysis. It demonstrates that the most valid specification of 
the overall PS model is provided in each case study, with reference to bias reduction. It also 
demonstrates what impact would look like under alternate specifications of the PS. This 
thesis uses the exploration as a platform to investigate how the inclusion of novel 
components, such as MLM, affect bias and impact estimates.  
As discussed in Chapter 5, the process of PS analysis is often broken down into three broad 
steps: estimation of the PS, conditioning using the PS, and the estimation of outcomes on 
conditioned data. This Chapter provides explorations for each case study for all 
specifications in each step. A further component of the Chapter involves estimating the 
sensitivity of the final PS model to omitted variable bias [361, 362]. This involves observing 
changes in results when a potential confounder of different strengths is simulated into each 
case study data set.  
8.1 Scope of robustness 
The robustness tests performed in this Chapter are designed to explore if, given the 
available covariates, the least biased specification of the PS model for each case study has 
been used. This includes testing iterations of conditioning technique, models used to 
estimate the PS and models used to estimate outcomes. The relative importance of each 
component, particularly the inclusion of MLM, is discussed. 
Each case study Chapter has presented an overall PS model, from which various iterations 
based on the PS, conditioning and outcomes are possible. The selection of the models used 
has been based on practical and theoretical concerns. The theoretical basis for the selection 
process was discussed in Chapters 5, 6 and, 7. This is extended in this Chapter relating 
primarily to practical concerns around the data. 
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A caveat to this Chapter is that it is beyond the scope of the thesis to provide all potential 
iterations in each step. This would create upwards of 4,000 potential iterations of the PS 
model making comparison nonsensical. Only those which are most relevant to the 
robustness of the results have been provided. 
For simplicity, when assessing outcome models only the primary indicators for each case 
study are explored. For the HIV/ANC case study this is improved HIV testing during ANC. 
For the HIV/TB case study these are improved percentage of TB incident patients being 
offered a HIV test and likelihood that health centres provide greater than 90% of TB incident 
patients who have taken a HIV test with their results.  
In the comparisons below, it may appear that other conditioning techniques are inferior.  
However, performance of different techniques is only relative to the data used for the two 
case studies. 
8.2 Covariate and PS model selection 
Establishing estimates as close as possible to the true PS is critical to reducing bias [30]. 
Creation of the PS involves selecting appropriate covariates, deciding on the correct 
specification of the regression model used to estimate the PS, and obtaining the predicted 
probabilities constituting the PS [75]. Steps one and three of this process have been covered 
in Chapters 6 and 7. In this section the second step, correct specification of the PS model, 
is discussed. This involves observing the effect of inclusion/exclusion of covariates used in 
the PS and the regression model used [150, 151, 153, 395]. 
This section presents results of HIV integration impact with covariates systematically omitted 
from the estimation of the PS. It also presents different iterations of the MLMs used for 
estimation of the PS. Each iteration is presented with its relative reduction in bias and 
estimation of outcome. Iterations are presented for both case studies.  
8.2.1 Covariates used to estimate PS 
When randomisation is not possible methods for bias reduction revolve around controlling 
or balancing covariates between two groups such as in quasi-experimental methods or 
multivariable regression. Such control is often suggested to be subject to researcher bias or 
p-hacking [396]. This is the concept in which researchers incrementally alter estimation 
models until a pre-determined ‘desirable’ result has been found.  
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A benefit of PS based techniques over standard regression is the ability to demonstrably 
improve covariate balance between treatment groups prior to seeing effect estimates of the 
eventual outcome, potentially reducing likelihood of researcher bias [135, 154]. 
Achieving this in a PS study involves creating and selecting a PS algorithm which is most 
able to demonstrably reduce bias between groups prior to estimating outcomes [150]. This 
method has been followed when balancing treatment groups throughout this thesis. A focus 
on covariate balance provides the greatest chance that the PS itself is correctly specified 
without being influenced by non-desired outcomes [135, 154].  
To demonstrate that the final model used in each case study (herein referred to as the full 
models), are the least biased, the effect that alternate specifications of the PS on balance 
and subsequent outcome estimations is presented.  
Different specifications are derived by systematically omitting variables from the PS. Bias 
using PS weighting is then assessed for each PS iteration. Results are presented in Table 
8.1 below.  Total covariates which were not balanced between treatment groups, using both 
p-values and standardised bias are presented for each model. The spread of results, using 
PS weighting and the full outcome model as per (23) and (24) in Chapter 5, are 
demonstrated. This includes point estimates, statistical significance and confidence bounds. 
Outcome results can be seen for each outcome in figures 8.1- 8.3.  
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Table 8.1. Balance between treatment and control groups by case study, post-weighting by specification of the PS, systematically excluding 
covariates 
HIV/TB HIV/ANC   
Covariate Excluded Covariates off 
balance SB* 
Covariates off 
balance p* 
Covariate Excluded Covariates off 
balance SB* 
Covariates off 
balance p* 
Full model 0 0 Full model 0 0 
HIV incidence 1 0 HIV Incidence 1 1 
Log density per health centre 1 0 Education 10 12 
Population adjusted consultations 2 0 Language/Ethnicity 0 2 
Population adjusted respiratory 
patients 
3 0 Wealth* 12 0 
Interaction Health exp/poverty 1 0 Age 12 0 
Categorical health expenditure* 3 0 1 or more other ANC test 1 1 
Categorical poverty* 2 0 ANC by doctor/obstetrician 7 8 
Total district population 2 0 Has Health insurance 12 0 
*covariates with multiple categories, *SB = Standardised Bias, *p = p value, balance is set at p value greater than 0.05 and standardised bias less than 
20 
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Figure 8-1 - Results from PSs estimated systematically omitting covariates for HIV/ANC case study 
 
No HIV = District HIV incidence, Edu = Education, Language = Language/ethnicity, Wealth = 
Wealth, Age = Age, ANC test = At least one other test during ANC, ANC doc = ANC performed by 
medical doctor/obstetrician, Insurance = If woman has insurance 
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Figure 8-2 Results from PSs estimated systematically omitting covariates for HIV/TB case study 
outcome 1 
 
No HIV = District HIV incidence, Ln density = Log density per health centre, Consult = Population 
adjusted consults, Resp = Population adjusted respiratory patients, Interaction = Interaction term of 
health expenditure/poverty, Health exp = Health expenditure, Poverty = district poverty, District pop 
= District population 
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Figure 8-3 Results from PSs estimated systematically omitting covariates for HIV/TB case study 
outcome 2 
 
No HIV = District HIV incidence, Ln density = Log density per health centre, Consult = Population 
adjusted consults, Resp = Population adjusted respiratory patients, Interaction = Interaction term of 
health expenditure/poverty, Health exp = Health expenditure, Poverty = district poverty, District pop 
= District population 
Results from both case studies demonstrate that excluding covariates influences overall 
balance. Only the full model in each of the case studies is successful in balancing all 
covariates both in terms of SB and p-values. This adds a measure of reliability to the results 
presented in the case study Chapters, suggesting the least biased models have presented. 
Omission of covariates, however, has a less pronounced effect on final estimation of 
outcomes. For the HIV/ANC case study point estimates of the effect of full integration vary 
from a 57% to 123% increase in HIV testing. Point estimates for HIV/TB vary little for 
percentage HIV tests for TB patients; however, they vary more with percentage of returned 
HIV tests. The first outcome ranges from -10% to -3% marginal decrease in percentage of 
HIV tests for TB patients caused by higher integration. The second outcome ranges from a 
30% to 150% increase in likelihood of health centres achieving greater than 90% of HIV 
tests returned.  This suggests that despite differing bias when omitting covariates, effect 
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estimation remains relatively stable and always in the same relative direction as full models, 
also falling within the confidence bounds of full model estimations. 
8.2.2 Multilevel PS estimation models 
As discussed in Chapter 5 the use of MLMs to estimate the PS is relatively novel. MLMs 
have been included primarily to account for potential cluster level bias arising from district 
level treatment assignment and covariates at the cluster level. The effect of including and 
excluding different multilevel components to the estimation of the PS estimation are 
compared. Comparison is made on each models’ ability to balance covariates and their 
estimation of outcomes.  
The general assumption under which most regression is performed is that individuals are 
not clustered [83]. This is clearly not the case with both sets of data. In standard regression, 
if clustering can be measured, then it generally should be included in some form in the 
regression model [83].  
With PS analysis, however, focus is on removing measurable biases between groups. If 
clustering is not affecting such bias reduction it is arguable that a MLM may not be the 
optimal regression model to use in estimating the PS. Such bias can be measured by 
observing the effect cluster membership has on treatment assignment or outcome [32].  
The exclusion of MLMs, however, is not justified in the presence of cluster level covariates 
which influence treatment or outcome [32]. This is because all influencing covariates should 
be included in PS estimation [356]. In this way cluster membership may also be considered 
an influencing covariate if it influences treatment or outcome. The assumption with such 
covariates is that unmeasured cluster level covariates are being controlled for with the PS 
through the use of some MLMs [32-34]. 
Cluster levels may be included in the PS as fixed or random effects [32-34]. For the two case 
studies presented in this thesis only random slopes are appropriate for inclusion of district 
level covariates due to collinearity with treatment of some clusters, as discussed in Chapter 
5. For regions, the highest-level cluster, both fixed and random effects in the HIV/ANC case 
study are possible as each region contains clusters of both treatment and control. This is 
not the case for the HIV/TB case studies’ highest cluster (health district) due to collinearity.  
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8.2.2.1 Models tested 
A variety of specifications for the estimation of the PS incorporating cluster is possible, 
including those that do not incorporate MLMs. The different iterations are presented below, 
formal presentations are available either in Chapter 5, or Appendix 3 depending on the 
model.  
Specifications for the HIV/ANC case study include: a 3-level model which includes a random 
intercept for district and region; the model presented in the case study Chapter (23); a 3-
level model including a random intercept for district and a fixed effect for region (25); a 2-
level model including random intercepts for district and omitting region (26); a 2-level model 
with random intercepts for region omitting district (27); and a single-level model that does 
not model higher levels. Specifications for the HIV/TB model include: a 2-level model which 
includes a random intercept for district; the model presented in the case study Chapter (24); 
and a single level model that does not model higher levels.  
Balance between these models is compared by demonstrating numbers of covariates off 
balance using both p-values and standardised bias. Coefficients, p-values and confidence 
bounds of outcomes following estimations of the PS, using the full model, are also presented 
in Table 8.2. 
6.1.1.2 Results and discussion 
As can be seen in Tables 8.2, 8.3 and 8.4 omitting MLMs from the PS estimation results in 
unbalanced covariates. This suggests that cluster membership affects the balance of 
measured confounders. It is highly likely that omitting district/region membership will bias 
results. Including MLMs in the estimation of the PS, as has been performed in the case 
studies, is critical in balancing treatment groups for the given data at both individual and 
cluster level. This is in line with previous research implementing simulations of MLM-PS [32-
34]. 
The amount of imbalance differs depending on the MLM used. Most models remain 
balanced, except for the naïve model for the HIV/ANC case study. Balance differs 
dramatically, particularly in terms of standardised bias, when using naïve or non-slope 
models with the HIV/TB case study. This is likely due to the higher reliance of the HIV/TB 
case study on district covariates to estimate the PS.  
187 
 
Omitting MLMs, regardless of balance, comes with the implicit assumption that cluster 
membership, particularly district, has no effect on treatment assignment or outcome. This is 
clearly not the case when assessing outcomes using the different MLM models [32-34]. The 
size of impact differs dramatically dependent on the level which is omitted. This finding is 
confirmed through simulation by Li et al and Arpino et al [32, 34]. The choice of the full model 
with both district and region membership for the HIV/ANC and the district membership for 
the HIV/TB membership is justified. On a theoretical basis, the use of a MLM when including 
district level covariates given the lack of variance for these covariates within clusters [32-34], 
violates standard regression assumptions [83]. 
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Table 8.2. Covariate balance and outcomes between HIV/ANC treatment and control groups post-weighting by PS model 
ML PS model Log 
likelihood 
p-value 95 CI SB (off 
balance) 
P value off 
balance 
Random district (lvl2(lvl 2) and region (lvl 3) Full model 1.2385 0.001 0.5109 1.9660 0 0 
Fixed region (lvl 3)  with random district (lvl 2) 0.5901 0.19 -0.2929 1.4732 1 1 
Fixed region (lvl 3) only 0.1421 0.581 -0.3631 0.6475 0 0 
Random region (lvl 3) only 0.1358 0.616 -0.3944 0.6661 0 0 
Random district (lvl 2) only 1.1957 0.009 0.3043 2.0871 0 0 
No multilevel 0.0151 0.961 -0.5842 0.6145 2 2 
CI = Confidence Interval, SB = standardised bias, balance for SB is set at < 20%, balance for p -value is set at >0.05 
Table 8.3 Covariate balance and outcomes between HIV/TB treatment and control groups post-weighting by PS model – Outcome 1 
ML PS model Coefficient p-value 95 CI Bias (off 
balance) 
P value off 
balance 
Random district (level 2) only -0.0625 0.000 -0.08 -0.0449 0 0 
No multilevel -0.0657  0.000 -0.07573  -0.0558  7 2 
CI = Confidence Interval, SB = standardised bias, balance for SB is set at < 20%, balance for p -value is set at >0.05 
Table 8.4 Covariate balance and outcomes between HIV/TB treatment and control groups post-weighting by PS model – Outcome 2 
ML PS model Log likelihood p-value 95 CI Bias (off 
balance) 
P value off 
balance 
Random district (level 2) only 1.5114 0.009 1.4306 1.5921 0 0 
No multilevel 0.789648  0.000 0.387175  1.19212  7 2 
CI = Confidence Interval, SB = standardised bias, balance for SB is set at < 20%, balance for p -value is set at >0.05 
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8.3 Conditioning technique specifications 
As discussed in Chapter 5, there is a variety of PS conditioning techniques which can be 
used to balance treatment and control groups using the PS. There is contention as to which 
conditioning technique produces least biased estimates [75, 156, 397-399]. 
It is likely that the choice of conditioning technique will be highly data specific [397-399]. 
Consequently, using and presenting multiple techniques will enable the best effect estimates 
to be selected based on bias reduction. Some approaches may also be more appropriate 
than others for the given data, based on theory or due to research purposes. Examples of 
this are the choice to estimate ATE or ATET [316] or the relative size of treatment groups 
[316]. This section discusses bias reduction and outcome estimations using different 
specifications and sub-specifications of conditioning techniques.  
Techniques are limited to the most common in the literature: Inverse Probability Weighting, 
and matching. Two methods of weighting are compared; weighting for the ATET and for 
ATE [315, 316]. These weights differ in their objectives and construction. They estimate 
differing impacts relevant to the population under study. As discussed in Chapter 5, ATE is 
a measure of impact for the entire population under study. ATET is impact restricted to only 
those receiving treatment and those most like them.  
For comparison, three further estimations of outcome are provided. These are covariate 
adjustment using the PS, covariate adjustment using the full spectrum of covariates used in 
the PS, and unadjusted regression. There are currently no comparable measures of balance 
check for these techniques and only estimates of outcome are provided.  
Each conditioning technique can involve various sub-specifications in how they are applied. 
These are also presented in this section. For weighting, sub-specification involves 
augmenting weights to assess the impact of outliers on estimated outcomes [315]. Outliers 
can occur when a PS is either close to 1 for control variables or close to 0 for treatment 
variables which pushes ATE weights to extreme values. Outliers for ATET weights only 
occur with control observations as treatment observations are all assigned a weight of one. 
Outliers may affect results if they are a majority, thus indicating that the PS model may not 
have been correctly specified. When observing weights this appears unlikely for both case 
studies as ATET weights have a maximum of 9 and 11 for the ANC and TB case studies 
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respectively. Regardless, augmentation is performed to assess effects on covariate balance 
and outcomes.  
Augmentation is performed by restricting PS weights to frequency percentiles of the weight. 
A 99th percentile will entail altering weights to be the maximum weight and minimum weight 
within the upper and lower 99th percentiles respectively. All weights lying outside the ranges 
are altered to be the maximum/minimum [315]. This procedure is repeated at 95th, 90th and 
75th percentiles.  
Deciding on how to match observations based on the PS can involve a range of 
specifications. These include: the number of matched observations, the distance of the PS 
allowed between matched observations known as calliper and, if repeated matches for the 
same observation are allowed involving the application of frequency weights known as 
replacement. The following matching algorithms have been tested: single matching without 
replacement and no calliper, matching individual observations with replacement and with 
calliper, matching two observations with calliper, and matching five observations with 
calliper. Calliper is set to the standard deviation of the PS multiplied by 0.2 as suggested by 
Caliendo et al [150]. 
8.3.1 Conditioning techniques and balance 
Each iteration is performed with the full PS model for each case study. Table 8.3 below 
demonstrates the number of covariates off balance, measured by both p-values and 
standardised bias, for each conditioning technique. 
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Table 8.5 Covariate balance pre and post weighting between treatment groups by conditioning technique 
HIV/ANC conditioning specification test HIV/TB conditioning specification tests 
Conditioning 
technique Specification Covariates Off Balance 
Conditioning 
technique Specification Covariates off balance 
  Bias >20% p values <0.05   Bias >20% p values <0.05 
IPW ATET    IPW ATET    
 ATET 0 0  ATET 0 0 
 ATET 99 0 0  ATET 99 3 0 
 ATET 95 0 1  ATET 95 3 0 
 ATET 90 0 1  ATET 90 3 0 
 ATET 75 3 0  ATET 75 2 0 
IPW ATE    IPW ATE    
 IPW 0 1  IPW 8 1 
 IPW 99 0 1  IPW 99 8 7 
 IPW 95 0 1  IPW 95 8 7 
 IPW 90 0 1  IPW 90 8 7 
 IPW 75 2 2  IPW 75 8 7 
Matching    Matching    
 N1nr 5 5  N1nr 5 0 
 N1 1 2  N1cal 7 0 
 N2 1 2  N2 4 0 
 n5 1 2  N5 5 0 
IPW = Inverse Probability Weighting, Figures following IPW indicate the level of augmentation (ie 99 = augmentation to the 99th weight percentile), 
ATET = Average Treatment Effect on the Treated, ATE = Average Treatment Effect, N1NR = Single Nearest Neighbour matching with no set radius, 
N1C = Single Nearest Neighbour Matching with replacement, N2 = Double Nearest Neighbour Matching with calliper, N5 = Five Nearest neighbour 
matching with calliper
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Except for full ATET weighting and its augmentation to the 99th percentile, all conditioning 
techniques are unable to balance all covariates across case studies. Only the full model can 
fully balance covariates with the HIV/TB case study. This demonstrates that the full models 
as presented in the case studies are the most appropriate in terms of bias reduction. 
In evaluating PS matching techniques, it should be noted that the PS itself has been geared 
towards weighting on ATET. In practical terms this means that when testing different 
iterations and combinations of covariates included in the PS, the technique used to assess 
balance has been ATET weighting. Impact for both case studies is being assessed as ATET, 
consequently ATE weights would not apply. Secondly, there are issues around the area of 
common support. A standard assumption in PS analysis is sufficient common support. There 
is no set limit, however, to what ‘sufficient’ entails [150]. It may differ depending on the 
conditioning technique given its mode of action. For example, when using matching the 
assumption of common support is much stronger [316]. Matching does not alter how 
outcomes are estimated, simply restricting observations to those most similar between 
groups. If no limit is set to the maximum distance observations need to be, and common 
support is weak, treatment and control groups are likely to be dissimilar [156]. If insufficient 
common support is achieved results may also be limited only to the region of common 
support affecting external validity [316]. When using ATET IPW common support may be 
less stringent as observations are not dropped using this class of technique. It is important, 
though, when using weighting that PSs for treatment groups lie roughly within the distribution 
of the control group [316].  
Using ATE IPW fuller common support may be required as this measures average outcomes 
across the whole population [316]. Few explorations of common support have been 
performed with MLM estimations of the PS, and to date the only published MLM-PS studies 
have incorporated ATE weighting. Simulation has shown that when estimating a MLM-PS 
using random intercepts in the presence of many clusters or clusters which are restricted to 
only treatment and control, scores tend towards extreme values, such as close to 0 or 1 [32].  
The overlap between treatment and control PSs is likely to be smaller.  
8.3.2 Conditioning techniques and outcomes 
As can be seen in figures 8.5-7, conditioning techniques are compared in terms of their point 
estimates of impact and subsequent CIs and p-values. Matching shows the greatest 
variation in point estimate primarily due to nearest neighbour matching without replacement 
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and calliper. In a situation where many similar PS values exist, such as in a clinical trial, PSs 
would be expected to be very similar thus making this technique more valid. In social science 
research, cluster level treatment assignment is less likely to produce a large number of 
similar matches for each treatment observation given heterogeneity across clusters such as 
districts. Matching has been demonstrated through simulation to potentially increase bias 
when PSs are dissimilar [156]. 
Importantly point estimates along different weighting augmentations remain quite stable. 
This indicates that outliers are having limited effect on the overall model strengthening the 
validity of results. As might be expected, differences are observed between ATE and ATET 
weights. This is because they are essentially estimating impact in different populations [316]. 
The ATE, which estimates impact in the overall population, provides more conservative 
estimations. 
Matching provides a more dispersed variety of outcomes, likely due to a limited number of 
close PS values on common support. Covariate adjustment and standard regression tend 
to also estimate more conservative impacts. Both techniques however are more analogous 
to estimating an ATE.  Overall the relatively stable estimates generally trending in the same 
direction indicates that potential misspecification would have had little effect on integration 
impact for both case studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8-4 Results from altering conditioning technique for HIV/ANC case study 
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IPW = Inverse Probability Weighting , Figures following IPW indicate the level of augmentation (ie 
99 = augmentation to the 99th weight percentile), ATET = Average Treatment Effect on the 
Treated, , ATE = Average Treatment Effect, N1NR =  Single Nearest Neighbour matching with no 
set radius, N1C = Single Nearest Neighbour Matching with replacement, N2 = Double Nearest 
Neighbour Matching with calliper, N5 = Five Nearest neighbour matching with calliper, RA = 
Regression Adjustment with all covariates , RA+PS = Regression Adjustment + Propensity Score 
as a covariate
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Figure 8-5 Results from altering conditioning technique for HIV/TB case study outcome 1 
 
IPW = Inverse Probability Weighting , Figures following IPW indicate the level of augmentation (ie 
99 = augmentation to the 99th weight percentile), ATET = Average Treatment Effect on the 
Treated, , ATE = Average Treatment Effect, N1NR =  Single Nearest Neighbour matching with no 
set radius, N1C = Single Nearest Neighbour Matching with replacement, N2 = Double Nearest 
Neighbour Matching with calliper, N5 = Five Nearest neighbour matching with calliper, Weight + 
RA = Regression adjustment + IPW ATET weighting, RA = Regression Adjustment, NA = Non-
Adjusted
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8-6 Results from altering conditioning technique for HIV/TB case study outcome 2 
 
IPW = Inverse Probability Weighting , Figures following IPW indicate the level of augmentation (ie 
99 = augmentation to the 99th weight percentile), ATET = Average Treatment Effect on the 
Treated, , ATE = Average Treatment Effect, N1NR =  Single Nearest Neighbour matching with no 
set radius, N1C = Single Nearest Neighbour Matching with replacement, N2 = Double Nearest 
Neighbour Matching with calliper, N5 = Five Nearest neighbour matching with calliper, FAR = Fully 
Adjusted regression, FAR PS = Fully Adjusted Regression + PS as a covariate 
8.4 Outcome models  
As with the estimation of the PS, different iterations are available for estimating the 
outcomes of integration following conditioning on the PS. The two case studies have made 
use of MLMs to provide conservative estimates through doubly-robust estimation.  
Several outcome models are compared to assess variability in estimated impact. For the 
HIV/ANC case study these include random intercepts for both district and region as per the 
case study (19), random intercepts for district only (28), region only (29), and a naïve model 
with no multilevel elements (30). For the HIV/TB case study outcome models include a 
model with random intercepts for both district and health district as per the case study (20-
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21), district only (31), health district only (32), and a naïve model with no district membership 
(33). Formal presentations of models not previously described are presented in Appendix 3. 
Results from the various models are presented below. 
Fixed effects have been used in the MLM estimation of PSs. This is not available with the 
outcome model in both case studies. Firstly, due to their being multiple level two clusters, in 
both case studies which have only treatment or control observations and thus are collinear 
with treatment. Secondly, in the case of HIV/ANC, the highest cluster level region does not 
contain sufficient time/region observations to provide reasonable comparisons. Thirdly, in 
the case of the HIV/TB case study, the highest cluster level, health district, is collinear with 
treatment.  
As can be seen in Tables 8.6 - 8 below impact estimates differ depending on the outcome 
model used. Estimates from the HIV/ANC case study vary from 109% to 135% increase in 
impact caused by higher integration.  
Little variation is seen between the model incorporating random intercepts for both district 
and region, and region alone. HIV/TB outcome 1 ranges from -7% to -6%, while outcome 2 
ranges from 64% to 151%. As with the HIV/ANC case study there is only subtle variation in 
coefficients and standard errors between models that include random intercepts.  
This is likely due to, firstly, a large degree of variability due to district membership being 
controlled during the PS estimation, and secondly, variation due to regional/district health 
cluster differences as opposed to district.  
From a theoretical standpoint the inclusion of MLMs allows two chances to account for bias 
due to clustering [32]. The data however points to a less pronounced effect for integration 
with exclusion of multilevel elements from outcome model estimates. Incorporating such 
doubly-robust estimators is therefore justified. Previous simulations find that MLM in the PS, 
while important, has a less pronounced effect than MLMs in outcome models [32-34]. The 
case studies here oppose this as MLMs on the PS have a strong effect. Regardless the 
difference in impact estimates suggests the necessity to include MLMs in both steps.  
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Table 8.6. Differences in impact estimation of fully integrated HIV/ANC services in Peru, by 
outcome model 
Outcome model 
Log 
likelihood SE p 95 CI 
Full model 1.2385 0.3712 0.001 0.5109 1.9660 
No region 1.3507 0.7122 0.058 -0.0452 2.7467 
No district 1.2385 0.3712 0.001 0.5109 1.9660 
Naïve model 1.0988 0.6602 0.096 -0.1951 2.3929 
SE = Standard Error, CI = Confidence Interval 
 
Table 8.7.  Differences in impact estimation of fully integrated HIV/TB services on in Peru on 
improved rate of HIV testing for TB, by outcome estimation model 
Outcome model Coefficient SE p 95 CI 
Full model -0.0625 0.0089 0 -0.08 -0.0449 
No district health -0.0625 0.0442 0.158 -0.1493 0.0242 
No district -0.0779 0.0041 0 -0.0859 -0.0698 
Naïve model -0.0779 0.0767 0.312 -0.2299 0.0741 
SE = Standard Error, CI = Confidence Interval 
Table 8.8. Differences in impact estimation of fully integrated HIV/TB services on in Peru on 
improved rate of returned HIV tests, by outcome estimation model 
Outcome model 
Log 
likelihood SE p 95 CI 
Full model 1.5114 0.0411 0 1.4306 1.5921 
No district health 1.5114 0.8618 0.08 -0.1778 3.2006 
No district 1.5114 0.0411 0 1.4306 1.5921 
Naïve model 0.7459 0.9452 0.43 -1.1066 2.5985 
SE = Standard Error, CI = Confidence Interval 
8.5 Sensitivity 
A key assumption of causality using PS analysis is that there are no unmeasured 
confounders influencing treatment assignment or outcome [29, 30]. This implies that all 
covariates which may describe treatment assignment or confounders of outcome estimation 
have been considered for inclusion in PS estimation. Given the natural complexity 
surrounding policy and integration research there are potentially infinite covariates that could 
be included in the estimation of a PS [43]. All potentially important covariates may be 
included in the PS model; however, the possibility of unmeasured confounders remain.  
Rosenbaum [361] devised a means of indirectly testing the unconfoundedness assumption. 
This was not by way of elucidating omitted covariates, instead by introducing a theoretical 
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covariate in to the overall PS estimation and measuring consequent changes in the 
estimation of outcomes. This in turn measured the sensitivity of the overall analysis to 
potentially unmeasured covariates. Intuitively the approach can measure how strongly an 
unmeasured covariate can affect treatment effect estimation.  
The procedure involves simulating a confounder into the PS model and testing its influence 
on the p-value and coefficient of outcome estimations [362]. The confounder is simulated to 
have a differing level of modifying effect of the treatment on outcome. If a PS model is highly 
susceptible to bias, then values will change dramatically with a relatively low amount of 
confounding [362]. This does not translate to there being unmeasured covariates, but rather 
that the overall model would be sensitive to unmeasured confounders if they were to exist.  
Testing the unconfoundedness assumption is clearly difficult as it is impossible to assign a 
value to something which has not been measured. Few sensitivity tests are available, none 
of which are ideal for the given data. Given the lack of available methods several caveats to 
this test are discussed here. Firstly, the technique relies on the Mantel and Haenszel test 
[362]. This measures the effect of a variable between a matched pair of observations. This 
restricts sensitivity only to PS matching as opposed to other conditioning techniques such 
as weighting. This is an issue as estimates of impact differ depending on the conditioning 
technique used, as demonstrated above, and matching has been suggested to be the least 
appropriate method given the available data. Further sensitivity methods are in development 
for weighting [400]; however, it is beyond the scope of this thesis to apply them given that 
they are as yet new and untested. A second issue is that Rosenbaum bounds estimate 
outcomes of the PS model, but standard software is currently unable to incorporate MLMs 
into the estimation [362]. This is an issue as outcomes in both case studies use MLMs to 
account for likely residual confounding based on cluster. Finally, at present there are no 
guidelines on the size of effect which should be estimated when conducting a sensitivity 
analysis with Rosenbaum bounds [362]. In this Chapter values from 0% to 100% are tested. 
Given the issues discussed above the sensitivity test is used as a rough guide to the 
sensitivity primarily of the PS itself, with the assumption that some omitted variables 
(belonging to district or higher clusters) are having some effect on outcomes. The results for 
both case studies are presented in Table 8.9 below.  
 
Table 8.9. Results from sensitivity of PS analysis to unmeasured confounders, by case study 
 
HIV/ANC                                       HIV/TB 
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Gamma* Statistical significance of estimated 
outcome 
Statistical significance of 
estimated outcome 
1 0.000088 0 
1.05 0.000198 0 
1.1 0.000419 0 
1.15 0.000827 0 
1.2 0.001531 0 
1.25 0.00268 1.10E-16 
1.3 0.004461 5.60E-16 
1.35 0.007098 1.90E-15 
1.4 0.010847 5.80E-15 
1.45 0.01598 1.60E-14 
1.5 0.02278 4.30E-14 
1.55 0.031516 1.10E-13 
1.6 0.042433 2.50E-13 
1.65 0.055737 5.70E-13 
1.7 0.071577 1.20E-12 
1.75 0.090041 2.50E-12 
1.8 0.111148 4.90E-12 
1.85 0.134849 9.30E-12 
1.9 0.161023 1.70E-11 
1.95 0.189491 3.00E-11 
2 0.220016 5.20E-11 
*Gamma = strength of confounding factor simulated into data 
Estimations of outcomes for both case studies remain statistically significant at extreme 
values of the simulated confounder. Results become slightly less significant at double the 
amount of confounding for the HIV/ANC case study; however, at larger levels of confounding 
they become more significant. Results remain significant across all levels of confounding for 
the HIV/TB study. This suggests that both estimations of the PS are relatively insensitive to 
potential unmeasured confounders. For the HIV/TB case study this implies little aside from 
the strong results. For the HIV/ANC case study it implies that the overall model may be 
sensitive to some measures of hidden bias, mainly at extreme bias values. When estimating 
the outcomes of integration using the full model doubly-robust estimators were included. 
This involved statistical models incorporating cluster effects into the estimation of outcomes. 
In doing this an inherent assumption is that not all confounders at the cluster level have been 
accounted for. The models specifically model standard errors at the level of the cluster. This 
implies a conservative estimation of statistical significance. 
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8.6 Discussion 
Model selection in PS studies is a recognised problem [312]. However, most focus is placed 
on the choice of covariates or conditioning technique [75, 312, 398, 401]. This Chapter has 
expanded model considerations to include appropriate regression models used to estimate 
the PS and outcomes, in the presence of clustering. Such selection follows the general 
approach taken throughout this thesis in matching theory and data when using a model with 
best fit for the purposes of impact evaluation. This process has been defended by 
demonstrating increased bias or outcome differences when using alternate specifications. 
The analysis shows that robust balance has been best achieved when using the full barrage 
of covariates as supplied in each case study. The chosen conditioning technique, ATET 
weighting, also shows greatest covariate balance. The choice of weighting is in contrast with 
some evaluations of conditioning techniques [150, 397-399]. However, is suggested on a 
theoretical basis given recent demonstration of shortcomings of the most common 
conditioning technique; matching [156]. On a practical basis, point estimates differ between 
techniques; however, they remain consistent for the primary outcome indicators. This 
indicates consistency across specifications.  
Both case studies show variation when omitting multilevel elements mostly in estimation of 
PS but also in outcome.  This is in line with previous findings using data simulation [32, 34, 
82]. This justifies the use of MLM-PS with this data in line with the assumption that when 
clustering affects outcome estimations it should be included in estimations [83]. The PS may 
be vulnerable to omitted variables for the HIV/ANC case study, although only at extreme 
values of simulated bias. Bias from clustering is also not included into sensitivity 
calculations. The HIV/TB PS is more robust to omitted variables. Overall these points 
demonstrate that the most appropriate model given the available data has been used for 
both case studies [32, 34, 82, 402].  
Methods used in each case study are similar, which is driven by similarities in each data set, 
in turn driven by similarities of the policy and its evaluation. Firstly, an ATET has been the 
desired estimate in both case studies, thus restricting the use of some conditioning 
techniques. Secondly, full integration has been applied selectively to relatively few sites. 
This has caused the relative size of treatment groups to dramatically differ. This has meant 
techniques which utilise a larger data set may be better suited for both case studies. Thirdly, 
full integration has been applied selectively to clusters. This has meant that clustering 
needed to be included at some stage of the evaluation. This is likely to be the case in 
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evaluations of social policy, though use of MLMs in the estimation of the PS is not universally 
required.  
Cluster level treatment assignment has limited the breadth of MLMs which may be used in 
the estimation of the PS. The combination of this issue and of the use of random intercepts 
has meant a likely estimation of many PSs which sit near zero or one [32]. This reduces 
observations which sit within the area of common support. The lack of common support has 
also led to the selection of PS weighting given the issues with matching discussed above. 
Finally given the variability associated with multiple clusters a doubly-robust estimation of 
outcomes has been used. Drawing from Chapter 4, this may be an important consideration 
given the frequency with which cluster level treatment assignment has occurred. 
There are distinct differences between each case study and the data sets reflecting common 
themes in health policy evaluation literature [374, 386]. HIV/ANC case study data has 
individuals as the unit of observation, while HIV/TB, the health facility. This has been due to 
procurement difficulties for lower level data for HIV/TB. This has in part dictated the relative 
amount of cluster level covariates. Averaging variables over an area leads to a loss of 
information. Some variables are by their nature only available at cluster level, for example 
district level HIV incidence. Other variables such as average district SES are more useful if 
able to be provided at the lowest level of observation. Given the relative lack of covariates 
in the HIV/TB data many more cluster level variables were used than in the HIV/ANC case 
study. This had a demonstrable effect on results, which were less likely to vary when adding 
multilevel elements to outcome models. The lack of geographical dispersion of the HIV/ANC 
data also restricted the use of fixed effects in the estimation of the PS. While not used in the 
final model, the HIV/ANC case study was able to test this approach.  
8.7 Conclusion  
This Chapter aimed to explore and discuss the various model variations which can be used 
during PS analysis. A key aim was to demonstrate that the approach most likely to reduce 
bias had been presented in the case study Chapters. It also aimed to explore how results 
can vary when model specifications are altered. Finally, it aimed to discuss the MLM-method 
highlighting important differences from and benefits that it has over traditional PS 
approaches.   
The full model for both case studies was shown to provide the greatest bias reduction. This 
leads to the conclusion that it is the most appropriate for both case studies and having been 
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correctly selected and specific. Covariates were shown to be off balance when differing from 
the full model across the various steps of a PS evaluation. Despite this, outcomes were 
shown to vary relatively little, suggesting stability of estimates and the of PS. This leads to 
the conclusion that given the limitations of the data, a correct specification, to reduce 
observable bias, had been achieved for each case study.  
A further conclusion can be drawn that multilevel elements are an important consideration 
when evaluating impact in both case studies given their effect on bias reduction and 
outcome estimations. Analysts should be aware that the inclusion of MLMs may be a 
significant area worthy of attention in PS studies at multiple steps. 
MLMs are only valid in a situation where clustering may be affecting treatment assignment 
or outcome. Though in all situations in which it is a potential issue it should be tested. The 
demonstration of alternative specifications of the overall impact models adds to the validity 
of estimates of impact obtained in each case study. This Chapter brings together the 
argument brought forward during this thesis that MLM-PS can address common problems 
in evaluating HIV integration. It has focused on discussing important technical and practical 
aspects of the method.  
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9 Discussion on findings and contributions provided by the thesis 
This thesis explored the application of methods which can address common issues limiting 
the evaluation of HIV integration. With certain assumptions, Multilevel Propensity Score 
Models (MLM-PS) proved to be feasible in addressing potential selection bias at multiple 
levels while incorporating clustering into impact estimation. The method was flexible enough 
to be applied ex-post with relatively little information around treatment assignment, thus 
addressing all three issues inhibiting integration evaluation. 
The application of MLM-PS was explored through application to two case studies of HIV 
integration. Both case studies also relied on secondary data, not collected for evaluation, 
implying it was conducted ex-post. MLM-PS was found to be capable of demonstrably 
reducing bias between treatment groups in both case studies, incorporating covariates at 
multiple levels. In doing so it was demonstrated to be sufficiently flexible to be applied 
despite limited information around treatment assignment. The case studies differed in the 
type of integration complex under evaluation and the type of data used to estimate impact, 
with important implications for the flexibility of the methods, as discussed later in this 
Chapter. Higher integration resulted in higher effectiveness in the case of the integration of 
HIV with ANC services. Results were mixed in the case of HIV/TB integration (using primary 
indicators). 
The thesis began by establishing HIV integration as an important health system 
strengthening tool, warranting evaluation. It was then described as facing inherent issues 
which make its evaluation problematic. One issue related to ambiguity around the term 
integration and consequent difficulties in aligning specific modalities to indicators for 
evaluation, using plausible mechanisms of action. This was overcome by a theoretical 
framework, which was developed and applied to comparative HIV integration modalities, 
consequently mapping appropriate indicators for evaluation. The extent to which selection 
bias, clustering and ex-post evaluation were present in the empirical HIV integration 
literature was demonstrated through systematic review. As suspected, all three issues 
occurred frequently; in the case of clustering this was often without appropriate methods to 
account for its potential effect.  
Different iterations of the MLM-PS method were compared. This demonstrated the utility of 
the MLM alterations from standard PS estimation. It was found that different iterations of the 
PS method apply best to HIV integration evaluation. It was found that the inclusion of MLMs 
into the estimation of the PS has a demonstrable effect on bias reduction, and so it is an 
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important inclusion for HIV integration evaluation when using regression. This was with the 
caveat that PS analysis is coupled with strong assumptions and key limitations. Overall it 
was found that despite frequent issues in empirical evaluations of HIV integration, pragmatic 
methods can be applied to reduce selection bias in assessing the impact of this important 
health policy. 
This Chapter discusses the findings from the thesis and draws several important 
conclusions, discussed in detail below. Firstly, specific aims and objectives, first stated in 
Chapter 1, have arguably been met. Secondly, robust discussion of key findings arising from 
the research are provided. Thirdly, ramifications of the results of the study are discussed. 
Fourthly, the original contributions of this thesis to the existing body of knowledge are 
highlighted. Fifthly, limitations and possible extensions of the research are presented. 
Finally, overall conclusions are drawn. 
9.1 Objectives and how they have been achieved 
Under the general aim of the thesis three specific aims and six specific objectives were 
presented in Chapter 1. This section reiterates them and discusses how they have been 
achieved. 
Aim 1) Analyse and assess concepts and methods for evaluation surrounding HIV 
integration in the literature 
This aim was met by performing first a targeted review of the integration literature and then 
a systematic review of empirical literature on HIV integration. The general review defined 
concepts used to describe integration and HIV integration. These concepts were unified to 
develop a theoretical framework for selecting indicators used later in the thesis. The 
systematic review focused on assessing methods which had previously been used to 
evaluate impact of HIV integration. The aim had two specific objectives: 
Objective 1. Develop a theoretical framework for understanding and comparing key 
concepts around HIV integration in primary facilities in relation to selection of indicators for 
evaluation. 
This objective related to a gap in the literature, that of a theoretical framework for mapping 
integration modalities to appropriate indicators and evaluation methods. This objective was 
met in Chapter 3 through the development of such a framework. The framework itself drew 
upon previous work describing the process of HIV integration along different health system 
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structures and functions. These were used and stratified along concepts of evaluation 
developed for selecting quality indicators for program evaluation.  
The framework was novel and was used to underpin important discussions on the use of 
key performance indicators and evaluation methods throughout the thesis. This new 
framework itself was successfully tested by applying it to two case studies of HIV integration.  
Objective 2. Examine the extent to which studies measuring effectiveness of HIV integration 
appropriately account for selection bias and clustering. 
This objective was met in Chapter 4, which comprised the review of the empirical literature 
on HIV integration in primary care in LMICS. Systematic review methods were used to 
select, arguably, all current literature on the topic. The literature demonstrated, as 
suspected, a lack of methods used to evaluate HIV integration that potentially accounts for 
potential selection bias. It was also confirmed that clustering and cluster level treatment 
assignment was an issue in empirical HIV integration research. This was likely due to 
inherent issues in the way that patients accessed integrated services and the frequent use 
of ex-post analysis 
Several other important methodological issues arose as part of the review: in HIV integration 
research; common HIV integration complexes evaluated to date; trends in methods within 
those complexes; and the wide variety of indicators that were used to measure HIV 
integration.  
Aim 2) Identify methods for evaluating the effectiveness of HIV integration as a health policy 
able to be applied ex-post. 
This aim was met by reviewing the literature on impact evaluation methods drawn from 
microeconomic evaluation. These methods focus on establishing a valid counterfactual 
when randomisation is unable to be used. A variety of methods were reviewed for their ability 
to account for specific issues frequently found in integration evaluation. This aim had one 
specific objective: 
Objective 3. Define methods for measuring impact of policy such as HIV integration which 
account for selection bias, clustering and are sufficiently flexible to be applied ex-post with 
little information on treatment assignment. 
In the general review of the literature (Chapter 2), methods which were able to reduce the 
likelihood of selection bias, such as those incorporating randomisation, were suggested to 
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be the best possible for establishing the causal effect of integration. HIV integration as a 
health policy, however, was shown through a systematic literature review to have inherent 
problems which made use of experimental methods impractical. These were: inability to 
randomise, clustering and clustered treatment assignment, and frequent reliance on ex-post 
evaluations.  
Common quasi-experimental methods were discussed in relation to their ability to 
strengthen causal claims, despite these issues. The most pragmatic method given the 
constraints described above was argued to be MLM-PS, using a difference in difference 
estimator where possible. Chapter 5 explored this approach.  
MLM-PS was shown to be able to create a valid counterfactual based on covariates 
potentially measured after the implementation of HIV integration at both the individual and 
cluster level and in doing so demonstrably reducing potential selection bias. The inclusion 
of MLM to estimate the PS was shown to allow cluster characteristics to be included when 
reducing selection bias. MLM-PS was argued to be the most flexible quasi-experimental 
technique when applied ex-post as it did not rely as heavily on information around treatment 
assignment as other methods. This was with the caveat that MLM-PS was subject to distinct 
limitations and subject to strong assumptions. 
Aim 3) Test identified methods estimating impact of HIV service integration given key issues 
around policy evaluation and data limitations, exploring potential reductions in bias and 
control for clustering. 
This aim was met by applying the MLM-PS method to two case studies of HIV service 
integration. Both case studies had the three identified common key issues creating barriers 
to improved impact estimates:  treatment and control are non-randomised, cluster level 
treatment assignment, and analysis being conducted ex-post. The MLM-PS method was 
explored by applying it to the case studies with a demonstrable reduction in selection bias. 
This aim had three specific objectives: 
Objective 4. Explore the feasibility of identified methods through impact evaluation of 
HIV/ANC service integration. 
Chapter 6 was an application of the MLM-PS method to real case study data. This Chapter 
described an impact evaluation of higher HIV/ANC service integration in Peru, which 
represented all three issues identified as inhibiting other empirical HIV integration evaluation 
research.  
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The MLM-PS method was demonstrated to be effective at reducing important biases 
identified between treatment groups while also controlling for clustering present in the data. 
This included cluster-level biases resulting from cluster level treatment assignment. The 
method was shown to reduce bias despite evaluation being conducted ex-post and when 
policy assignment had been non-random, using secondary cross-sectional data.  In using 
this method HIV/ANC was shown to be highly effective in increasing the likelihood of HIV 
tests being performed as part of ANC. 
Objective 5. Explore the feasibility of identified methods through impact evaluation of 
HIV/TB service integration. 
Chapter 7 was also an application of the MLM-PS method to real case study data, that of 
HIV and TB service integration. The data differed from the HIV/ANC case study in several 
important ways. It used routine government surveillance data and analysis relied heavily on 
cluster level covariates. Despite these differences the MLM-PS method was shown to also 
be effective in reducing biases between treatment and control groups while controlling for 
clustering. The HIV/TB integration complex in this impact evaluation was shown to have 
mixed results in relation to HIV testing.  
Objective 6. Explore the robustness of the methods and data used to evaluate HIV service 
integration. 
Chapter 8 was an exploration of the MLM-PS method used in both case studies. This 
Chapter showed the different ways in which MLM-PS can be applied. It also showed that 
the specification chosen for each case study was the best possible for the given data. 
Technical points important to the use of MLMs, PSs and MLM-PS were discussed in relation 
to the data and in general. A large array of specifications of MLM-PS showed the robustness 
of results and flexibility of the methods in relation to HIV service integration evaluation.  
9.2 Key conclusions drawn from the research conducted throughout the thesis 
Achievement of the aims and objectives described above has resulted in five key 
conclusions of the thesis. A brief discussion of each is presented below: 
1. HIV integration has commonly been evaluated ex-post with limited control of bias. 
This issue highlights an important point for use of empirical evidence in evidence-based 
policy. While estimates of impact using flawed methods is not ideal, such empirical evidence 
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should not be discounted. However, caution should be employed when interpreting findings 
from such evaluations. There is clearly a space for improved methods when evaluating HIV 
integration that does not lend itself to randomisation. 
2. HIV integration has been frequently performed on data that is clustered, using 
regression, and which reflects cluster level treatment assignment. 
This complicates the issue of selection bias. The lack of MLMs when clustering is present, 
and regression is used further weakens the confidence which can be placed in conclusions 
drawn from impact evaluations. This is because omitting control for clustering when it is 
present can have dramatic effects on statistical significance and magnitude of impact.  
Cluster level treatment assignment adds a level of complexity to study design as it 
complicates the use of some MLMs. It appears to be common in HIV service integration. 
Given the frequency which health policies are applied to facility or district level it may also 
be indicative of a wider problem in health policy evaluation. This points to a need to carefully 
consider MLMs in the evaluation of HIV integration. 
3. The MLM-PS method is a pragmatic alternative when randomisation is not available 
for reducing bias, controlling for clustering, and being applied ex-post. It was 
demonstrated that the method can remove bias using data representative of the three 
issues. 
PS methodologies rely on strong assumptions, such as no unmeasured confounders, which 
will never make them preferable to effective randomisation. However, given the frequency 
of issues involved in evaluation of HIV integration, PS methods may offer a best-case 
scenario alternative. They are flexible enough to be utilised ex-post assuming a rich array 
of covariates are available.  
The inclusion of the MLM aspect can allow proper inclusion of clustered data structuring, 
bias reduction at the cluster level, and the incorporation of important cluster level 
confounders in establishing a valid counterfactual.  
MLMs also allows flexibility in how PSs can be applied, particularly in the presence of cluster 
level treatment assignment. PSs are arguably more flexible than other quasi-experimental 
techniques in the need for information around treatment assignment. They also offer distinct 
pragmatic advantages over multivariable regression. 
4. HIV/ANC and HIV/TB full service integration in Peru appears have mixed impact 
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Fully integrated HIV/ANC health services had a strong causal effect relating to improved use 
of essential services. Fully integrated HIV/TB centres, however, had a slight decrease in the 
percentage of HIV tests given for TB patients. This contrasted with results from an alternate 
indicator: the percentage of patients who did receive a HIV test, then received their results, 
showing it was significantly higher in the case of fully integrated services. This paints a mixed 
picture in Peru. This result is important, as HIV tests during ANC and for TB patients are 
essential interventions for preventing further morbidity and mortality.  
9.3 Discussion on key themes 
The thesis progressively identified important themes and issues relevant to evaluating HIV 
integration. Results from applying MLM-PS using different data sources have implications 
for the flexibility of the method and opportunities for evaluation in varied settings. Various 
specifications within MLM-PS have been used with implications for how the method may be 
applied. The method, however, relies on strong assumptions and has key limitations. MLM-
PS may also be more relevant in some settings than other quasi-experimental methods 
however may have limited scope of applicability. Key differences between integration 
complexes have become apparent. The differences arising from the results of case studies 
also warrant exploration. The following section discusses these issues in depth. 
9.3.1 Methodological issues with HIV integration evaluation 
Ideally, better quality data should be pursued to improve evidence-based decision making. 
When not possible however, quasi-experimental methods, apart from limited matching, have 
not yet been used to evaluate the impact of HIV integration. Given that previous literature 
on the topic has mostly been unable to address potential selection bias, there is a space for 
pragmatic quasi-experimental methods. 
To explore this, the MLM-PS method was tested and applied to HIV integration case studies. 
Several interesting issues arose, relating to the data used for impact evaluation and the 
indicators of impact. 
9.3.1.1 Data 
Two case studies were used to demonstrate the feasibility of applying MLM-PS. Both 
focused on HIV service integration but they differed in the type/source of data used. The 
HIV/ANC case study relied on repeated cross-sectional data collected as part of the DHS 
series. Large secondary survey data represents a common stream in the HIV integration 
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empirical literature. Drawing from the systematic review in Chapter 4, within the empirical 
HIV integration literature, it is common for cross-sectional data to be collected either by an 
unrelated third party or more commonly by the authors of the evaluation article. The HIV/TB 
case study differed in using Ministry of Health standard programmatic surveillance data 
sourced from the National Tuberculosis Program. Surveillance data was also commonly 
used in other evaluations of HIV integration. 
In the case studies, each data set posed different pragmatic and technical challenges. For 
example, the HIV/ANC data was de-identified at the individual level with only a code to 
indicate district. The anonymity of the data required sourcing information outside the original 
data to ascertain treatment groups. For the HIV/TB data set fully integrated observations 
were easier to isolate as the health centre name was provided. This data was, however, 
limited in terms of variables and covariates measured. This necessitated using alternate 
sources to ‘build’ sufficient covariates for PS estimation. The HV/TB data set was therefore 
much more reliant on using cluster level covariates. Both these issues affect the validity of 
estimates drawn from the data. 
Different strains of problems, therefore, occur with the different types of data. Surveillance 
data will restrict available covariates and will likely be averaged at facility level [389]. It will, 
however, be more practical, cheaper to collect and often available in panel format at facility 
or higher level. Cross sectional data will likely contain a wider selection of covariates and 
allow manipulation of included covariates by the analyst [374]. It will be less readily available 
and often require more costly primary data collection. Issues of costs should be weighed 
with issues of study design. Surveillance data are pre-collected and ready to be used for 
evaluation, but is often averaged at the facility level, implying a loss of information from the 
individual. It also reduces sample size, which was an issue in the impact evaluations 
performed as part of this thesis.  
Despite these issues this thesis has demonstrated that surveillance data can still be used 
incorporating cluster level covariates and using MLM-PS. Routine surveillance data are 
criticised as being low quality, although surveillance systems are constantly being improved 
[386]. Surveillance data are useful for policies such as integration which rely on applying 
fixed changes to infrastructure. This is because other infrastructural changes, which can be 
measured at the facility level, may be controlled. Linking costing data may be easier than 
other data types as surveillance data lists facility or names of sub-national units. Routine 
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surveillance data can also avoid some recognised problems with surveys, such as recall 
bias [403].  
Pre-collected large nationally representative surveys such as the DHS series can be 
manipulated to evaluate impact as per the HIV/ANC case study. They have clear 
shortcomings such as a lack of control over collected variables, and reliance on a wide 
distribution to increase the likelihood of sampling treatment and control areas. Despite this, 
surveys such as DHS include a relatively large selection of variables. This improves the 
likelihood that outcomes and covariates can be included for analysis. DHS sampling is 
performed incorporating elements of randomisation that may help to reduce some forms of 
bias [331]. DHSs are sometimes performed in repeated waves, which allow inclusion, to 
some extent, of control for time. The survey is regularly conducted without a specific 
intervention in mind, eliminating research participation bias. Large surveys such as the DHS 
may also be utilised to gain an understanding of the impact of policies such as integration. 
To the author’s knowledge, this thesis undertook the first impact evaluation of integration 
performed using the DHS. As with routine surveillance data, this thesis has demonstrated 
the feasibility of MLM-PS in concert with data sets such as the DHS, removing bias at 
multiple levels to improve impact estimates of policies such as integration. 
9.3.1.2 Indicators 
Isolating relevant indicators for impact of integration is a recognised problem [16, 22, 39, 404-
410]. Given that integration inherently implies the combination of two or more health system 
components, the best indicators are those that can reflect a change in both components. 
This limits the use of single program/service indicators, particularly if there is no strong 
theoretical basis for reflecting changes appropriate to context, such as HIV deaths in a 
concentrated or low-level HIV epidemic as discussed in Chapter 3.  
Integration is a complex process which is applied to address specific barriers to optimal 
health system performance. Indicators of death and disability, especially in concentrated 
epidemic settings, may not be reflective of the changes which integration makes on the 
system. Reductions in mortality are also complex and multi-factorial within an intricate 
system [210]. It is therefore unsurprising that previous literature has focused on indicators 
which measured process as opposed to outcomes.  
Additional problems with indicators arise given that in many settings some components of 
HIV services may already be integrated [43]. In high prevalence settings HIV testing is now 
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commonly provided with many basic services, such as ANC. In these situations, piloting a 
fully integrated model will only be able to be compared to a partially, as opposed to non-
integrated model of integration. This limits the potential differences by which impact is 
measured. 
Testing models where not all services are available must rely on process indicators which 
are available in both models. An example is HIV testing in fully and partially integrated 
settings. In some instances, certain process indicators will not be useful as one model does 
not provide the specific service: for example, ART in partially integrated models [62]. In this 
case, to use ART as an appropriate indicator of impact the unit of observation will need to 
encompass the higher level of care in which it is provided.  In a partially integrated setting, 
ART is only available at higher facilities. To measure the difference between partially and 
fully integrated models, analysis will need to be moved to the area encompassing both 
primary and secondary facilities. This potentially impacts sample size for analysis. It may 
also create pragmatic issues with data collection [240, 241]. 
9.3.2 Statistical issues with HIV integration evaluation 
Randomised controlled trial is the strongest design for estimating unbiased causal effects of 
a given health policy. However, quasi-experimental methods present an opportunity for 
reducing potential bias when randomisation is not feasible. As discussed in Chapter 2, 
various quasi-experimental designs are available. This section discusses important issues 
which have arisen during the research relating to other quasi-experimental methods and 
statistical issues around MLM-PS. 
9.3.2.1 Alternate approaches to evaluation 
MLM-PS was discussed as being the most pragmatic method given the restrictions imposed 
by integration. Alternate methods may be more applicable if such restrictions are not 
imposed. For example, Instrumental Variables (IVs) may be favoured over PSs for 
addressing endogeneity, when unobserved or unmeasurable bias is likely [154]. On a 
theoretical basis, IVs can address unobserved or unmeasurable bias while PSs are 
restricted to observable biases. An IV approach is also capable of incorporating MLM 
elements at several stages [411, 412]and can be applied ex-post and to non-randomised data 
[413]. Both PS and IV methods rely on specific characteristics within the data. For the IV this 
is primarily availability of a valid instrument, where ‘valid’ refers to restrictions in the form the 
instrument can take [413]. For the PS the pre-requisite is a rich array of covariates associated 
214 
 
with treatment, outcome or both [356]. For the case studies used in this thesis, PS was 
argued to be more useful as there was limited information around the attribution of treatment. 
Based on the systematic review this may be a common problem in HIV integration 
evaluation, making finding a suitable instrument problematic. 
During the systematic review Chapter several studies using cluster randomised trials (CRT) 
were found. The CRT is a pragmatic approach to difficulties in randomising interventions or 
policy at the individual level and is potentially less costly than and RCT [137]. All CRTs 
evaluating HIV integration, however, used potentially problematically small sample sizes. 
Two separate studies in Kenya recognise the problems with small cluster numbers and 
attempt to account for this by using further statistical techniques [273, 278]. Cohen et al [278] 
randomised only 18 HIV clinics but made use of a staged process of integration in a pseudo-
stepped wedge design. Washington et al [273] randomised only 12 facilities but matched 
them according to size prior to randomisation. Regardless, a small cluster sample size has 
been demonstrated to be highly susceptible to bias with further complications derived from 
variation in cluster size [414]. This reduces the effectiveness of controlling for bias through 
randomising clusters. Reaching sample sizes suggested by the theoretical literature may be 
difficult as more clusters potentially means more sites from which data needs to be collected. 
There is, however, a potential middle ground incorporating quasi-experimental methods with 
CRTs. A pragmatic solution may be to randomly assign clusters, but also measure individual 
and cluster level imbalance and use MLM-PS to balance it if found [415]. The incorporation 
of MLMs in this case allows the inclusion of important cluster level information into the PS.  
9.3.2.2 MLM-PS 
Different iterations of the overall MLM-PS model were tested primarily as part of the 
robustness Chapter (Chapter 8). Weighting in this instance was shown to most reduce bias. 
There is contention in the PS literature as to which conditioning technique is most able to 
reduce bias in general. Simulations have shown that no one technique performs best across 
all types of data [75, 156, 397-399]. The selection of conditioning technique appears largely to 
be data dependent as discussed in Chapter 8. Recent discussion has shown that matching 
may tend to increase bias in samples which have relatively large differences between 
treatment and control groups [156]. Using PSs in a MLM environment, particularly in the 
presence of cluster level treatment assignment, will drive large proportions of the PS to tend 
towards zero or one [32]. This makes the use of matching less practical.  
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The MLM-PS method has been argued throughout this thesis to be the most practical for 
evaluating HIV integration in certain circumstances. The use of a PS for causal effects, 
particularly in observational data, however remains controversial. Firstly, a general 
assumption of the PS method is that there are no unmeasured confounders. This is unlikely 
given the breadth of confounding factors presence in social science research. The hope with 
the PS is that these confounders are also controlled by proxy through measured 
confounders. However, the omission of potential variables remains relevant to the PS 
debate [356]. Secondly, there is the potential for endogeneity through unmeasured or 
unmeasurable variables. PSs are intuitively unable to address this form of endogeneity as 
can other quasi-experimental methods, such as IV. IV methods, however, also remain 
controversial in some settings [154, 155, 157]. Finally, the choice of conditioning technique 
clearly plays an important role in reliability of estimates. As highlighted above, a poorly 
selected conditioning algorithm is likely to increase bias between groups [156].  
Despite the inherent problems with PS methods, value should be placed on their pragmatism 
for policy makers. As mentioned in Chapter 5, PS methods are a two-step process which 
can be used as a barrier to researcher bias. This differentiates PS from attempting to 
establish causality with multivariable regression. An important benefit of PS methods is the 
ability to demonstrate reductions in bias post-application. This may be a powerful tool for 
conveying the importance of addressing bias to policy makers [135].  
9.3.3 Integration and health policy 
Ex-post analysis is a pragmatic approach to evaluating the impact of a program or policy. 
Clearly it is not ideal. Pre-planning evaluation with control over how the policy is applied and 
how it is measured is more likely to result in unbiased estimates of policy impact. The 
systematic review suggested that ex-post evaluation occurs with relative frequency in 
empirical HIV integration research. As with ex-post evaluation, clustering and to a lesser 
extent bias, are overlooked in the HIV integration empirical literature. A wider question may 
be to what extent ex-post evaluation and clustering is occurring in other areas of empirical 
health policy research. This has implications for the quality of empirical evidence used in 
evidence-based policy. This section provides a discussion on trends in integration evaluation 
and novel methods in integration evaluation. 
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9.3.3.1 Common themes in integration evaluation 
Ex-post evaluation was used in 52% of empirical HIV integration studies. The relative 
percentage seems to differ depending on the HIV integration complex. HIV/TB integration 
had the highest percentage of studies conducted ex-post. In 2004 the WHO released 
guidelines on integrating HIV and TB services [118]. Following this the Global fund for AIDS, 
Tuberculosis, and Malaria (GFATM) suggested fund recipients integrate HIV and TB as a 
pragmatic method for controlling the diseases [416-418]. Integrating was also written into 
the GFATM guidelines for applying for HIV financing. Several studies [240, 251, 261, 265, 
419] suggested that these guidelines were a prime reason for integrated programs being 
more likely to receive funding from the GFATM.  
Most reported research identified through the systematic review focused on evaluating 
service integration as opposed to other functions. Evaluation of functions such as Monitoring 
and Evaluation (M&E) is inherently difficult as it is itself the mechanism by which health 
system performance is measured. This limits the use of standard indicators requiring 
exploration of alternatives. For example, measuring the consistency with which TB-positive 
children have their CD4 counts registered as a result of integrated of TB and HIV registers 
[242]. Finance and governance functions are often centralised at higher or national levels 
limiting the availability of comparisons. Evaluations in these instances may be better 
undertaken as qualitative research.  
9.3.3.2 Context and the success of integration 
The case studies forming part of this thesis found mixed impacts for HIV service integration. 
In contrast prior empirical research suggests that integration has generally resulted in 
positive outcomes. Aside from potential bias related to methods, context may play a large 
role in the relative success of integration models. The relative success of integration as a 
policy may be reliant on contextual pre-conditions which dictate if services can be integrated 
and if integration will achieve desired outcomes [43].  
Context includes important aspects of the facility where integrated services are accessed. If 
inadequate space is available to support integrated services, performance may be inhibited 
[43]. Community level indicators may also play a role such as the willingness or knowledge 
of patients to use integrated services [420]. Demand generation in the community has been 
described as a key function of the health system in the context of integration [13, 14]. Despite 
this, community members who do not trust the competence of certain cadres of health 
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worker may be unwilling to use services, thus inhibiting the success of integration [421]. In 
contrast community engagement may be used to best target integration enabling better 
outcomes: for example, inclusion of community groups in the selection of integrated sites 
[422]. The wider health system context will also influence the effectiveness of integration at 
both national and sub-national levels [297]. An enabling policy environment [423] and 
sufficiently devolved agency of health managers or health workers to make decisions [424] 
appear to affect the relative success of integration.  
Integrating HIV services may result in a cost-saving for a health systems perspective, 
particularly over the long term [13,14]. In the short term however implementing integration 
will likely occur transactional costs. These can include physically altering infrastructure, re-
training health staff, holding joint planning meetings or aligning information systems among 
others [23]. Given that the evaluation of integration drawn from this thesis has shown to 
result in a marginal benefit over the standard of care, the decision to implement integration 
should weigh potential benefits against, short- and long-term costs. 
Analysis of case study data presented in the thesis demonstrated how contextual factors 
may be included in rigorous evaluation of HIV integration. The ability of MLM-PS to 
incorporate such context when estimating impact is relevant to integration evaluation into 
the future.  
9.4 Recommendations drawn from research conducted throughout the thesis 
The following section provides seven recommendations based on the research conducted 
in this thesis. The first recommendation relates to the HIV integration literature and methods 
used to establish impact. Clear issues arise with lack of methods/study design used to 
evaluate impact of HIV integration models that account for selection bias. This is likely due 
to inherent issues around evaluating HIV integration. Recommendation 1 is for greater 
consideration of sources of potential bias when estimating impacts of HIV integration.  
The second recommendation relates to the common issues of clustering in HIV integration 
evaluation and cluster level treatment assignment. Using naïve regression when clustering 
is present reduces the reliability of impact estimates. Cluster level treatment assignment 
also complicates the use of certain impact evaluation techniques. Recommendation 2 is that 
Issues of clustering be addressed to increase confidence in estimates of HIV integration 
impact. 
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Recommendation 3 revolves around the choice of method used when randomisation is not 
available. Various quasi-experimental techniques can be used. Specifically, MLM-PS, may 
be a pragmatic approach to simultaneously addressing selection bias and clustering when 
evaluation is conducted ex-post. MLM-PS provides greater confidence in estimated impacts. 
Recommendation 3 is that consideration be given by other researchers to the use of MLM-
PS for evaluating integration. 
The fourth recommendation relates to specifications used during a PS analysis. As 
discussed in the robustness Chapter a variety of iterations of technique are possible when 
using MLM-PS. It is important to select appropriate iterations based on theory where 
possible and on the structure of the data. Recommendation 4 is that when PS and MLM-PS 
analysis is used, a variety of PS models be used and documented; purposively selecting the 
final model, or models, based on likely and demonstrable reductions in bias. 
The fifth recommendation relates to the expansions of evaluation of HIV integration. 
Integration is clearly an important issue as health systems grow and become more complex 
and have increasing budget constraints. Not all integration modalities may warrant 
implementation. Integration should continue to be evaluated, albeit with improved evaluation 
methods. Recommendation 5 is that HIV integration evaluation should consider the 
contextual, structural, and functional factors which influence appropriate indicators. 
The sixth recommendation revolves around HIV/ANC integration in Peru. Full integration 
within the country was shown to be effective in improving the use of essential services. The 
continued use and scale up of HIV/ANC integration may increase coverage of HIV testing 
during ANC. This has ramifications for prevention of the virus throughout the country. It may 
therefore be a strong policy option in Peru. Recommendation 6 is the continued use and 
potential scale-up of HIV/ANC service integration in Peru. This is with the caveat that a 
further increase in scale would warrant appropriate evaluation incorporating costs. 
The seventh recommendation relates to HIV/TB Service integration in Peru. HIV/TB full 
integration was shown to have mixed results. Despite improved return of HIV tests, HIV/TB 
integration still resulted in a marginal reduction in HIV tests given. Depending on the priority 
of the HIV program, this may be evidence for a scale-up of HIV/TB integration. Given that 
the negative aspects of HIV/TB full integration were marginal, a decision on the use this 
integration model may be tied to a comparison of cost-effectiveness of the two models. 
Recommendation 7 is that policy makers in Peru consider a needs-based approach to full 
integration of HIV/TB including continuation and scale-up of the policy. 
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9.5 Original contribution to knowledge of the thesis 
This section highlights four key original contributions to knowledge by the research 
conducted during this thesis.  
1) A framework for mapping plausible indicators for comparative HIV integration 
modalities 
The thesis presents the first framework for assessment of methods and indicators of HIV 
integration evaluation. Other frameworks described in the literature limit their scope to 
describing the process of integration or how it may be applied.  
2) A systematic review highlighting the gap in methods to account for selection bias and 
clustering in HIV integration research, also demonstrating the frequency of ex-post 
evaluation. 
Through a systematic review of the literature, the widespread lack of methods accounting 
for selection bias and clustering in empirical evidence for HIV integration has been 
uncovered. The same review demonstrated the extent to which HIV integration evaluation 
is conducted ex-post. To the author’s knowledge this is the only such review. 
3) The demonstration of methods capable of accounting for selection bias and 
clustering, which are flexible enough to be conducted ex-post 
The MLM-PS method used to evaluate HIV integration and potentially other health policies 
which face similar evaluation issues was explored and applied. While not developed by the 
author this method has been demonstrated to be feasible when dealing with issues common 
to evaluation of HIV integration. The use of MLM-PS is novel within the evaluation of HIV 
integration. 
4) Impact evaluations of HIV/ANC and HIV/TB integration using methods accounting for 
selection bias and clustering 
This thesis presents the first impact evaluations of HIV/ANC and HIV/TB service integration 
in Peru. Both HIV integration complexes have previously had limited impact evaluation, 
particularly with methods which account for selection bias ad clustering, globally. 
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9.6 Limitations of the research  
Despite having successfully met the aims and objectives set out for this thesis several 
limitations were noted. 
In Chapters 2 and 5 and above, it was highlighted that alternative quasi-experimental 
methods may be used to evaluate HIV integration, but only MLM-PS was tested due to 
limitations presented by the case study data. Ideally, various other techniques, particularly 
IVs, which are also likely to fit the issues with HIV integration evaluation, should also be 
tested. Further methods, however, were beyond the scope of this thesis due to limitations 
of case study data. 
One of the aims of the thesis was to demonstrate the effectiveness of HIV/ANC and HIV/TB 
service integration. As often mentioned, this is best achieved through study design 
incorporating randomisation. Randomisation was not possible; the next appropriate 
approach was MLM-PS although this method has several key limitations highlighted above. 
Consequently, a limitation of this thesis is an inability to use randomised data to establish 
the effectiveness of the two HIV integration complex models. 
HIV/ANC and HIV/TB integration were measured for impact. Other examples of common 
HIV integration complexes were identified in the systematic review. Evaluation of this 
broader range of HIV integration was beyond the scope of this thesis but is a fruitful field for 
on-going research. 
Although the methods used in this thesis were selected due to their pragmatism in the face 
of non-ideal data, the shortcomings of the data used should still be discussed. The HIV/TB 
data set was limited in timeframe which meant that estimations of impact could not include 
estimates before integration had been applied. Secondary data in both case studies limited 
the selection of indicators for impact. Most covariates used when estimating propensity 
scores for both case studies represented potential demand side confounding issues, with 
only a limited selection of supply side and quality confounders included. This is a key 
limitation of both case studies. Broadening the range of indicators may have offered further 
insight into the effectiveness of full integration in Peru. 
The case studies used within this thesis are drawn from the same integration exercise, as 
described in chapter 2. While unlikely evaluating separate exercises in this way may create 
spill over effects or omitted variable bias. As an example, if a pregnant woman has recently 
been diagnosed with TB, she may have already been offered and/or accepted a HIV test as 
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standard. This makes her less likely to accept a HIV test when offered as part of her ANC 
check, thus biasing results. Potential bias hinges on a woman having been diagnosed and 
be pregnant within the same calendar year, which remains sufficiently unlikely to have 
occurred at samples large enough to influence results. Regardless, results from both 
evaluations should be interpreted with caution given simultaneous application. 
Finally, as data collection was limited, variables to show the impact of integration were 
limited. Despite the importance of HIV testing to both integration complexes other variables 
would have given a broader range of impact for use in policy making, in particular, costing 
data. Given that integration is targeted towards improvements in effectiveness and 
reductions in cost, evaluations would benefit from cost-effectiveness analysis. 
9.7 Extensions of the research 
Following the successful completion of the research in this thesis, possible extensions are 
highlighted. As discussed in Chapter 2, using evidence-based policy relies on the availability 
of unbiased estimates of impact. This may incorporate the use of the MLM-PS method where 
applicable. Given its utility, evaluation of other HIV integration complexes in other priority 
countries may be performed. In addition, evaluation along different health system functions 
would help give a fuller picture of the impact of HIV integration on health systems in different 
administrative contexts. 
A natural progression of the case studies provided is that towards the inclusion of cost-
effectiveness analysis in HIV integration programs. Cost is a critical variable in program 
choice in all LMICs. 
Finally, methods developed to inform policy are only useful if able to influence policy. An 
extension of this research may be to assess if MLM-PS is pragmatic in the policy analysis 
field, also if it is able to convey the importance of controlling for bias when policy-makers 
undertake reviews to inform applied evidence-based policy. 
9.8 Thesis conclusions                  
This thesis has argued that methods are available which can address key limitations to 
evaluation of HIV integration. The use of MLM-PS allows the inclusion of important 
contextual information which has been shown to dictate the relative success of integration. 
In the changing face of the HIV epidemic and broader trends in population health, the 
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incorporation of sound integration models will be increasingly important to achieve 
strengthened health systems. The methods presented in this thesis provide a basis for 
evaluating models and giving sound reliable evidence that can be used for improving health 
policy.   
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Appendix 2 Search Terms used for systematic review of methods for evaluating the 
impact of integration of HIV programs and services in LMICs 
 
Search terms are provided only for Scopus: 
TOPIC: (Delivery of Health Care, Integrated) OR MeSH HEADING:exp: (Delivery of Health 
Care, Integrated) OR TOPIC: (integrat* OR coordinat* OR co-ordinat* OR link* OR 
collocat* OR combined )) AND TOPIC: ( program* OR care OR service* ) AND TITLE-
ABS-KEY( "Afghanistan" OR "Albania" OR "Algeria" OR "American Samoa" OR "Angola" 
OR "Armenia" OR "Azerbaijan" OR "Bangladesh" OR "Belarus" OR "Belize" OR "Benin" 
OR "Bhutan" OR "Bolivia" OR "Bosnia and Herzegovina" OR "Botswana" OR "Brazil" OR 
"Bulgaria" OR "Burkina Faso" OR "Burundi" OR "Cabo Verde" OR "Cambodia" OR 
"Cameroon" OR "Central African Republic" OR "Chad" OR "China" OR "Colombia" OR 
"Comoros" OR "Democratic Republic of Congo" OR "Congo" OR "Costa Rica" OR "Cote 
d'Ivoire" OR "Ivory Coast" OR "Cuba" OR "Djibouti" OR "Dominica" OR "Dominican 
Republic" OR "Ecuador" OR "Egypt" OR "El Salvador" OR "Equatorial Guinea" OR 
"Eritrea" OR "Ethiopia" OR "Fiji" OR "Gabon" OR "The Gambia" OR "Georgia" OR 
"Ghana" OR "Grenada" OR "Guatemala" OR "Guinea" OR "Guinea Bissau" OR "Guyana" 
OR "Haiti" OR "Honduras" OR "India" OR "Indonesia" OR "Iran" OR "Iraq" OR "Jamaica" 
OR "Jordan" OR "Kazakhstan" OR "Kenya" OR "Kiribati" OR "Democratic People's 
Republic of Korea" OR "Kosovo" OR "Kyrgyz Republic" OR "Lao DPR" OR "Lebanon" OR 
"Lesotho" OR "Liberia" OR "Libya" OR "Macedonia" OR "Madagascar" OR "Malawi" OR 
"Malaysia" OR "Maldives" OR "Mali" OR "Marshall Islands" OR "Mauritania" OR 
"Mauritius" OR "Mexico" OR "Micronesia" OR "Moldova" OR "Mongolia" OR "Morocco" OR 
"Mozambique" OR "Myanmar" OR "Namibia" OR "Nepal" OR "Nicaragua" OR "Niger" OR 
"Nigeria" OR "Pakistan" OR "Palau" OR "Panama" OR "Papua New Guinea" OR 
"Paraguay" OR "Peru" OR "Philippines" OR "Romania" OR "Russian Federation" OR 
"Rwanda" OR "Samoa" OR "Sao Tome and Principe" OR "Senegal" OR "Serbia" OR 
"Sierra Leonne" OR "Solomon Islands" OR "Somalia" OR "South Africa" OR "South 
Sudan" OR "Sri Lanka" OR "St Lucia" OR "St Vincent and the Grenadines" OR "Sudan" 
OR "Suriname" OR "Swaziland" OR "Syrian Arab Republic" OR "Tajikistan" OR "Tanzania" 
OR "Thailand" OR "Timor-Leste" OR "Togo" OR "Tonga" OR "Tunisia" OR "Turkey" OR 
"Turkmenistan" OR "Tuvalu" OR "Uganda" OR "Ukraine" OR "Uzbekistan" OR "Vanuatu" 
OR "Vietnam" OR "West Bank of Gaza" OR "Yemen" OR "Zambia" OR "Zimbabwe" OR 
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Africa OR "sub-Saharan Africa" OR "low and middle income countr*" OR "low income 
countr*" OR "middle income country*" OR "low or middle income countr*" OR "developing 
country" OR "underdeveloped country" OR "resource limited" OR LMIC) AND TITLE-ABS-
KEY ( mnch OR mch OR "child health" OR immunization OR "family planning" OR 
"Maternal health" OR "community health" OR "adolescent health" OR cholera OR dengue 
OR fascioliasis OR trypanosomiasis OR leishmaniasis OR elephantiasis OR yaws OR 
"buruli ulcer" OR dracunculiasis OR leprosy OR schistosomiasis OR helminths OR 
''chagas disease'' OR onchocerciasis OR alcohol* OR "substance abuse" OR dementia 
OR hiv OR tuberculosis OR malaria OR sexually* OR "mental health" OR anaemia OR 
"vitamin a" OR deficiency OR fortified OR micronutrient* OR zinc OR diabetes OR cancer 
OR emergency OR ambulatory OR ANC OR antenatal OR ante-natal OR obstetric OR 
neonatal OR deworm* OR prevent* OR oral OR dental OR allied OR rehab*) 
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Appendix 3. STATA code example  
The following code is presented for the HIV/ANC case study. Each line of code is presented 
with a corresponding statistical model where relevant and/or a description. The steps 
represent the different steps in estimation of the propensity score as presented in Chapter 
6. Subscripts for each model can be found in Chapter 6 in line with its corresponding label.  
Key: 
→ Code description 
► Code 
 
1. Estimation of propensity score 
Mixed effects regression with random intercepts and slopes 
Model (23) as per Chapter 6: 
Logit (PSkjk) = β0 + δk + δjk + β7incjk + β1eduhjk + β2wealthhjk + β3agehjk + β4anchjk + β5profhjk 
+ β6inshjk 
→// Mixed effects estimation of propensity score random intercepts and slopes 
→// Set equation for cluster level covariate (district HIV incidence) 
►eq slope: inc 
→// Set constant 
►generate cons = 1 
►eq inter: cons 
→// Perform mixed effects regression 
►xi: gllamm treatment edu lang v012 i.twealth urianc profanc ins, i(num_dist v024) 
►family(binomial) link(logit) nrf(2 1) eqs(inter slope inter) nip(12) 
A)   Estimation of propensity score 
Predicted probabilities (ie the individual propensity score) 
→// Predicted probabilities (empirical Bayes prediction – as per Li et al [32] 
►gllapred pscoreme if e(sample)==1, mu 
2. Generate IPW-ATET weights based on propensity score 
Model: 
𝐼𝑃𝑊 𝐴𝑇𝑇ℎ𝑗𝑘 =  𝑍ℎ𝑗𝑘 + (1 − 𝑍ℎ𝑗𝑘) [
?̂?ℎ𝑗𝑘
1−?̂?ℎ𝑗𝑘
]  
→// Generate weights 
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►gen atet=1 if treatment==1 
►replace atet=pscoreme/(1-pscoreme) if treatment==0 
3. Perform balance checks using weights 
►xi: pbalchk treatment treatment edu lang v012 i.twealth urianc profanc ins inc,wt(atet) 
graph p 
*There are various different iterations of pbalchk, altering can produce alternate 
specifications of balance check 
 
4. Measure outcomes using probability weighted regression 
Model (19) as per Chapter 5: 
Logit (ehjk) = β0 + δk + δjk + γ1U1jk… γqUqjk + β1X1hjk…βpXphjk                
→// Set level 1 (pregnant women) PS weights stub 
►gen pw1 = atet 
→//Set level 2 (this also sets for level 3) weights at constant stub 
►gen pw2 = 1 
→// Outcome model 
►xi: gllamm outcome i.treatment*i.preint2, family(binomial) i(num_dist v024) link(logit) 
pweight(pw) 
→// where i.treatment*i.preint2 is an interaction term 
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Appendix 4. Additional PS and outcome models tested during robustness of results 
Chapter 8 
 
Parameter descriptions not provided here can be found in Chapter 8 
 
Further PS specifications:  
Logit (ehjk) = β0 + βRk  + δjk +  γ1U1jk… γmUjk + β1X1hjk…βnXnhjk            (25) 
Logit (ehjk) = β0 + δjk + γ1U1jk… γmUjk + β1X1hjk…βnXnhjk             (26) 
Logit (ehjk) = β0 + δk  + γ1U1jk… γmUjk + β1X1hjk…βnXnhjk             (27) 
 
General description: Where h are pregnant women attending ANC during pregnancy (h = 
1...H), in district j (j = 1....J) in region k (k = 1….K). Where ehjk is the individual propensity 
score describing the binary likelihood of receiving treatment (Z = 1) or control (Z = 0). β0 is 
the constant. Where ehjk is the individual propensity score describing the binary likelihood of 
woman h, in district j, in region k, of receiving treatment (Z = 1) or control (Z = 0).  
β1Xhjk…βnXhjk are individual level h covariates which need to be balanced between treatment 
and control groups. γ1U1jk… γmUjk are covariates at the level of the cluster, the method of 
modelling is described below.  
Model specific description: (25) Rk is a dummy coded variable for each region. District level 
covariates γ1U1jk… γmUjk are modelled as random slopes with a distribution  β𝑈~ N (0,
σ2
𝑈
). 
(26) District level covariates γ1Ujk… γmUjk are modelled as random slopes with a distribution 
 β𝑈~ N (0,
σ2
𝑈
). (27) District level covariates γ1Ujk… γmUjk are modelled as at level h. 
Further outcome Specifications 
HIV/ANC 
Logit(Yhjk)= β0 + δjk  + βZhjk + γThjk + (βγ)Z hjkThjk              (28)      
Logit(Yhjk)= β0 + δk + βZhk + γThk + (βγ)ZhkThk              (29)  
Logit(Yhjk)= β0 + βZhjk + γThjk + (βγ)Z hjkThjk               (30) 
Describing a sample of n units, from region k (k = 1….K), each including nk units indexed by 
district j = 1….nk, which in turn each includes n units from district j (j = 1….J), each including 
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njk units indexed by pregnant woman attending ANC h = 1…njk. Logit(Yhjk) is the likelihood 
of receiving a HIV test during ANC, weighted as per (16) for pregnant woman h, in district j, 
in region k, in treatment group Z, in time period T. δjk is a random intercept drawn for district 
j membership drawn from a normal distribution. δ𝑗𝑘~ N(0,
σ2
δ𝑗𝑘
). δk is a random intercept for 
region also drawn from a normal distribution δ𝑗~ N(0,
σ2
δ𝑗
). Zhjk is a binary variable indicating 
treatment group Z = 0,1. Thjk is a categorical variable indicating time period T = 0,1,2. ZhjkThjkα 
is an interaction of treatment and time categories.  
HIV/TB 
Logit(Yhjk)= β0 + δjk + βZhjk + γThjk + (βγ)ZhjkThjk + ehjk            (31a) 
Logit(Yhjk)= β0 + δk + βZhk + γThk + (βγ)ZhkThk + ehjk            (32a)    
Logit(Yhjk)= β0 + βZhjk + γThjk + (βγ)Z hjkThjk + ehjk            (33a) 
Logit(Yhjk)= β0 + δjk + Zhjk + Thjk + ZhjkThjk              (31b) 
Logit(Yhjk)= β0 + δk + Zhk + Thk + ZhkThk              (32b)    
Logit(Yhjk)= β0 + Zhjk + Thjk + Z hjkThjk               (33b) 
Relating to models (a):  
Describing a sample of n units, from health administrative area k (k = 1….K), each including 
nk units indexed by district j = 1….nk, which in turn each includes n units from district j (j = 
1….J), each including njk units indexed by health facility h = 1…njk. Where Yhjk is the marginal 
percentage of TB positive patients, weighted as per (16) receiving an HIV test in health 
facility h, in district j, in health administrative area k, in treatment group Z. Zhjkα is an indicator 
of treatment where Z=0,1. δk is a random intercept for health administrative area drawn from 
a normal distribution  δ𝑘~ N(0,
σ2
δ𝑘
). δjk is a random intercept for each district drawn from a 
normal distribution δ𝑗𝑘~ N(0,
σ2
δ𝑗𝑘
). ehkj is the error term. 
Relating to models (b): 
Describing a sample of n units, from health administrative area k (k = 1….K), each including 
nk units indexed by district j = 1….nk, which in turn each includes n units from district j (j = 
1….J), each including njk units indexed by health facility h = 1…njk. Where Yhjk is the binary 
estimation of the likelihood of a health facility to have >90% of HIV test results, weighted as 
per (16). Zhjkα is an indicator of treatment where Z=0,1. δk is a random intercept for health 
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administrative area drawn from a normal distribution  δ𝑘~ N(0,
σ2
δ𝑘
). δjk is a random intercept 
for each district drawn from a normal distribution δ𝑗𝑘~ N(0,
σ2
δ𝑗𝑘
).  
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